• SHOP
  • COMBOS
  • TESTIMONIALS
  • CART
  • INGREDIENTS
    • 2-DEOXY-D-GLUCOSE (2DG)
    • ACACIA CYANOPHYLLA FLOWER
    • ACORI GRAMINEI RHIZOMA
    • AEGLE MARMELOS CORREA
    • AGARICUS BLAZEI
    • AGED GARLIC EXTRACT
    • AFRAMOMUM MELEGUETA
    • ALOE ARBORESCENS
    • ALBIZIA
    • ALPINIA OFFICINARUM
    • ALTERNANTHERA SESSILIS
    • AMERICAN GINSENG
    • AMYGDALIN
    • ANACYCLUS PYRETHRUM
    • ANGELICA ARCHANGELICA
    • ANGELICA SINENSIS
    • ANTRODIA
    • ARTICHOKE LEAF
    • ARTOCARPIN
    • AJUGA TURKESTANICA
    • ASHWAGANDHA
    • ASPALATHIN
    • ASTRAGALUS COMPLANATUS
    • AVENA SATIVA
    • BACOPA MONNIERI
    • BAVACHIN
    • BEE POLLEN
    • BETULINIC ACID
    • BOSWELLIC ACID
    • BREVILIN A
    • CAMPESTEROL
    • CAPSAICIN
    • CARCININE
    • CASTICIN
    • CHRYSIN
    • CIANIDANOL
    • CINNAMOMUM ZEYLANICUM
    • CITRULLUS COLOCYNTHIS
    • CITRUS RETICULATA PEEL
    • CODONOPSIS
    • CONJUGATED LINOLEIC ACID
    • COSTUNOLIDE
    • CYANIDIN
    • CUCURBITACIN D
    • DAIDZEIN
    • DECURSIN
    • DELPHINIDIN
    • DIGITALIS PURPREA (DIGOXIN)
    • DIOSMIN
    • ECKLONIA CAVA
    • ELLAGIC ACID
    • EMBELIN
    • ERIODICTYOL
    • GALLIC ACID
    • GLYCITEIN
    • GLYCYRRHIZIN
    • HYPERFORIN
    • ICARIIN
    • ISORHAMNETIN
    • ISOORIENTIN
    • ISOVITEXIN
    • JACEOSIDIN
    • KAEMPFEROL
    • KIGELIA AFRICANA
    • KURARINONE
    • LEMON BALM
    • LICORICIDIN
    • LIPOIC ACID
    • LUPEOL
    • MAGNOLOL
    • MENAQUINONE 4
    • MULBERRY LEAF
    • NARINGENIN
    • NOBILETIN
    • OLEACEIN
    • OLEANOLIC ACID
    • OLIVE OIL
    • ORIDONIN
    • PARTHENOLIDE
    • PHLOROGLUCINOL
    • PHLORIZIN
    • PICEATANNOL
    • PRISTIMERIN
    • PROANTHOCYANIDINS
    • PROCYANIDIN B3
    • PSEUDOLARIC ACID B
    • PTEROSTILBENE
    • RUTIN
    • SOLIDAGO VIRGAUREA
    • TANGERETIN
    • TARAXASTEROL
    • TRICHOSTATIN A
    • WEDELOLACTONE
    • WOGONIN
    • YERBA MATE
  • ABOUT
  • SCIENTIFIC STUDIES
    • ADAPTOGENS
    • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
    • ADDICTION & THE BRAIN
    • ADDICTION & STRESS
    • ADDICTION WITHDRAWAL
    • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
    • ADIPOCYTE DIFFERENTIATION
    • ADROPIN
    • ALLERGIES & CYTOKINES
    • ALDOSTERONE & OBESITY/HYPERTENSION
    • ALZHEIMER’S, DEMENTIA, PARKINSON’S
    • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
    • ADVANCED GLYCATION END PRODUCTS (AGES)
    • ADDICTION TREATMENT
    • ADDICTION & DOPAMINE
    • AMPK
    • ANTI AGING
    • ANTIAGING EFFECTS OF COFFEE
    • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
    • ANTI-APOPTOTIC PATHWAYS
    • ANTI ATHEROGENIC
    • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
    • ANTI CARIOGENIC (Protecting From Tooth Decay)
    • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
    • ANTI GLYCATIVE
    • ANTI GLYCATION AGENTS
    • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
    • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
    • ANTI WRINKLE AGENTS
    • ANXIOGENIC
    • ANXIOLYTIC
    • APOPTOSIS
    • APOPTOSIS IN 3T3-L1
    • AUTOPHAGY
    • BCL-2
    • BCL-W
    • BCL-XL
    • BDNF
    • BECLIN-1 & AUTOPHAGY
    • BH3 MIMETICS
    • BIM aka BCL2L11
    • BIOMIMETIC HYDROXYAPATITE
    • BMI-1
    • BPA & OBESITY
    • BRASSINOSTEROIDS
    • CALORIE RESTRICTION
    • CALORIE RESTRICTION & LIFESPAN EXTENSION
    • CARBAMYLATION
    • CARBONYL SCAVENGER
    • CARBONYL STRESS
    • CARDIOPROTECTIVE AGENTS
    • CARDIAC GLYCOSIDES
    • CATALASE
    • CELL CYCLE ARREST
    • CENTENARIANS
    • CDK5
    • CHOLESTEROL EFFLUX
    • COGNITIVE ENHANCEMENT
    • COLD SHOCK PROTEINS
    • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
    • CONDITIONED PLACE PREFERENCE
    • CORTICOTROPIN RELEASING FACTOR
    • COSMECEUTICAL
    • CRYOTHERAPY
    • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
    • CYP2E1
    • CYTOKINES IN PAIN, INFLAMMATION & AGING
    • DAF-16
    • DEPERSONALIZATION
    • DIABETES & CANCER
    • DIHYDROTESTOSTERONE (DHT)
    • DNA METHYLATION & AGING
    • DNA REPAIR
    • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
    • DRY FASTING AND FLUID RESTRICTION FASTING
    • DYNORPHIN
    • ELLAGITANNINS
    • ENDOCRINE DISRUPTING CHEMICALS
    • ENLARGED HEART AND CARDIOMEGALY
    • EPIGENETIC ALTERATIONS
    • EPIGENETIC MODIFIERS
    • EPINEPHRINE
    • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
    • EXCITOXICITY & THE BRAIN
    • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
    • EXTRACELLULAR MICROVESICLES
    • EXTENDS LIFESPAN
    • EXTINCTION TRAINING
    • FASTING & THE BRAIN
    • FASTING & CANCER
    • FASTING MIMICKING DIET
    • FEAR EXTINCTION
    • FGF21
    • FLAVONES
    • GABA (γ-AMINOBUTYRIC ACID)
    • GALLOTANNINS
    • GLUCONEOGENESIS
    • GLUCOCORTICOID RECEPTOR ACTIVATION
    • GLUTAMATE & BRAIN
    • GLYCATION
    • GUT BRAIN AXIS
    • GYPENOSIDE
    • KLOTHO
    • K OPIOD RECEPTOR & ADDICTION
    • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
    • FGF21
    • FOXO3
    • FOXO4
    • HALLMARKS OF AGING
    • HAIR GROWTH
    • HAIR REGENERATION
    • HAIR REPIGMENTATION
    • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
    • HMGB1
    • HORMESIS
    • HPA AXIS
    • HSP70, THE ANTI-AGING PROTEIN
    • HSP90 INHIBITORS
    • HYPERGLYCEMIA
    • HYPERALGESIA
    • HYPERINSULINEMIA
    • HYPOTHALAMIC PITUITARY ADRENAL HPA AXIS
    • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
    • HYPOCRETIN OREXIN
    • IKK
    • IL-6/STAT3
    • IRISIN
    • ISOFLAVONES
    • IMMUNOSENESCENCE
    • INHIBITION OF ADVANCED GLYCATION END PRODUCTS
    • INCREASE PROTEIN SYNTHESIS
    • INCREASES SPERMATOGENESIS
    • INFECTOBESITY
    • INFLAMMATION & ANXIETY
    • INFLAMMATION & CANCER
    • INFLAMMATION & DEPRESSION
    • INFLAMMATION & OBESITY
    • INFLAMMAGING
    • INHIBITION OF RENAL GLUCOSE REABSORPTION
    • INSULIN & AGING
    • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
    • INSULIN & MTOR
    • INSULIN & OBESITY
    • INSULIN OXIDATIVE STRESS
    • INTERMITTENT FASTING
    • JAK INHIBITION ALLEVIATES SASP
    • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
    • KETONE BODIES
    • KETOGENIC DIET
    • LACTOBACILLUS REUTERI
    • LACTOFERRIN
    • LEYDIG CELL STEROIDOGENESIS
    • LIFESPAN EXTENSION
    • LIVER REGENERATION
    • LIPOLYTIC AGENTS
    • LIPID DROPLETS
    • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
    • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
    • MATRIX METALLOPROTEINASES (MMPs)
    • MCL-1
    • MDM2 INHIBITION AS SASP INHIBITOR
    • MEDICINAL MUSHROOMS
    • MEDITERRANEAN DIET
    • METABOLIC REPROGRAMMING
    • METABOLIC SYNDROME
    • METHIONINE RESTRICTION
    • MITOCHONDRIAL UNCOUPLING
    • MONKEYPOX
    • MSG (MONOSOSODIUM GLUTAMATE)
    • MUSCLE FORCE PRODUCTION
    • MUSCLE ATROPHY (PREVENTING)
    • MYOGENESIS
    • MYOSTATIN INHIBITION
    • MYOSTATIN INHIBITION PRESERVES MUSCLE
    • mTORC2
    • mTOR: THE RAPID AGING PATHWAY
    • NATURAL ANTICOAGULANTS
    • NATURAL AROMATASE INHIBITORS
    • NEUROGENESIS (GROWING NEW BRAIN CELLS)
    • NEUROCHEMISTRY OF ADDICTION
    • NEUROPLASTICITY
    • NEUROINFLAMMATION
    • NEUROPROTECTIVE AGENTS
    • NEUTRALIZING OXIDATIVE STRESS WITH MEDICINAL PLANTS
    • NMDA & ANXIETY & DEPRESSION
    • NMDA RECEPTOR & FEAR
    • NON OPIOD ANALGESICS
    • NOOTROPICS
    • NORADRENERGIC
    • NOREPINEPHRINE
    • NRF2: MASTER REGULATOR OF THE AGING PROCESS
    • NF-KB
    • NUTRACEUTICAL
    • OBESOGENS
    • ONCOGENE ACTIVATION INDUCED SENESCENCE
    • ORGANOTINS
    • OVERNUTRITION
    • OXIDATIVE STRESS & AGING
    • P16INK4A
    • P38MAPK
    • P53: TUMOR SUPRESSOR
    • PERIODONTITIS
    • PHOSPHATIDYLINOSITOL 3 KINASE
    • PHYTOCHEMICALS
    • PHYTOSTEROLS
    • PHYTOSTANOLS
    • PHYTOECDYSTEROIDS
    • PROANTHOCYANIDINS
    • PROTEIN CARBONYLATION
    • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
    • POLYPHENOLS AS COVID-19 TREATMENT & PREVENTION
    • PPARY2
    • PREMATURE SENESCENCE
    • PREVENTING SKIN AGING
    • PUFAS
    • PURGATIVES
    • RADIATION EXTRACT
    • RAPAMYCIN (MTOR INHIBITION)
    • RED WINE
    • RENAL (KIDNEY) PROTECTIVE AGENTS
    • REMINERALIZATION OF TEETH
    • REMYELINATION
    • REPAIR OF DNA BREAKS “DOUBLE STRAND”
    • RESTORE INSULIN SENSITIVITY
    • REVERSAL OF OBESITY
    • SASP & ADIPOSE TISSUE
    • SEX HORMONE BINDING GLOBULIN
    • SENESCENT CELLS, SASP & SENOLYTICS
    • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
    • SGLT2 INHIBITORS
    • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
    • SHBG
    • SIRT1
    • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
    • SKIN ELASTICITY
    • SKIN PHOTOAGING (Preventing & Repairing)
    • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
    • SIRT1 & LONGEVITY
    • SMALLPOX
    • SUGAR & AGING
    • STAR PROTEIN
    • STAT3
    • STEM CELL EXHAUSTION
    • STEM CELL REGENERATION
    • STEM CELL THERAPY
    • STIMULATED LIPOLYSYS
    • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
    • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
    • STRESS & AGING
    • STRESS & THE BRAIN
    • TELOMERE SHORTENING & PREMATURE AGING
    • TIME RESTRICTED FEEDING
    • THROMBOLYTICS (PLANT BASED)
    • TRAUMATIC BRAIN INJURY (HEALING)
    • TRYPTOPHAN HYDROXYLASE 2
    • VISCERAL ADIPOSITY
    • XENOBIOTICS
    • XENOESTROGEN
  • HOME
  • CONTACT
  • TELEGRAM PORTAL
  • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
  • The Ultimate Dry Fasting Resource
  • MY ACCOUNT
  • RESET PASSWORD
0
blank
LIVER REGENERATION
September 24, 2022
blank
LACTOBACILLUS REUTERI
September 24, 2022
  1. Biological role of lactoferrin.
  2. lactoferrin, lactoferrin receptors and iron metabolism
  3. Transferrins: insights into structure and function from studies on lactoferrin
  4. Structure of human lactoferrin at 3.2-A resolution.
  5. Identification of the bactericidal domain of lactoferrin
  6. lactoferrin in milk from different species.
  7. A bactericidal effect for human lactoferrin
  8. The involvement of lactoferrin in the hyposideremia of acute inflammation
  9. Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms
  10. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment
  11. lactoferrin and transferrin: a comparative study
  12. Structure of human lactoferrin: Crystallographic structure analysis and refinement at 2· 8 Å resolution
  13. lactoferrin, an iron-binbing protein Ni neutrophilic leukocytes
  14. lactoferrin levels in normal human tears.
  15. Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes
  16. Killing of gram-negative bacteria by lactoferrin and lysozyme.
  17. lactoferrin: a promoter of polymorphonuclear leukocyte adhesiveness
  18. lactoferrin content of peripheral blood cells
  19. Inhibition of bacteria by lactoferrin and other iron-chelating agents
  20. Association of lactoferrin with specific granules in rabbit heterophil leukocytes
  21. Inhibition of lipid peroxidation by the iron-binding protein lactoferrin
  22. Identification and characterization of the human lactoferrin-binding protein from Neisseria meningitidis
  23. lactoferrin biosynthesis during granulocytopoiesis
  24. Structural studies on bovine lactoferrin
  25. lactoferrin turnover in man.
  26. Bactericidal activity of human lactoferrin: differentiation from the stasis of iron deprivation
  27. The biological role of lactoferrin.
  28. Heat stability of bovine lactoferrin at acidic pH
  29. Thermal behavior of bovine lactoferrin in water and its relation to bacterial interaction and antibacterial activity
  30. Measurement of fecal lactoferrin as a marker of fecal leukocytes
  31. Receptor binding of lactoferrin by human monocytes
  32. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin
  33. lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo.
  34. Bactericidal activity of human lactoferrin: influence of physical conditions and metabolic state of the target microorganism
  35. Kinetic parameters for denaturation of bovine milk lactoferrin
  36. Forms of lactoferrin: their antibacterial effect on enterotoxigenic Escherichia coli
  37. Supplementation of an adapted formula with bovine lactoferrin: 1. Effect on the infant faecal flora
  38. Distribution of lactoferrin in human salivary glands
  39. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin
  40. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin
  41. Comparison of lactoferrin content in colostrum between different cattle breeds
  42. lactoferrin in plasma measured by an ELISA technique: evidence that plasma lactoferrin is an indicator of neutrophil turnover and bone marrow activity in acute …
  43. Amounts of lactoferrin in human colostrum and milk
  44. lactoferrin in human ocular tissues.
  45. lactoferrin concentration during involution of the bovine mammary gland
  46. Iron acquisition by Helicobacter pylori: importance of human lactoferrin
  47. The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei
  48. Tear lactoferrin: a bacteriostatic and complexing protein
  49. Complete nucleotide sequence of human mammary gland lactoferrin.
  50. The role of lactoferrin in the bactericidal function of polymorphonuclear leucocytes.
  51. cDNA and protein sequence of bovine lactoferrin.
  52. Comparative analysis of the transferrin and lactoferrin binding proteins in the family Neisseriaceae
  53. The isolation and bacteriostatic properties of lactoferrin from bovine milk whey
  54. lactoferrin deficiency as a consequence of a lack of specific granules in neutrophils from a patient with recurrent infections. Detection by immunoperoxidase staining …
  55. Structure, function and flexibility of human lactoferrin
  56. lactoferrin binding sites and nuclear localization in K562 (S) cells
  57. Distribution of transferrin, ferritin, and lactoferrin in human tissues.
  58. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N‐terminal region of bovine lactoferrin
  59. Bovine lactoferrin mRNA: sequence, analysis, and expression in the mammary gland
  60. lactoferrin in human milk: its role in iron absorption and protection against enteric infection in the newborn infant.
  61. The nutritional role of breast‐milk IgA and lactoferrin
  62. Characterization of lactoferrin interaction with Streptococcus mutans
  63. Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis.
  64. Fungicidal effect of human lactoferrin against Candida albicans
  65. The binding of human lactoferrin to mouse peritoneal cells.
  66. Effects of iron-saturated lactoferrin on iron absorption
  67. Inhibition of Growth of Candida albicans by Iron-Unsaturated lactoferrin: Relation to Host-Defense Mechanisms in Chronic Mucocutaneous Candidiasis
  68. Variation of lactoferrin and mastitis and their heritabilities
  69. Bacteriostatic activity of bovine milk lactoferrin against mastitic bacteria
  70. Diet and faecal flora in the newborn: lactoferrin.
  71. Iron-binding properties of bovine lactoferrin in iron-rich solution
  72. The role of lactoferrin in the nonspecific immune response on the ocular surface.
  73. Interaction of bovine lactoferrin with other proteins of milk whey
  74. Production of biologically active recombinant human lactoferrin in Aspergillus oryzae
  75. lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo.
  76. Interaction of lactoferrin and lipopolysaccharide (LPS): effects on the antioxidant property of lactoferrin and the ability of LPS to prime human neutrophils for enhanced …
  77. Nucleotide sequence of human lactoferrin cDNA.
  78. lactoferrin deficiency associated with altered granulocyte function
  79. Isolation and function of a receptor for human lactoferrin in human fetal intestinal brush-border membranes
  80. Modulation of natural killer and lymphokine‐activated killer cell cytotoxicity by lactoferrin
  81. lactoferrin stimulates colony stimulating factor production in vitro and in vivo.
  82. lactoferrin expression in the mouse reproductive tract during the natural estrous cycle: correlation with circulating estradiol and progesterone
  83. Bovine lactoferrin in involuting mammary tissue
  84. Breast milk lactoferrin levels in relation to maternal nutritional status.
  85. Bovine mammary lactoferrin: implications from messenger ribonucleic acid (mRNA) sequence and regulation contrary to other milk proteins
  86. Influence of Bovine lactoferrin on the Growth of Listeria monocytogenes
  87. Concentration of lactoferrin and transferrin throughout lactation in cow’s colostrum and milk
  88. Concentrations of lactoferrin and iron in human milk at different stages of lactation
  89. Molecular weight, single‐chain structure and amino acid composition of human lactoferrin
  90. Pathophysiology of rhinitis. lactoferrin and lysozyme in nasal secretions.
  91. The effect of trypsin on bovine transferrin and lactoferrin
  92. Multiple molecular forms of human lactoferrin. Identification of a class of lactoferrins that possess ribonuclease activity and lack iron-binding capacity.
  93. Interaction between lactoferrin and ovotransferrin and Candida cells
  94. Enhancement of resistance to bacterial infection in rainbow trout, Oncorhynchus mykiss (Walbaum), by oral administration of bovine lactoferrin
  95. Concentration of lactoferrin in milk of normal lactating cows and changes occurring during mastitis.
  96. … synthesis of polyethylene glycol-protein adducts; effects on function, receptor recognition, and clearance of superoxide dismutase, lactoferrin, and α2-macroglobulin
  97. Identification of lactoferrin as an essential growth factor for human lymphocytic cell lines in serum-free medium
  98. Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface.
  99. Killing of Actinobacillus actinomycetemcomitans by human lactoferrin
  100. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin
  101. Isolation of lactoferrin from human whey by a single chromatographic step.
  102. Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin
  103. lactoferrin-lipopolysaccharide interactions. Effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells.
  104. Inhibition by lactoferrin and κ-Casein Glycomacropeptide of Binding of Cholera Toxin to its Receptor
  105. lactoferrin and iron absorption in newborn infants
  106. The human secretory immunoglobulin system: immunohistological localization of γA, secretory” piece,” and lactoferrin in normal human tissues
  107. lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system.
  108. lactoferrin: its role as a Ga-67-binding protein in polymorphonuclear leukocytes
  109. Supplementation of an adapted formula with bovine lactoferrin. 2. Effects on serum iron, ferritin and zinc levels
  110. The non-immune inflammatory response: serial changes in plasma iron, iron-binding capacity, lactoferrin, ferritin and C-reactive protein
  111. Specific binding of lactoferrin to brush-border membrane: ontogeny and effect of glycan chain
  112. Domain closure in lactoferrin: two hinges produce a see-saw motion between alternative close-packed interfaces
  113. Ultrastructural localization of lactoferrin and myeloperoxidase in human neutrophils by immunogold
  114. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis
  115. An enzyme-linked immunoassay (ELISA) for measurement of lactoferrin
  116. Tear lactoferrin levels in patients with external inflammatory ocular disease.
  117. Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue.
  118. Plasmodium falciparum: inhibition in vitro with lactoferrin, desferriferrithiocin, and desferricrocin
  119. Metal‐Combining Properties of Human lactoferrin (Red Milk Protein) 1. The Involvement of Bicarbonate in the Reaction
  120. Association of lactoferrin with lysozyme in granules of human polymorphonuclear leukocytes
  121. Metal substitution in transferrins: the crystal structure of human copper-lactoferrin at 2.1-. ANG. resolution
  122. Preliminary observations on lactoferrin secretion in human vaginal mucus: variation during the menstrual cycle, evidence of hormonal regulation, and implications for …
  123. lactoferrin and transferrin damage of the gram-negative outer membrane is modulated by Ca2+ and Mg2+
  124. Plasma lactoferrin reflects granulocyte activation in vivo
  125. Fe-saturation and proteolysis of human lactoferrin: effect on brush-border receptor-mediated uptake of Fe and Mn
  126. Potent bactericidal activity of bovine lactoferrin hydrolysate produced by heat treatment at acidic pH
  127. Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from lactoferrin
  128. Association of lactoferrin with other proteins, as demonstrated by changes in electrophoretic mobility
  129. … Antigen (L1) in Human Peripheral Blood Leukocytes: Immunofluorescence and Immunoperoxidase Staining Features in Comparison with Lysozyme and lactoferrin
  130. Calcium-dependent polymerization of lactoferrin
  131. Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production.
  132. Human lactoferrin stimulates thymidine incorporation into DNA of rat crypt cells
  133. Specificity of the lactoferrin and transferrin receptors in Neisseria gonorrhoeae
  134. Bactericidal effect of lactoferrin on Legionella pneumophila
  135. lactoferrin in human amniotic fluid
  136. … density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of …
  137. Alterations in lactoferrin in salivary gland disease
  138. … -dependent and ascorbate-dependent formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Are lactoferrin and transferrin promoters of …
  139. Basal and reflex human tear analysis: II. Chemical analysis: lactoferrin and lysozyme
  140. Ultrastructural localisation of lactoferrin and glycoprotein in human bronchial glands.
  141. lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues.
  142. Heparin-binding properties of lactoferrin and lysozyme.
  143. Localization of lactoferrin in the male reproductive tract
  144. Lysozyme and lactoferrin quantitation in the crevicular fluid
  145. Lysozyme, lactoferrin, and secretory immunoglobulin A content in breast milk: influence of duration of lactation, nutrition status, prolactin status, and parity of mother
  146. The effect of human serum transferrin and milk lactoferrin on hydroxyl radical formation from superoxide and hydrogen peroxide.
  147. Expression of cloned human lactoferrin in baby-hamster kidney cells
  148. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn’s disease.
  149. Thermodynamics of gallium complexation by human lactoferrin
  150. lactoferrin receptors in piglet small intestine: lactoferrin binding properties, ontogeny, and regional distribution in the gastrointestinal tract
  151. Protective influence of lactoferrin on mice infected with the polycythemia-inducing strain of Friend virus complex
  152. Membrane-bound lactoferrin alters the surface properties of polymorphonuclear leukocytes.
  153. Serum myeloperoxidase and lactoferrin in neutropenia
  154. Iron uptake and increased intracellular enzyme activity follow host lactoferrin binding by Trichomonas vaginalis receptors.
  155. Isolation of lactoferrin from human milk by metal-chelate affinity chromatography
  156. The acquisition of human lactoferrin by Mycoplasma pneumoniae
  157. The developmental profile of lactoferrin in mouse epididymis
  158. Plasma myeloperoxidase and lactoferrin measured by radioimmunoassay: relations to neutrophil kinetics
  159. lactoferrin and lysozyme in carcinomas of the parotid gland
  160. Regulation of human myelopoiesis by prostaglandin E and lactoferrin
  161. The chromium, manganese, cobalt and copper complexes of human lactoferrin
  162. The effect of trypsin and chymotrypsin on the in vitro antimicrobial and iron-binding properties of lactoferrin in human milk and bovine colostrum: unusual resistance of …
  163. X-ray solution scattering reveals conformational changes upon iron uptake in lactoferrin, serum and ovo-transferrins
  164. Origin of intact lactoferrin and its DNA-binding fragments found in the urine of human milk-fed preterm infants. Evaluation by stable isotopic enrichment
  165. lactoferrin and lysozyme in milk during acute mastitis and their inhibitory effect in Delvotest P
  166. Iron availability from an infant formula supplemented with bovine lactoferrin
  167. Prooxidant activity of transferrin and lactoferrin.
  168. Isolation of bovine immunoglobulins and lactoferrin from whey proteins by gel filtration techniques
  169. lactoferrin effects on phagocytic cell function. I. Increased uptake and killing of an intracellular parasite by murine macrophages and human monocytes.
  170. Differential molecular mechanism of the estrogen action that regulates lactoferrin gene in human and mouse.
  171. Influence of lactoferrin on the entry process of Escherichia coli HB101 (pRI203) in HeLa cells
  172. The concentration of lactoferrin in tears of normals and of diabetics
  173. Identification of the transferrin-and lactoferrin-binding proteins in Haemophilus influenzae
  174. lactoferrin in the mouse uterus: analyses of the preimplantation period and regulation by ovarian steroids.
  175. Salivary lysozyme, lactoferrin and peroxidases: antibacterial effects on cariogenic bacteria and clinical applications in preventive dentistry.
  176. Isolation of lactoferrin cDNA from a human myeloid library and expression of mRNA during normal and leukemic myelopoiesis
  177. lactoferrin and lysozyme levels in synovial fluid
  178. Expression and characterization of human lactoferrin in yeast Saccharomyces cerevisiae
  179. lactoferrin binds to neutrophilic membrane DNA
  180. lactoferrin receptors in normal and leukaemic human blood cells
  181. lactoferrin-catalysed hydroxyl radical production. Additional requirement for a chelating agent
  182. Modulation of classical C3 convertase of complement by tear lactoferrin.
  183. Inhibition of Escherichia coli by bovine colostrum and post-colostral milk. II. The bacteriostatic effect of lactoferrin on a serum susceptible and serum resistant strain of …
  184. IgA, IgG, IgM and lactoferrin contents of human milk during early lactation and the effect of processing and storage
  185. Multiple forms of lactoferrin in normal and leukemic human granulocytes.
  186. Effect of lactoferrin on iron solubility under neutral conditions
  187. lactoferrin and lysozyme deficiency in airway secretions: association with the development of bronchopulmonary dysplasia
  188. Changes in lactoferrin, immunoglobulin G, bovine serum albumin, and alpha-lactalbumin during acute experimental and natural coliform mastitis in cows
  189. Polymorphism and altered methylation of the lactoferrin gene in normal leukocytes, leukemic cells, and breast cancer
  190. A solid-phase radioimmunoassay for the measurement of lactoferrin in human plasma: variations with age, sex, and disease.
  191. Immunohistologic studies of human lacrimal gland: localization of immunoglobulins, secretory component and lactoferrin
  192. One-step isolation of lactoferrin using immobilized monoclonal antibodies
  193. The human female reproductive tract: Immunohistological localization of γA, γG, γM, secretory “piece,” and lactoferrin
  194. lactoferrin gene promoter: structural integrity and nonexpression in HL60 cells
  195. lactoferrin effects of phagocytic cell function. II. The presence of iron is required for the lactoferrin molecule to stimulate intracellular killing by macrophages but not to …
  196. Effects of ionic strength and pH on the thermostability of lactoferrin
  197. Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium
  198. lactoferrin binding to human peripheral blood cells: an interaction with a B-enriched population of lymphocytes and a subpopulation of adherent mononuclear cells
  199. Isolation of a lactoferrin cDNA clone and its expression in human breast cancer
  200. Inhibition of mastitic bacteria by bovine milk apo-lactoferrin evaluated by in vitro microassay of bacterial growth
  201. Iron uptake from lactoferrin and transferrin by Neisseria gonorrhoeae
  202. Interaction of lactoferrin, monocytes, and T lymphocyte subsets in the regulation of steady-state granulopoiesis in vitro.
  203. Structure of the recombinant N-Terminal lobe of human lactoferrin at 2· 0 Å resolution
  204. Anti-oxidant activity of bovine lactoferrin on iron/ascorbate induced lipid peroxidation
  205. Expression of alpha-lactalbumin, alpha-S1-casein, and lactoferrin genes is heterogeneous in sheep and cattle mammary tissue.
  206. lactoferrin in the gingival crevice as a marker of polymorphonuclear leucocytes in periodontal diseases
  207. lactoferrin-mediated modulation of mononuclear cell activities: I. Suppression of the murine in vitro primary antibody response
  208. Spectroscopic study of bovine lactoferrin
  209. lactoferrin is a marker for prolactin response in mouse mammary explants
  210. Anion binding by human lactoferrin: results from crystallographic and physicochemical studies
  211. Clearance and binding of native and defucosylated lactoferrin
  212. Characterization of estrogen-responsive mouse lactoferrin promoter.
  213. lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending …
  214. Separation of immunoglobulins and lactoferrin from cheese whey by chelating chromatography
  215. Antibacterial prophylaxis with lactoferrin in neutropenic patients
  216. Isolation and characterization of rhesus monkey milk lactoferrin
  217. Expression of lactoferrin in human stomach
  218. Kinetic effect of human lactoferrin on the growth of Escherichia coli 0111.
  219. COUP-TF acts as a competitive repressor for estrogen receptor-mediated activation of the mouse lactoferrin gene
  220. Studies on human lactoferrin by electron paramagnetic resonance, fluorescence, and resonance Raman spectroscopy
  221. Molecular forms of lactoferrin in stool and urine from infants fed human milk
  222. Plasma lactoferrin levels in pregnancy and cystic fibrosis.
  223. The superoxide-dependent transfer of iron from ferritin to transferrin and lactoferrin
  224. Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity.
  225. Impact of proteases on iron uptake of Pseudomonas aeruginosa pyoverdin from transferrin and lactoferrin
  226. Immunohistochemical distribution of immunoglobulins, lactoferrin, and lysozyme in human minor salivary glands
  227. Plasma lactoferrin levels in newborn preterm infants: effect of infection
  228. Characterization of epithelial elements in human major salivary glands by functional markers: localization of amylase, lactoferrin, lysozyme, secretory component, and …
  229. The relationship of lactoferrin to the anemia of renal cell carcinoma
  230. Identification of a human lactoferrin-binding protein in Staphylococcus aureus
  231. lactoferrin, transferrin and acidic isoferritins: regulatory molecules with potential therapeutic value in leukemia.
  232. Uptake of lactoferrin by the liver. I. Role of the reticuloendothelial system as indicated by blockade experiments.
  233. An inducible expression system for the production of human lactoferrin in Aspergillus nidulans
  234. lactoferrin and secretory IgA in the bronchoalveolar lavage fluid from patients with a stable asthma
  235. Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation.
  236. Serum-levels of lactoferrin, lysozyme and myeloperoxidase in normal, infection-prone and leukemic children
  237. A rapid and sensitive non-competitive avidin-biotin assay for lactoferrin
  238. lactoferrin binding to neutrophilic polymorphonuclear leucocytes.
  239. Enhanced production of hydroxyl radicals by the xanthine-xanthine oxidase reaction in the presence of lactoferrin
  240. Studies of the N-terminal half of human lactoferrin produced from the cloned cDNA demonstrate that interlobe interactions modulate iron release.
  241. Isolation and characterization of opioid antagonist peptides derived from human lactoferrin
  242. lactoferrin: the role of conformational changes in its iron binding and release
  243. Metal and anion binding sites in lactoferrin and related proteins
  244. Lysozyme and lactoferrin in sputum from patients with chronic obstructive lung disease.
  245. Uptake of lactoferrin by mononuclear phagocytes inhibits their ability to form hydroxyl radical and protects them from membrane autoperoxidation.
  246. Immunocytochemical localization of lactoferrin in human neutrophils
  247. Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections
  248. Genetic evidence that Neisseria gonorrhoeae produces specific receptors for transferrin and lactoferrin
  249. Absorption of lactoferrin-iron in suckling pigs
  250. Isolation and characterization of murine lactoferrin
  251. Separation and characterization of the C-terminal half molecule of bovine lactoferrin
  252. Human lactoferrin binding to Porphyromonas gingivalis, Prevotella intermedia and Prevotella melaninogenica
  253. lactoferrin derived from neutrophils inhibits the mixed lymphocyte reaction
  254. Characterization of the human transferrin and lactoferrin receptors in Haemophilus influenzae
  255. Zinc transport by lactoferrin in human milk
  256. In vitro growth inhibition of mastitis-causing coliform bacteria by bovine apo-lactoferrin and reversal of inhibition by citrate and high concentrations of apo-lactoferin
  257. Isolation of lactoferrin and its concentration in sows’ colostrum and milk during a 21-day lactation
  258. lactoferrin, lysozyme, and β2-Microglobulin levels in cerebrospinal fluid
  259. Specificity and modulation of the action of lactoferrin, a negative feedback regulator of myelopoiesis
  260. The ingestion and digestion of human lactoferrin by mouse peritoneal macrophages and the transfer of its iron into ferritin.
  261. Binding and endocytosis of apo-and holo-lactoferrin by isolated rat hepatocytes.
  262. Interaction of lactoferrin and transferrins with the outer membrane of Bordetella pertussis
  263. lactoferrin‐mediated transfer of iron to intracellular ferritin in human monocytes
  264. Interaction of lactoferrin with Escherichia coli cells and correlation with antibacterial activity
  265. Comparative studies on the chemical and immunochemical properties of human milk, human pancreatic juice and bovine milk lactoferrin.
  266. Effect of transferrin, lactoferrin and chelated iron on human T‐lymphocytes
  267. A simple test for lacrimal gland function: a tear lactoferrin assay by radial immunodiffusion
  268. Interaction of human lactoferrin with the rat liver
  269. Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae.
  270. Two apparent molecular forms of bovine lactoferrin
  271. lactoferrin and iron absorption in the small intestine
  272. Gastric luminal digestion of lactoferrin and transferrin by preterm infants
  273. Enzyme linked immunosorbent assay for lactoferrin. Plasma and tissue measurements
  274. Regulation of colony-stimulating activity production. Interactions of fibroblasts, mononuclear phagocytes, and lactoferrin.
  275. The occurrence of immunoglobulin fragments, two types of lactoferrin and a lactoferrin-IgG2 complex in bovine colostral and milk whey
  276. Human leukocyte elastase, cathepsin G, and lactoferrin: family of neutrophil granule glycoproteins that bind to an alveolar macrophage receptor.
  277. The binding of human milk lactoferrin to immunoglobulin A
  278. Isolation and characterization of porcine milk lactoferrin.
  279. Effect of lactoferrin on the growth of a human colon adenocarcinoma cell line-comparison with transferrin
  280. lactoferrin and lysozyme in the intrahepatic bile duct of normal livers and hepatolithiasis: An immunohistochemical study
  281. Spectroscopic analysis of the unfolding of transition metal-ion complexes of human lactoferrin and transferrin.
  282. lactoferrin binding by leukemia cell lines
  283. Ability of Pseudomonas pseudomallei malleobactin to acquire transferrin-bound, lactoferrin-bound, and cell-derived iron
  284. Iron mobilisation from lactoferrin by chelators at physiological pH
  285. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
  286. Crystallographic data for human lactoferrin
  287. Stimulatory Effect of Human lactoferrin on DNA Synthesis in BALB/c 3T3 Cells
  288. lactoferrin specifically inhibits endocytosis of chylomicron remnants but not alpha-macroglobulin.
  289. A specific iron stain for iron-binding proteins in polyacrylamide gels: application to transferrin and lactoferrin
  290. Preliminary crystallographic studies on bovine lactoferrin
  291. Collaborative bacteriostatic activity of bovine lactoferrin with lysozyme against Escherichia coli O111
  292. Effect of heat treatment and other milk proteins on the interaction of lactoferrin with monocytes
  293. Structural organization of the mouse lactoferrin gene
  294. lactoferrin binds to cell membrane DNA. Association of surface DNA with an enriched population of B cells and monocytes.
  295. Identification and purification of transferrin-and lactoferrin-binding proteins of Bordetella pertussis and Bordetella bronchiseptica
  296. lactoferrin in human pancreas
  297. lactoferrin decreases monocyte-induced fibroblast production of myeloid colony-stimulating activity by suppressing monocyte release of interleukin-l
  298. Iron-binding fragments from the N-terminal and C-terminal regions of human lactoferrin
  299. Nucleotide and primary amino acid sequence of porcine lactoferrin
  300. Cloning and sequencing of the porcine lactoferrin cDNA
  301. The lactoferrin test for the diagnosis of keratoconjunctivitis sicca in clinical practice.
  302. lactoferrin binding to human platelets.
  303. Fluctuations of lactoferrin protein and messenger ribonucleic acid in the reproductive tract of the mouse during the estrous cycle
  304. Selective defect in myeloid cell lactoferrin gene expression in neutrophil specific granule deficiency.
  305. Feedback regulation of granulopoiesis: polymerization of lactoferrin abrogates its ability to inhibit CSA production
  306. Association of dry eye signs and symptoms with tear lactoferrin concentration.
  307. lactoferrin—specific localization in the nuclei of human polymorphonuclear neutrophilic leukocytes
  308. Human lactoferrin binding in clinical isolates of Staphylococcus aureus
  309. Bovine lactoferrin receptors in Staphylococcus aureus isolated from bovine mastitis
  310. Synthesis of lactoferrin and transport of transferrin in the lactating mammary gland of sheep
  311. Structural study of the sugar chains of human lactoferrin: finding of four novel complex-type asparagine-linked sugar chains
  312. lactoferrin‐an iron binding protein in synovial fluid
  313. Iron is not required in the lactoferrin stimulation of thymidine incorporation into the DNA of rat crypt enterocytes
  314. Estrogen response module of the mouse lactoferrin gene contains overlapping chicken ovalbumin upstream promoter transcription factor and estrogen receptor …
  315. Relationships between levels of lysozyme, lactoferrin, salivary peroxidase, and secretory immunoglobulin A in stimulated parotid saliva
  316. lactoferrin and IgG immunoglobulins from involuted bovine mammary glands
  317. Combined inhibitory effect of lactoferrin and lactoperoxidase system on the viability of Streptococcus mutans, serotype c
  318. An enzyme linked immunosorbent assay for measurements of lactoferrin in duodenal aspirates and other biological fluids
  319. The relations between tear fluid concentrations of lysozyme, tear-specific prealbumin and lactoferrin
  320. Suppression of mouse myelopoiesis by administration of human lactoferrin in vivo and the comparative action of human transferrin
  321. Iron retention from lactoferrin-supplemented formulas in infant rhesus monkeys
  322. lactoferrin release and interleukin-1, interleukin-6, and tumor necrosis factor production by human polymorphonuclear cells stimulated by various lipopolysaccharides …
  323. Supplementation of milk with iron bound to lactoferrin using weanling mice: L. Effects on hematology and tissue iron.
  324. Early fall of circulating iron and rapid rise of lactoferrin in septicemia and endotoxemia: an early defence mechanism
  325. Release of lactoferrin and elastase in human allergic skin reactions.
  326. lactoferrin-binding proteins in Shigella flexneri
  327. Human milk-derived lactoferrin inhibits mitogen and alloantigen induced human lymphocyte proliferation
  328. Lysozyme and lactoferrin in human maxillary sinus mucosa during chronic sinusitis
  329. Functional activities of acidic isoferritins and lactoferrin in vitro and in vivo.
  330. Immunoradiometric assay of plasma lactoferrin
  331. Bacteriostatic activity of bovine lactoferrin in mastitic milk
  332. lactoferrin from human breast milk and from neutrophil granulocytes. Comparative studies of isolation, quantitation, characterization and iron binding properties
  333. Binding of lactoferrin and transferrin to the human promonocytic cell line U937. Effect on iron uptake and release.
  334. Neutrophil lactoferrin content in viral infections
  335. Small molecule analogs for the specific iron-binding site of lactoferrin: a single-crystal x-ray structure of bis (methanol) bis [2-(5-methylpyrazol-3-yl) phenolato] iron (III) …
  336. The purification of lactoferrin from human whey by batch extraction
  337. lactoferrin in relation to acute phase proteins in sera from newborn infants with severe infections
  338. lactoferrin and albumin in human pancreatic juice
  339. Oxygen radical-induced erythrocyte hemolysis by neutrophils. Critical role of iron and lactoferrin.
  340. Myeloperoxidase and lactoferrin of blood neutrophils and plasma in chronic granulocytic leukaemia
  341. Inhibition of hemolytic complement activity by lactoferrin in tears
  342. Regions located in both the N-lobe and C-lobe of human lactoferrin participate in the binding interaction with bacterial lactoferrin receptors
  343. Neutropenia induced by systemic infusion of lactoferrin
  344. Radioimmunoassay of lactoferrin in pancreatic juice as a test for pancreatic diseases
  345. Metal‐Combining Properties of Human lactoferrin: The Effect of Nitration of lactoferrin with Tetranitromethane
  346. In vitro and in vivo (LD50) effects of human lactoferrin on bacteria.
  347. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
  348. The biological significance of the non-immunoglobulin protective proteins in milk: lysozyme, lactoferrin, lactoperoxidase
  349. lactoferrin in benign hypertrophy and carcinomas of the prostatic gland
  350. Fate of human lactoferrin and myeloperoxidase in phagocytizing human neutrophils: effects of immunoglobulin G subclasses and immune complexes coated on latex …
  351. … iron in knee-joint synovial fluid from arthritic patients and its relationship to the extracellular antioxidant activities of caeruloplasmin, transferrin and lactoferrin
  352. Gel electrophoresis of human tears reveals various forms of tear lactoferrin
  353. … -in the Epithelium of Normal and Inflamed Gastric Mucosa: Immunohistochemical Localization of Immunoglobulins, Secretory Component, Lysozyme, and lactoferrin
  354. Correlations between human salivary levels of lysozyme, lactoferrin, salivary peroxidase and secretory immunoglobulin A with different stimulatory states and over …
  355. lactoferrin binding molecules in human seminal plasma
  356. Affinities of Treponema pallidum for human lactoferrin and transferrin.
  357. lactoferrin, lysozyme, and beta 2-microglobulin in cerebrospinal fluid. Elevated levels in patients with acute cerebrovascular lesions as indices of inflammation.
  358. Glandular secretion of lactoferrin in a patient with neutrophil lactoferrin deficiency
  359. Regulation of granulopoiesis: the lactoferrin controversy
  360. In vitro studies of lactoferrin and murine granulopoiesis
  361. The resistance of transferrin, lactoferrin and caeruloplasmin to oxidative damage.
  362. Sequential purification of lactoferrin, lysozyme and secretory immunoglobulin A from human milk
  363. Changes in lactoferrin and other proteins in a case of chronic recurrent parotitis
  364. The effect of bovine lactoferrin on muscle growth in vivo and in vitro
  365. Immunohistochemical localization of lactoferrin in bovine exocrine glands
  366. Neutrophilic granulocytes in acute bacterial infection. Sequential studies on lysozyme, myeloperoxidase and lactoferrin.
  367. lactoferrin, anti-lactoferrin antibodies and inflammatory disease
  368. Development and evaluation of luminescence‐based sandwich assay for plasma lactoferrin as a marker for sepsis and bacterial infections in paediatric medicine
  369. Relationship of plasma lactoferrin content to neutrophil regeneration and bone marrow infusion
  370. Spectroscopic studies on copper (II) complexes of human lactoferrin
  371. Turnover of human lactoferrin in the rabbit
  372. Cross-reactivity and sequence homology between the 65-kilodalton mycobacterial heat shock protein and human lactoferrin, transferrin, and DR beta subsets of major …
  373. High‐Resolution Localization of lactoferrin in Human Neutrophils: Labeling of Secondary Granules and Cell Heterogeneity
  374. The molecular weight of bovine lactoferrin
  375. Concentrations of thiocyanate, hypothiocyanite,’free’and ‘total’lysozyme, lactoferrin and secretory lgA in resting and stimulated whole saliva of children aged 12–14 …
  376. Trypsin and lactoferrin levels in pure pancreatic juice in patients with pancreatic disease.
  377. lactoferrin in aspirates of odontogenic cyst fluid.
  378. Plasma lactoferrin and neutrophil elastase in rheumatoid arthritis and systemic lupus erythematosus
  379. Cytidine deaminase activity in synovial fluid of patients with rheumatoid arthritis: relation to lactoferrin, acidosis, and cartilage proteoglycan release.
  380. The adsorption from solutions of β-lactoglobulin mixed with lactoferrin or lysozyme onto silica and methylated silica surfaces
  381. Normal distribution of lysozyme-and lactoferrin-secreting cells in the chinchilla tubotympanum
  382. Binding of bovine lactoferrin to Streptococcus agalactiae
  383. Immunohistologic localization of immunoglobulins, secretory component, and lactoferrin in the developing human fetus
  384. Amino acid sequence of cysteic peptides of lactoferrin and demonstration of similarities between lactoferrin and transferrin
  385. lactoferrin catabolism in the rat liver
  386. lactoferrin and serum albumin of human casein in colostrum and milk
  387. lactoferrin in rabbit bile: its relation to iron metabolism
  388. lactoferrin interacts with deoxyribonucleic acid: a preferential reactivity with double-stranded DNA and dissociation of DNA-anti-DNA complexes
  389. Breast‐milk IgA and lactoferrin survival in the gastrointestinal tract–a study in rural Gambian children
  390. Preparation of lactoferrin by hydrophobic interaction chromatography from milk acid whey
  391. Interaction of calmodulin with lactoferrin
  392. Binding and ingestion of human lactoferrin by mouse alveolar macrophages.
  393. Intracellular lysozyme and lactoferrin in myeloproliferative disorders.
  394. Mycobacteria and human autoimmune disease: direct evidence of cross-reactivity between human lactoferrin and the 65-kilodalton protein of tubercle and leprosy …
  395. Immunohistochemical demonstration of lactoferrin in follicular adenomas and thyroid carcinomas
  396. Correlation between human lactoferrin binding and colicin susceptibility in Escherichia coli
  397. Luminal digestion of lactoferrin in suckling and weanling rats
  398. The isolation and characterization of lactoferrin from sow milk and boar seminal plasma
  399. Release of iron from phagocytosed Escherichia coli and uptake by neutrophil lactoferrin
  400. Uptake and handling of iron from transferrin, lactoferrin and immune complexes by a macrophage cell line
  401. lactoferrin: nuclear localization in the human neutrophilic granulocyte?
  402. lactoferrin‐binding sites at the surface of HT29‐D4 cells: Comparison with transferrin
  403. lactoferrin: Its Role as a Regulator of Human Granulopoiesis?a
  404. lactoferrin conformation and metal binding properties
  405. Failure of rabbit reticulocytes to incorporate conalbumin or lactoferrin iron
  406. Uptake and re-secretion of human lactoferrin by B lymphocytes
  407. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.
  408. lactoferrin concentration in human parotid saliva as measured by an enzyme-linked immunosorbent assay (ELISA)
  409. Relationships between iron and vanadium metabolism: the association of vanadium with bovine lactoferrin
  410. Purification and characterization of intact lactoferrin found in the urine of human milk-fed preterm infants.
  411. Neutrophil lactoferrin content: Variation among mammals
  412. Immunological studies of lactoferrin in human placentae
  413. Enzyme immunoassay of lactoferrin in newborn term infants: reference values and influence of diet
  414. Bacteriostasis of Escherichia coli by bovine lactoferrin, transferrin and immunoglobulins (IgG1, IgG2, IgM) acting alone or in combination
  415. Immunoglobulins, lysozyme and lactoferrin in the teat and udder of the dry cow during endotoxin‐induced inflammation
  416. Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin.
  417. Tear lysozyme and lactoferrin levels in giant papillary conjunctivitis and vernal conjunctivitis.
  418. Electrophoretic comparisons of lactoferrin from bovine mammary secretions, milk neutrophils, and human milk
  419. An enzyme-linked immunosorbent assay for plasma-lactoferrin. Concentrations in 362 healthy, adult blood donors
  420. Immunocytochemical detection of lactoferrin in human gastric carcinomas and adenomas.
  421. Distribution of lactoferrin in the normal and inflamed human prostate: an immunohistochemical study
  422. Diminished release of lactoferrin from polymorphonuclear leukocytes of human neonates
  423. Plasma lactoferrin Measured by an Enzyme‐Linked Immunosorbent Assay (ELISA) Measurements on Adult and Infant Plasma
  424. Purification of transferrins and lactoferrin using DEAE affi-gel blue.
  425. Regulation of human bone marrow lactoferrin and myeloperoxidase gene expression by tumor necrosis factor-alpha.
  426. Iron uptake from transferrin and lactoferrin by rat intestinal brush-border membrane vesicles
  427. Comparison of the electron spin echo envelope modulation (ESEEM) for human lactoferrin and transferrin complexes of copper (II) and vanadyl ion
  428. Serum lactoferrin in leukaemia and polycythaemia vera
  429. … of the chylomicron‐remnant‐recognition sites on parenchymal and Kupffer cells of rat liver Selective inhibition of parenchymal cell recognition by lactoferrin
  430. Microfiltration affinity purification of lactoferrin and immunoglobulin G from cheese whey
  431. lactoferrin in pure pancreatic juice in chronic pancreatitis.
  432. Plasma and serum lactoferrin levels in cystic fibrosis. Relationship with the presence of cystic fibrosis protein
  433. Neutrophil degranulation inhibits potential hydroxyl-radical formation. Relative impact of myeloperoxidase and lactoferrin release on hydroxyl-radical production by …
  434. Ovine lactoferrin: isolation from colostrum and characterization
  435. Combined Bactericidal Effect of Human lactoferrin and Lysozyme Against Streptococcus mutans serotype c
  436. Development of secretory elements in murine tubotympanum: lysozyme and lactoferrin immunohistochemistry
  437. lactoferrin in the duodenal juice of patients with chronic calcifying pancreatitis
  438. … Mannoprotein Fraction from Candida albicans that Enhances Human Polymorphonuclear Leukocyte (PMNL) Functions and Stimulates lactoferrin in PMNL Inhibition …
  439. Enzyme-linked immunosorbent assays of bovine lactoferrin and a 39-kilodalton protein found in mammary secretions during involution
  440. Demonstration of lactoferrin in tumor tissue from two patients with positive gallium scans
  441. Uptake of lactoferrin by the liver. III. Critical role of the protein moiety.
  442. Plasma lactoferrin in patients with neutropenia
  443. lactoferrin and lysozyme in arthritic exudates
  444. Plasma lactoferrin levels in leukaemias
  445. lactoferrin binding to its intestinal receptor
  446. In vitro culture of cryopreserved bovine mammary cells on collagen gels: synthesis and secretion of casein and lactoferrin
  447. Influence of milk proteins on lipid oxidation in aqueous emulsion: II. Lactoperoxidase, lactoferrin, superoxide dismutase and xanthine oxidase
  448. The effect of lactoferrin, an iron-binding protein on complement activity
  449. Diagnosis of chronic pancreatitis by measurement of lactoferrin in duodenal juice.
  450. Impaired receptor binding and decrease in isoelectric point of lactoferrin after interaction with human monocytes
  451. lactoferrin‐inducible monocyte cytotoxicity for K562 cells and decay of natural killer lymphocyte cytotoxicity
  452. Activation of human neutrophils by phorbol ester decreases the cytoplasm compactness and the lactoferrin content of the granulocytes
  453. lactoferrin acts on Ia-like antigen-positive subpopulations of human monocytes to inhibit production of colony stimulatory activity in vitro.
  454. lactoferrin in human prostate tissue
  455. Purification and characterization of bovine lactoferrin from secretions of the involuting mammary gland: identification of multiple molecular weight forms.
  456. Bovine lactoferrin binding to six species of coagulase-negative staphylococci isolated from bovine intramammary infections
  457. Immunohistological localization of γG, γA, γM secretory piece and lactoferrin in the human female genital tract
  458. lactoferrin: affinity purification from human milk and polymorphonuclear neutrophils using monoclonal antibody (II 2C) to human lactoferrin, development of an …
  459. Relative ratios of lactoferrin, albumin, and acid phosphatase seminal levels as sperm quality markers in fertile and infertile men
  460. Salivary lactoferrin in primary Sjögren’s syndrome.
  461. lactoferrin activates plasma membrane oxidase and Na+ H+ antiport activity
  462. Relationships between human parotid saliva lysozyme lactoferrin, salivary peroxidase and secretory immunoglobulin A in a large sample population
  463. Effects of lactoferrin on human granulopoiesis in vitro.
  464. lactoferrin inhibits prostaglandin E2 secretion by breast milk macrophages
  465. Isolation and partial characterization of ovine lactoferrin
  466. Uptake of lactoferrin by the liver. II. Endocytosis by sinusoidal cells.
  467. A monoclonal antibody-based immunoassay for human lactoferrin
  468. The latency of serum acute phase proteins in meningococcal septicemia, with special emphasis on lactoferrin
  469. lactoferrin, a protein of human pancreatic external secretion
  470. Clinical significance of antineutrophil cytoplasmic autoantibodies with specificity for lactoferrin in renal diseases
  471. The N-linked oligosaccharides of human lactoferrin are not required for binding to bacterial lactoferrin receptors
  472. The effect of digestive enzymes on the binding and bacteriostatic properties of lactoferrin and vitamin B12 binder in human milk
  473. A subpopulation of human polymorphonuclear neutrophils contains an active form of lactoferrin capable of binding to human monocytes and inhibiting production of …
  474. Biosynthesis and processing of lactoferrin in bone marrow cells, a comparison with processing of myeloperoxidase
  475. Specific binding of lactoferrin to Aeromonas hydrophila
  476. Abnormal distribution of complex carbohydrates in neutrophils of a patient with lactoferrin deficiency
  477. Identification and comparative analysis of the lactoferrin and transferrin receptors among clinical isolates of gonococci
  478. Anti-bovineβ-lactoglobulin antibodies react with a human lactoferrin fragment and bovineβ-lactoglobulin present in human milk
  479. lactoferrin acts on IA and IE/C antigen+ subpopulations of mouse peritoneal macrophages in the absence of T lymphocytes and other cell types to inhibit production of …
  480. Role of antibody and enterobactin in controlling growth of Escherichia coli in human milk and acquisition of lactoferrin-and transferrin-bound iron by Escherichia coli
  481. Protein concentrations in sputa from asthmatic children: albumin, lactoferrin, γA and γG
  482. Human lactoferrin supplementation of infant formulas increases thymidine incorporation into the DNA of rat crypt cells.
  483. Characterization of an additional protein in pancreatic juice of men with chronic calcifying pancreatitis Identification to lactoferrin
  484. Quantitation of lactoferrin in odontogenic cyst fluids.
  485. Effects of ultrasonic homogenization of human milk on lipolysis, IgA, IgG, lactoferrin and bacterial content
  486. Interaction of human lactoferrin with DNA: one-step purification by affinity chromatography on single-stranded DNAagarose
  487. Plasma lactoferrin as a marker of infection in elderly individuals
  488. The concentration of lactoferrin in tears during post‐operative ocular inflammation
  489. lactoferrin uptake and iron processing into macrophages: a study in familial haemochromatosis
  490. Unfolding of iron and copper complexes of human lactoferrin and transferrin.
  491. Salivary lactoferrin in a selected group of subjects with exceptional extrinsic dental staining
  492. Isolation and characterisation of lactoferrin separated from human whey by adsorption chromatography using Cibacron Blue F3G-A linked affinity adsorbent
  493. Serum and plasma myeloperoxidase, elastase and lactoferrin content in acute myeloid leukaemia
  494. A non competitive enzyme immunoassay of human lactoferrin in biological fluids
  495. Bacterial-lipopolysaccharide-induced release of lactoferrin from human polymorphonuclear leukocytes: role of monocyte-derived tumor necrosis factor alpha
  496. Localization of lactoferrin and nonspecific cross‐reacting antigen in human breast carcinomas. An immunohistochemical study using the Avidin—biotin—peroxidase …
  497. lactoferrin binding properties of Vibrio cholerae.
  498. Iron‐saturated lactoferrin as a comitogenic substance for neonatal rat hepatocytes in primary culture
  499. Serum lactoferrin in lepromatous leprosy patients.
  500. Distribution of lactoferrin in human fetal tissues
  501. Specificity of lactoferrin as an inhibitor of granulocyte-macrophage colony-stimulating activity production from fetal mouse liver cells
  502. Relationship between N-acetyl-β-D-glucosaminidase activity and cell count, lactose, chloride, or lactoferrin in cow milk
  503. Structurally intact (78-kDa) forms of maternal lactoferrin purified from urine of preterm infants fed human milk: identification of a trypsin-like proteolytic cleavage event …
  504. Transcriptional regulation of two myeloid-specific genes, myeloperoxidase and lactoferrin, during differentiation of the murine cell line 32D C13
  505. Metal‐Combining Properties of Human lactoferrin: The Possible Involvement of Tyrosyl Residues in the Binding Sites. Spectrophotometric Titration
  506. Hemodialysis-induced increase in serum lactoferrin and serum eosinophil cationic protein as signs of local neutrophil and eosinophil degranulation
  507. Rapid radiometric assay used to assess lactoferrin in granulocytes.
  508. Removal of 14 N-terminal amino acids of lactoferrin enhances its affinity for parenchymal liver cells and potentiates the inhibition of beta-very low density …
  509. lactoferrin in human neutrophilic polymorphonuclear leukocytes in relation to iron metabolism
  510. Plasma lactoferrin reflects granulocyte activation via complement in burn patients
  511. lactoferrin, a major soluble protein of bovine oestrous cervical mucus
  512. Characterization of lactoferrin binding by Aeromonas hydrophila
  513. Effect of the progesterone-inducible proteins human lactoferrin and chicken avidin on lymphocyte proliferation
  514. Release of lactoferrin by polymorphonuclear leukocytes after aerosol challenge with Escherichia coli
  515. Evidence for the presence of lactoferrin in odontogenic keratocyst fluids.
  516. Augmented release of human leucocyte lactoferrin (and elastase) during coagulation.
  517. Preliminary crystallographic studies of copper (II)-and oxalate-substituted human lactoferrin
  518. Immunocytochemical and enzymecytochemical studies on the intracellular transport mechanism of secretory immunoglobulin A and lactoferrin in human salivary …
  519. Inhibition of histamine release in vitro by a blocking factor from human serum: comparison with the iron binding proteins transferrin and lactoferrin
  520. lactoferrin interferes with uptake of iron from transferrin and asialotransferrin by the rat liver
  521. The effect of lactoferrin on complement mediated modulation of immune complex size
  522. Immuno‐electron microscopic tracing of lactoferrin, a regulator of myelopoiesis, into a subpopulation of human peripheral blood monocytes
  523. Ultrastructural localization of lactoferrin in the granules other than typical secondary granules of human neutrophils.
  524. A tentative method for rapid preparation of iron-saturated lactoferrin by affinity chromatography
  525. lactoferrin inducible monocyte cytotoxicity defective in esterase deficient monocytes
  526. Use of light microscopic immunotechniques in selecting preparation conditions and immunoprobes for ultrastructural immunolabelling of lactoferrin
  527. Influence of T-lymphocytes and lactoferrin on the survival-promoting effects of IL-1 and IL-6 on human bone marrow granulocyte-macrophage and erythroid progenitor …
  528. Different segmental flexibility of human serum transferrin and lactoferrin
  529. Distribution and subcellular localization of lactoferrin in human tissues with special reference to the submandibular gland
  530. Ferritin-dependent lipid peroxidation by stimulated neutrophils: inhibition by myeloperoxidase-derived hypochlorous acid but not by endogenous lactoferrin
  531. Serological and fluorescence studies of the heat stability of bovine lactoferrin
  532. Absence of the largest platelet-von Willebrand multimers in a patient with lactoferrin deficiency and a bleeding tendency
  533. Flow cytometric analysis of intracellular myeloperoxidase and lactoferrin in leukemia diagnosis
  534. Ultrastructural localization of lactoferrin and iron-binding protein in human neutrophils and rabbit heterophils.
  535. Detection of bacterial interaction with lactoferrin by an enzyme-linked ligand binding assay (ELBA)
  536. Serum lactoferrin and C-reactive protein in mother and newborn after preterm rupture of membranes
  537. 67Ga-transferrin and 67Ga-lactoferrin binding to tumor cells: Specific versus nonspecific glycoprotein-cell interaction
  538. Endocytosis and degradation of bovine apo-and holo-lactoferrin by isolated rat hepatocytes are mediated by recycling calcium-dependent binding sites
  539. Metal ligand-induced alterations in the surface structures of lactoferrin and transferrin probed by interaction with immobilized copper (II) ions
  540. Electron spin echo envelope modulation evidence for carbonate binding to iron (III) and copper (II) transferrin and lactoferrin.
  541. Recent knowledge of the structure and function of lactoferrin and ferritin
  542. lactoferrin in the myeloproliferative disorders: a search for granulopoietic regulator defects
  543. Anomalous neutrophil granule distribution in a patient with lactoferrin deficiency: pertinence to the respiratory burst
  544. Rapid purification of porcine colostral whey lactoferrin by affinity chromatography on single-stranded DNA-agarose. Characterization, amino acid composition and N …
  545. Influence of apo‐and iron‐saturated lactoferrin and transferrin, immunoglobulin G and serum albumin on proliferation of bovine peripheral blood mononuclear cells
  546. Electroimmunodiffusion on cellulose acetate: a rapid method for analysis of bovine lactoferrin in chromatography effluents
  547. … studies of obstructive adenitis in human submandibular salivary glands. I. Immunohistochemical demonstration of lactoferrin, lysozyme and carcinoembryonic antigen
  548. Evidence for a different mechanism of lactoferrin and transferrin translocation on HT 29-D4 cells
  549. Agglutination of Streptococcus mutans serotype C cells but inhibition of Porphyromonas gingivalis autoaggregation by human lactoferrin
  550. Stimulation of reduced lysozyme regeneration by transferrin and lactoferrin
  551. lactoferrin Triggers In Vitro Proliferation of T Cells of Lewis Rats Submitted to Mycobacteria‐Induced Adjuvant Arthritis
  552. Simultaneous calcium‐dependent delivery of neutrophil lactoferrin and reactive oxygen metabolites to erythrocyte targets: Evidence supporting granule‐dependent …
  553. Interacting properties of bovine lactoferrin with immobilized Cibacron blue F3GA in column chromatography
  554. Effect of fixation on the antigenicity of human lactoferrin in paraffin-embedded tissues and cytocentrifuged cell smears
  555. Elevated serum levels of lactoferrin and eosinophil cationic protein in schizophrenic patients
  556. lactoferrin in rheumatoid arthritis and systemic lupus erythematous.
  557. Immunological identification of lactoferrin as a shared antigen on radioiodinated human sperm surface and in radioiodinated human seminal plasma
  558. Comparison between lactoferrin and subepithelial matrix protein binding in Staphylococcus aureus associated with bovine mastitis
  559. Enzyme immunoassay of bovine lactoferrin and serum albumin in acid precipitated and ultracentrifugal wheys
  560. The denaturation of lactoferrin and transferrin by urea
  561. The relative stabilities of 67Ga complexes lactoferrin and transferrin at various pH’s
  562. lactoferrin in pure pancreatic juice
  563. lactoferrin as an indicator of septicemia and endotoxemia in pigs
  564. Stimulation of superoxide and lactoferrin release from polymorphonuclear leukocytes by the type 2 fimbrial lectin of Actinomyces viscosus T14V
  565. lactoferrin binding to peripheral human leukocytes
  566. Immunomodulatory and anti-oxidant effects of bovine lactoferrin in man
  567. lactoferrin stimulates the production of leucocyte migration inhibitory factor by human peripheral mononuclear leucocytes.
  568. Plasma lactoferrin reflects neutrophil activation in psoriasis
  569. Small molecule analogues for the specific metal-binding site of lactoferrin. Part 2. Phenolato-complexes of copper (II) and the nature of the charge-transfer transition in …
  570. The nutritive value of bovine lactoferrin
  571. ANCA with specificity for lactoferrin in systemic lupus erythematosus (SLE)
  572. Nitric oxide interaction with lactoferrin and its production by macrophage cells studied by EPR and spin trapping
  573. Effects of purified iron-saturated human lactoferrin on spleen morphology in mice infected with Friend virus complex.
  574. The association of Ga-67 and lactoferrin
  575. A siderophore production mutant of Bordetella bronchiseptica cannot use lactoferrin as an iron source
  576. Homogeneous immunochemical technique for determination of human lactoferrin using excitation transfer and phase-resolved fluorometry
  577. lactoferrin concentration in the parotid saliva of patients with chronic pancreatitis
  578. Synergistic effect of human lactoferrin and recombinant murine interferon-gamma on disease progression in mice infected with the polycythemia-inducing strain of the …
  579. Preliminary crystallographic studies of the amino terminal half of human lactoferrin in its iron-saturated and iron-free forms
  580. Oxidative radioiodination damage to human lactoferrin
  581. The role of lactoferrin released by phagocytosing neutrophils in the regulation of colony-stimulating activity production by human mononuclear cells.
  582. Abnormalities in myelopoietic regulatory interactions with acidic isoferritins and lactoferrin in mice infected with Friend virus complex: association with altered …
  583. Plasma lactoferrin content in pregnancy.
  584. Stimulation of proliferation and immunoglobulin M production by lactoferrin in human-human and mouse-mouse hybridomas cultures in serum-free conditions
  585. Susceptibilities of lactoferrin and transferrin to myeloperoxidase-dependent loss of iron-binding capacity
  586. The diagnostic value of salivary fluid levels of β2-microglubulin, lysozyme and lactoferrin for primary Sjögren’s synrome
  587. The production of tumour necrosis factor, tissue thromboplastin, lactoferrin and cathepsin C during lipopolysaccharide stimulation in whole blood
  588. An immunohistochemical study of the distribution of lysozyme, lactoferrin, α1-antitrypsin and α1-antichymotrypsin in salivary adenoid cystic carcinoma
  589. Monoclonal antibody (II2C) to human lactoferrin inactivates the myelopoietic suppressive effect of human lactoferrin in vitro.
  590. lactoferrin, C‐reactive Protein, α‐1‐Antitrypsin and Immunoglobulin GA in Cerebrospinal Fluid in Meningitis
  591. Immunocytochemical localization of lactoferrin in human pancreas.
  592. Immunohistochemical distribution of ferritin, lactoferrin, and transferrin in granulomas of bovine paratuberculosis
  593. Iron-binding proteins in the human vitreous: lactoferrin and transferrin in health and in proliferative intraocular disorders
  594. Serum and plasma measurements of neutrophil granule proteins during cardiopulmonary bypass: a model to estimate human turnover of lactoferrin and …
  595. A hemagglutination-inhibition immunoassay for lactoferrin
  596. lactoferrin secretion in alcoholic pancreatic disease
  597. Radioimmunoassay for murine lactoferrin, a protein marker of myeloid and mammary epithelial secretory cell differentiation
  598. The distribution of ferritin, lactoferrin and transferrin in granulomatous lymphadenitis of bovine paratuberculosis
  599. Low pH binding of vanadyl to bovine lactoferrin: Electron spin resonance studies
  600. lactoferrin: no evidence for its role in regulation of CSA production by human lymphocytes and monocytes.
  601. Immunohistochemical investigation of lysozyme, lactoferrin, α1‐antitrypsin, α1‐antichymotrypsin and ferritin in parotid gland tumors
  602. Nuclear localization of lactoferrin in the human granulocyte: Artifact incurred during slide preparation.
  603. Binding of collagen, fibronectin, lactoferrin, laminin, vitronectin and heparan sulphate to Staphylococcus aureus strain V8 at various growth phases and under nutrient …
  604. Selectively aspirated pure pancreatic secretion. Viscosity, trypsin activity, protein concentration and lactoferrin content of pancreatic juice in chronic pancreatitis.
  605. … of acidic isoferritins that suppress hematopoietic progenitor cells is induced by purified L cell colony stimulating factor and suppressed by human lactoferrin.
  606. Plasma lactoferrin content: differential effect of steroid administration and infective illnesses: lack of effect of ambient temperature at which specimens are collected
  607. The fractionation and characterization of bovine tear proteins, especially lactoferrin
  608. lactoferrin in cervical mucus of patients with chorioamnionitis
  609. Enzyme-immunoassay (ELISA) using IgY antibodies against lactoferrin.
  610. Supplementation of milk with iron bound to lactoferrin using weanling mice. II: Effects on tissue manganese, zinc, and copper.
  611. Myeloperoxidase, lactoferrin and elastase in bronchoalveolar lavage and plasma in pneumonia
  612. Inhibition of colony-stimulating factor (CSF) production by postburn serum: Negative feedback inhibition mediated by lactoferrin.
  613. lactoferrin-deficient neutrophil polymorphonuclear leucocytes in leukaemias: a semiquantitative and ultrastructural cytochemical study.
  614. lactoferrin-mediated formation of oxygen radicals by NADPH-cytochrome P-450 reductase system
  615. Immunohistochemical demonstration of lysozyme and lactoferrin in salivary pleomorphic adenomas
  616. NEUTROPHIL PHAGOCYTOSIS OF TREPONEMA DENTICOLA AS INDICATED BY EXTRACELLULAR RELEASE OF lactoferrin
  617. Immunohistochemical demonstration of ceruloplasmin and lactoferrin in a series of 59 thyroid tumors
  618. Myeloid regeneration after bone‐marrow transplantation monitored by serum measurements of my eloper oxidase, lysozyme and lactoferrin
  619. Secretory component and lactoferrin in pure pancreatic juice in chronic pancreatitis
  620. Immunohistochemical detection of lactoferrin in different human glandular tissues with special reference to the exocrine pancreas
  621. lactoferrin levels and unsaturated iron-binding capacity in colostrum of Brazilian women of two socioeconomic levels.
  622. … significance of serum measurements of lactoferrin, lysozyme and myeloperoxidase in acute myeloid leukemia (AML): Recognition of a new variant, high‐lactoferrin …
  623. Early response in neonatal septicemia. The effect of Escherichia coli, Streptococcus agalactiae and tumor necrosis factor on the generation of lactoferrin
  624. Levels of salivary lysozyme, lactoperoxidase, and lactoferrin in diabetic hamsters
  625. Heterogeneity of human lactoferrin due to differences in sialic acid content
  626. Duodenal lactoferrin in patients with chronic pancreatitis and gastrointestinal diseases
  627. Modulation of Friend virus infectivity in vivo by administration of purified preparations of human lactoferrin and recombinant murine interleukin-3 to mice.
  628. Cross-reaction of antibodies to human lactoferrin with HBAg.
  629. [27] Cell culture assay of biological activity of lactoferrin and transferrin
  630. Cytidine deaminase and lactoferrin in inflammatory synovial fluids. Indicators of local polymorphonuclear cell function?
  631. Relative value of oestrogen receptor assay, lactoferrin content, and glucose-6-phosphate dehydrogenase activity as prognostic indicators in primary breast cancer
  632. Interleukin 1-induced depression of iron and zinc: role of granulocytes and lactoferrin
  633. Thermal destruction of immunoglobulin A, lactoferrin, thiamin and folic acid in human milk
  634. Genetic aspects of the bacteriostatic acting whey proteins lactoferrin and lysozyme.
  635. Guinea pig tears contain lactoferrin and transferrin
  636. Assessment of total immunoreactive lactoferrin in hematopoietic cells using flow cytometry
  637. Augmentation of human monocyte chemiluminescence by iron-saturated lactoferrin
  638. lactoferrin, myeloperoxidase, lysozyme and eosinophil cationic protein in exudate in delayed type hypersensitivity
  639. lactoferrin effects on the interaction of blood forms of Trypanosoma cruzi with mononuclear phagocytes
  640. Preparation and characterization of monoclonal antibodies to human neutrophil cathepsin G, lactoferrin, eosinophil peroxidase, and eosinophil major basic protein
  641. Immunoreactive lactoferrin in resting, activated, and neoplastic lymphocytes
  642. lactoferrin in middle ear effusion
  643. Method for thermally treating lactoferrin.
  644. Decrease of lactoferrin concentration in the tears of myotonic muscular dystrophy patients
  645. Salivary secretion in chronic pancreatitis with special reference to albumin and lactoferrin
  646. Protective effect of lactoferrin during a systemic experimental infection of rabbits with Escherichia coli
  647. Rabbit plasma iron level after in vivo administration of lactoferrin
  648. … of salivary gland origin: immunohistochemical evaluation of filament proteins, S-100 α and β, glial fibrillary acidic proteins, neuron-specific enolase, and lactoferrin
  649. Susceptibility of bovine lactoferrin to plasmin and chymosin
  650. Granulocyte oxygen radicals as potential suppressors of hemopoiesis: potentiating roles of lactoferrin and elastase; inhibitory role of oxygen radical scavengers.
  651. … of affinity-purified lactoferrin from neutrophils of patients with chronic myelogenous leukemia, and lactoferrin/H-ferritin-cell interactions in a patient with lactoferrin …
  652. Cofactor requirements for expression of lactoferrin bactericidal activity on enteric bacteria
  653. Lack of correlation between iron stores and plasma lactoferrin concentration
  654. Gamma interferon induces colony-forming cells of the human monoblast cell line U937 to respond to inhibition by lactoferrin, transferrin, and acidic isoferritins.
  655. In vitro antimicrobial activities of lactoferrin, its concomitant use with cefpodoxime proxetil and clinical effect of cefpodoxime proxetil
  656. Iron binding to human lactoferrin alters reactivity of the protein with plant lectins
  657. lactoferrin and C-reactive protein in response to cytostatic drugs with emphasis on methotrexate
  658. Platelet-activating factor—and leukotriene B4-induced release of lactoferrin from blood neutrophils of atopic and nonatopic individuals
  659. Bone‐marrow regeneration after therapy‐induced hypoplasia monitored by serum measurements of lactoferrin, lysozyme and myeloperoxidase
  660. Elastase α‐proteinase inhibitor and lactoferrin concentrations in endotracheal aspirates of ventilated newborns
  661. Development and Clinical Evaluation of Immunoluminometric Assays for lactoferrin and Elastase-α1-Proteinase Inhibitor Complexes in Body Fluids with Special …
  662. lactoferrin and serum albumin in the conjunctival fluid of eyes operated for senile cataract
  663. Lysozyme and lactoferrin in normal and inflammatory changes of the gastric mucosa
  664. Does bovine lactoferrin resist absorption in the small intestine of neonatal and adult pigs?
  665. Detection of localization and internalization of membrane DNA in the Tetrahymena by the lactoferrin–colloidal gold technique.
  666. Specificity of the intestinal lactoferrin receptor
  667. Immunohistochemical localization of lysozyme, lactoferrin, al-antichymotrypsin, and α1-antichymotrypsin, and α1-antitrypsin in salivary gland of human fetuses
  668. Bimodal effects of lactoferrin on proliferation of an interleukin‐2‐dependent cytotoxic t‐lymphocyte cell line
  669. Growth inhibition of Staphylococcus aureus after experimental infection of the udder by high and low concentration of lactoferrin and lysozyme in milk.
  670. … complex class-II antigens on U937 cells and induction of responsiveness of U937 colony-forming cells to suppression by lactoferrin, transferrin, acidic isoferritins, and …
  671. Effects of orally administered bovine lactoferrin on the faecal Enterobacteriaceae of SPF mice fed milk
  672. Different profiles of induced cotton effects of human and bovine lactoferrin by cibacron blue F3GA binding.
  673. Isolation of human lactoferrin by affinity chromatography using insolubilized bovine β-lactoglobulin.
  674. The isolation and identification of lactoferrin from bovine tears
  675. Immunochemical and physico-chemical characteristics of lactoferrin in human body fluids
  676. Decreased lactoferrin content in granulocytes from subjects with Actinobacillus actinomycetemcomitans associated periodontal diseases.
  677. Use of an affinity immunosorbent for the isolation of lactoferrin from breast milk serum
  678. In vivo study of lactoferrin and murine rebound myelopoiesis
  679. lactoferrin and transferrin fragments react with nitrite to form an inhibitor of Bacillus cereus spore outgrowth
  680. Effect of ACTH and oxytocin treatment on lactoferrin and citrate in cows’ milk
  681. lactoferrin: biochemistry, physiological roles, and value in human biology
  682. Protective Effect of lactoferrin on Caerulein-lnduced Acute Pancreatitis in Rats
  683. … 48-h dental plaque accumulation in young human adults and the concentrations of hypothiocyanite,’free’and ‘total’lysozyme, lactoferrin and secretory immunoglobulin …
  684. The ability of Neisseriae to use lactoferrin as an iron source depends on the presence of a lactoferrin binding site
  685. An Immunohistochemical Study of Normal Human Neonate and Adult Parotid Gland Tissue: Detection of Lysozyme, lactoferrin, a1-Antichymotrypsin, a1-Antitrypsin …
  686. Stimulation by bovine lactoferrin of nerve growth factor synthesis/secretion in mouse LM cells
  687. Tear lactoferrin content in normal Chinese adults and various ocular diseases
  688. Effect of bovine milk antigens and egg lysozyme on the binding of 59Fe-lactoferrin to platelet plasma membranes
  689. Mucoepidermoid carcinomas: immunohistochemical studies on keratin, S-100 protein, lactoferrin, lysozyme and amylase.
  690. Stimulation of Cl secretion by lactoferrin across canine airway epithelial cells in culture
  691. Immunohistochemical identification of ferritin, lactoferrin and transferrin in leprosy lesions of human skin biopsies
  692. Inhibition by bovine lactoferrin of adhesion of L929 cells cultured in serum-free git medium
  693. The interaction between human pancreatic carboxylester hydrolase (bile-salt-stimulated lipase of human milk) and lactoferrin
  694. Serum lactoferrin in children and the correlation to blood leucocytes
  695. Sequential Studies on Serum‐Levels of Lysozyme, lactoferrin and Eosinophil Cationic Protein in Alcoholics after Alcohol Withdrawal
  696. The effect of zinc on [59Fe] lactoferrin binding to blood neutrophilic leucocytes and colostral cells.
  697. The role of lactoferrin in regulating colony stimulating factor
  698. Effect of orally administered bovine lactoferrin and bovine IgG on the establishment of Escherichia coli in the digestive tract of gnotobiotic mice and human newborn …
  699. Hafnium binding to comparison: comparison between lactoferrin and other transferrins
  700. Plasma lactoferrin and the blood count of polynuclear neutrophils
  701. Detection of lactoferrin and myeloperoxidase release from single neutrophils by a protein A plaque assay
  702. lactoferrin co-purifies with myeloperoxidase and is recognised by anti-neutrophil cytoplasm antibodies
  703. Anti-lactoferrin antibodies in patients with rheumatoid arthritis with vasculitis
  704. lactoferrin inhibits Interleukin-2 production in mixed
  705. Within-subject variation of elastase/α1-protease inhibitor complexes and lactoferrin in plasma
  706. Process for separating and purifying lactoferrin from milk using sulfate compound.
  707. Non-specific binding of transferrin and lactoferrin to polystyrene culture tubes: role of the radioligand
  708. lactoferrin content in feces in ileostomy-operated children fed human milk
  709. Increase in lactoferrin and elastase α‐1‐proteinase inhibitor complexes but lack of complement activation and IL‐6 response following thoracic surgery
  710. Intestinal lactoferrin receptor: presence and specificity during development
  711. lactoferrin and fibrinogen degradation products in saliva
  712. Plasma lactoferrin levels in patients with chronic calcifying pancreatitis
  713. Ultrastructural localization of DNA on ultrathin sections of resin‐embedded tissues by the lactoferrin‐gold complex
  714. lactoferrin and transferrin levels in the seminal plasma of infertile men
  715. Plasma lactoferrin content in neutropenic patients: effects of treatment with recombinant granulocyte-macrophage colony-stimulating factor.
  716. 1392 ENHANCED URINARY lactoferrin EXCRETION IN PREMATURE INFANTS FED HUMAN MILK
  717. Tear lactoferrin in keratoconjunctivitis sicca
  718. Can lactoferrin supplementation improve the availability of iron from milk?
  719. Immunochemical comparison of lactoferrin of human milk and lactoferrin of neutrophils
  720. Duodenal output of lactoferrin in normal subjects and correlation to output of amylase, bicarbonate, and total bile acids
  721. Compounds Which Mediate Gallium-67 Tranfer from lactoferrin to Ferritin
  722. Congenital and acquired lactoferrin deficiencies in neutrophils
  723. Enhancement of mammary gland mononuclear cell proliferation by interleukin‐2 in the presence of lactoferrin
  724. Effect of enterochelin and pH on uptake of iron from lactoferrin by Escherichia coli
  725. … colony stimulating factor and natural and recombinant murine interleukin 3 without and with pretreatment of mice with purified iron-saturated human lactoferrin
  726. Comparison of cytosolic calcium shifts, superoxide generation, and lactoferrin secretion in the neutrophils of atopies and nonatopics
  727. Beta 2-microglobulin, lysozyme and lactoferrin in cerebrospinal fluid in patients with lymphoma or leukaemia: relationship to CNS involvement and the effect of …
  728. Critical study of the analysis of lactoferrin in duodenal fluid in the diagnosis of chronic pancreatitis
  729. Biochemical characterization of lactoferrin and a 39 kilodalton protein isolated from bovine mammary secretions during involution
  730. Serum lactoferrin level in normal conditions and in pathology
  731. Activities derived from established human myeloid cell lines reverse the suppression of cell line colony formation by lactoferrin and transferrin.
  732. Aspects of preanalytical variation of lactoferrin and elastase/α1-protease inhibitor complexes
  733. Quantitative immunoenzyme determination of the lactoferrin and alpha-lactalbumin in the blood serum of cancer patients
  734. Selective adsorption of bovine lactoferrin onto partially sulfated chitosan beads
  735. … response in septicemia in newborns and their mothers: Effect of Escherichia coli, Streptococcus agalactiae and tumor necrosis factor on lactoferrin release and the …
  736. lactoferrin in synovial fluid
  737. lactoferrin in human lung tumors
  738. Persistent deficiency of myeloperoxidase and lactoferrin in granulopoietic cells of patients with acute leukemia
  739. Plasma levels of lactoferrin in children suffering from cystic fibrosis
  740. Determination of lactoferrin in the diagnosis of diseases of the pancreas
  741. lactoferrin and transferrin–iron-binding proteins in physiological and pathological vitreous bodies
  742. Serum siderophilin (transferrin) and ekkrinosiderophilin (lactoferrin) as non-specific microbiostatic agents in human health and disease: clinical implications (author’s …
  743. Isolation and physico-chemical properties of lactoferrin from swine neutrophils
  744. lactoferrin in acute necrotizing pancreatitis
  745. Plasma lactoferrin Concentration in Acute Non-Lymphocytic Leukaemia (ANLL)
  746. Synthetic iron chelating agents as probes of the iron coordination site and metal ion exchange kinetics of transferrin and lactoferrin
  747. The resistance of transferrin, lactoferrin and caeruloplasmin to oxidative damage: a reply
  748. Interleukin-6 ablates the accessory cell-mediated suppressive effects of lactoferrin on human hematopoietic progenitor cell proliferation in vitro.
  749. The antibacterial properties of bovine lactoferrin as evaluated by a microassay for bacterial growth
  750. … THAT IS THERMALLY DERIVED FROM NITRITE AND THE FORMATION OF ANALOGOUS INHIBITORS FROM lactoferrin OR TRANSFERRIN FRAGMENTS …
  751. lactoferrin and fibronectin in tears of patients undergoing cataract surgery
  752. lactoferrin levels in pure pancreatic secretion of chronic pancreatitis (author’s transl)
  753. Immunohistochemical detection of lactoferrin of human milk in the tissues of the human and the fetus
  754. Pharmacokinetics of human milk lactoferrin in intact mice and tumor-carrying animals
  755. Studies on the in vitro synthesis of lactoferrin and lactate dehydrogenase in human tumor cells
  756. The Influence of Blood Sampling Techniques on Plasma Concentrations of lactoferrin and Elastase-α1-PI
  757. Study on the Stability of Bovine lactoferrin
  758. Interaction between human lactoferrin and B lymphocytes
  759. X-Ray Structural Studies of lactoferrin
  760. lactoferrin serum levels in burned patients.
  761. Immunochemical determination of human lactoferrin
  762. Radiolabelled lactoferrin in the detection of occult sepsis
  763. lactoferrin Uptake by the Reticuloendothelial System of the Mouse Liver
  764. Coupling of carboxymethylated (His) 2 luteinizing hormone releasing hormone to poly-dl-alanyl chains (spacer groups) polymerised on human lactoferrin
  765. Plasma lactoferrin levels in pregnancy and cystic fibrosis.[Radioimmunoassay]
  766. lactoferrin and immunoglobulins of the pleural space
  767. The influence of degree of iron saturation and some physical parameters on the thermal stability of lactoferrin.
  768. lactoferrin Content in Feces in Ileostomy-operated
  769. Cloning and sequencing of the cDNA for bovine lactoferrin: this thesis is submitted to Massey University as partial fulfilment of the requirements for the degree of …
  770. Determination of plasma lactoferrin by the” double sandwich” immunoenzymatic method in heterogeneous phase
  771. Distribution of lactoferrin in the colonic mucosa in ulcerative colitis
  772. Immunofluorescence study of lactoferrin-synthesizing thymus cells
  773. Relation between lactoferrin Level and Number of Bifidobacterium or Candida in Feces
  774. Identification of lactoferrin in the Saliva of Patients with Gingivitis
  775. Comparative immunohistochemical study of lysozyme and lactoferrin in human neonate and adult parotid glands
  776. Expression of lactoferrin and myeloperoxidase genes in blasts of acute lymphoblastic leukemia
  777. Comparison of the Interaction of lactoferrin with Hepatocytes, Lymphocytes and Monocytes
  778. The development of an enzyme-linked immunosorbent assay for bovine lactoferrin: a thesis presented in partial fulfilment of the requirements for the degree of Master …
  779. lactoferrin as Complement Inhibitor in Synovial Fluid
  780. Affinity Properties of Tryptic Fragments of Bovine lactoferrin with Immobilized Cibacron Blue
  781. Mechanism of radiogallium localization in tumors: role of iron-binding proteins, transferrin and lactoferrin
  782. MEASUREMENT OF lactoferrin IN HUMAN MILK AND NEONATAL FAECES AND EXPLORATION OF RELATION BETWEEN THEM
  783. Interactions of lactoferrin with monocytic and mucosal cells; its role in iron uptake and absorption
  784. Cloning two cDNA sequences coding for lactoferrin from human mammary gland.
  785. Expression and characterisation of the n-terminal half of human lactoferrin:[t] his thesis is submitted to Massey University as partial fulfilment of the requirements for the …
  786. Diagnosis of chronic pancreatitis based on the determination of lactoferrin and calcium in the duodenal juice?
  787. CHARACTERIZATION OF THE ANTIBACTERIAL EFFECTS OF HUMAN lactoferrin ON GRAM-NEGATIVE ENTERIC BACTERIA.
  788. Collaborative bacteriostatic activity of bovine lactoferrin with lysozyme against Escherichia coli 0111.
  789. lactoferrin Stimulates the Production of “Leukocyte Migration Inhibitory Factor”(LIF) by Mononuclear Leukocytes
  790. Salivary immunoglobulins and lactoferrin in dental caries
  791. Polymorphism and Altered Methylation of the lactoferrin Gene in Normal Leukocytes, Leukemic Cells, and Breast Cancer1
  792. Stimulation of expression of IgM and IgG receptors on human thymus lymphocytes after treatment with lactoferrin in vitro
  793. of lactoferrin in pure pancreatic juice may be useful diagnostic aid in pancreatic disorders
  794. Human lactoferrin: isolation of highly purified preparations from human milk, various physico-chemical properties and distribution in normal and tumor tissues
  795. Serum levels of lactoferrin and myeloperoxidase in chronic idiopathic and secondary neutropenia: A preliminary report
  796. EFFECT OF MUCOSAL PROTEINS ALPHA AMYLASE AND lactoferrin ON LEGIONELLA PNEUMOPHILA.
  797. Immunohistochemical Study of Lysozyme and lactoferrin in the Middle Ear and Eustachian Tube Mcosa
  798. The effect of hormonal contraceptives and pregnancy on iron metabolism, plasma lactoferrin levels and granulocyte count in women
  799. lactoferrin Immunoreactivity and Binding Sites in Neurons, Neuritic Plaques, and Neurofibrillary Tangles in Alzheimer’s Disease
  800. Plasma lactoferrin and Elastase in Healthy Pregnant Women and Pregnancy Associated Toxaemia
  801. Influence of lactoferrin on Iron Absorption from Human Milk in Infants
  802. … of energy spectral information in nuclear imaging and investigation of protein binding of cationic radionuclides by lactoferrin. Comprehensive progress report, October …
  803. Preparation of copper, nickel and manganese lactoferrin from cow and buffalo colostrum and their bacteriostatic role.
  804. A Biochemical and Functional Study of Leukemia Associated Inhibitory Activity and lactoferrin: Two Regulators of Myelopoiesis
  805. Immunohistochemical localization of lysozyme and lactoferrin in salivary pleomorphic adenomas
  806. Crystallographic and physicochemical studies on metal and anion substituted human lactoferrin: a thesis presented in partial fulfilment of the requirements for the …
  807. Studies on lactoferrin, a metal binding protein in human milk: a thesis presented in partial fulfilment of the requirements for the degree of Doctor of Philosophy in …
  808. Iron-dependent binding of 8-anilinonaphthalene-1-sulphonate by both lactoferrin and transferrin.
  809. Serum Levels of Ferritin, lactoferrin and Lysozyme in Patients with Disseminated Non-Seminomatous Germ Cell Tumors Are Influenced by Chemotherapy
  810. THE IN VITRO UPTAKE OF GALLIUM-67 BY MONOCYTES AND LYMPHOCYTES IN THE PRESENCE OF lactoferrin AND TRANSFERRIN.
  811. … , 1981-November 30, 1982.[ODIFICATIONS; COMPUTERS; EQUIPMENT INTERFACES; OPTIMIZATION; lactoferrin; TRANSFERRIN; BACTERIA; PATHOGENS; …
  812. Cover picture: Immunogold localization of cytochrome b (20 nm) and lactoferrin (10 nm) on cryofixed molecular distillation dried human neutrophils. See related …
  813. /sup 67/Ga-transferrin and/sup 67/Ga-lactoferrin binding to tumor cells: Specific vs nonspecific glycoprotein-cell interaction
  814. Immunohistochemical Studies on S-100 Protein and lactoferrin in Salivary Gland Tumors
  815. 31 THE EFFECT OF DIETARY lactoferrin AND IRON ON THE FAECAL FLORA OF THE NEWBORN
  816. Levels of the C 4 component of the complement, lactoferrin and leukocytic thermostabile alpha glycoprotein during the treatment of patients with systemic rheumatic …
  817. 83. HUMAN lactoferrin AND IRON TRANSPORT ACROSS HUMAN COLON CARCINOMA CELL MONOLAYERS HT29 CL. 19A
  818. lactoferrin: a general review
  819. lactoferrin: molecular structure and biological function
  820. lactoferrin: a multifunctional immunoregulatory protein?
  821. Three-dimensional structure of diferric bovine lactoferrin at 2.8 Å resolution
  822. Occurrence, structure, biochemical properties and technological characteristics of lactoferrin
  823. A review: the active peptide of lactoferrin
  824. Structure and biological actions of lactoferrin
  825. lactoferrin is a lipid A-binding protein
  826. lactoferrin: a multifunctional glycoprotein
  827. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA
  828. lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process
  829. Structure of human diferric lactoferrin refined at 2.2 Å resolution
  830. Elucidation of the antistaphylococcal action of lactoferrin and lysozyme
  831. lactoferrin levels in term and preterm milk
  832. Bacterial transferrin and lactoferrin receptors
  833. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice
  834. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.
  835. Synergic antistaphylococcal properties of lactoferrin and lysozyme
  836. A system for production of commercial quantities of human lactoferrin: a broad spectrum natural antibiotic
  837. Hepatitis C virus envelope proteins bind lactoferrin
  838. Antibacterial activity in bovine lactoferrin-derived peptides
  839. Separation of lactoferrin-a and-b from bovine colostrum
  840. Antibacterial peptides of bovine lactoferrin: purification and characterization
  841. lactoferrin in infant formulas: effect on oxidation
  842. Milk and dairy products in cancer prevention: focus on bovine lactoferrin
  843. lactoferrin: A marvelous protein in milk
  844. Inhibition with lactoferrin of in vitro infection with human herpes virus
  845. Activation of macrophages by lactoferrin: secretion of TNF‐α, IL‐8 and NO
  846. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice
  847. Characterization of the glycosaminoglycan-binding region of lactoferrin
  848. Structure of the bovine lactoferrin-encoding gene and its promoter
  849. Candidacidal activities of human lactoferrin peptides derived from the N terminus
  850. Bacterial lactoferrin receptors
  851. Expression of human lactoferrin in milk of transgenic mice
  852. Expression of full-length bioactive antimicrobial human lactoferrin in potato plants
  853. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin.
  854. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier
  855. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin
  856. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein
  857. Identification, characterization, and immunogenicity of the lactoferrin-binding protein from Helicobacter pylori
  858. Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice
  859. Activation of intestinal mucosal immunity in tumor‐bearing mice by lactoferrin
  860. Three-dimensional structure of mare diferric lactoferrin at 2.6 Å resolution
  861. Giardicidal activity of lactoferrin and N-terminal peptides
  862. Isolation and characterization of sheep lactoferrin, an inhibitor of platelet aggregation and comparison with human lactoferrin
  863. lactoferrin: Natural-Multifunctional-Antimicrobial
  864. Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice
  865. Thermal denaturation of human lactoferrin and its effect on the ability to bind iron
  866. Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin
  867. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells
  868. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide
  869. Transferrins: iron release from lactoferrin
  870. Three-dimensional structure of lactoferrin
  871. lactoferrin is responsible for the fungistatic effect of human milk
  872. Bovine lactoferrin induces both mucosal and systemic immune response in mice
  873. Identification of Pneumococcal Surface Protein A as a lactoferrin-Binding Protein of Streptococcus pneumoniae
  874. lactoferrin concentration in milk of bovine clinical mastitis
  875. Human lactoferrin induces phenotypic and functional changes in murine splenic B cells.
  876. Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium
  877. lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes
  878. Sequence analysis of camel (Camelus dromedarius) lactoferrin
  879. Estrogen-related receptor, hERR1, modulates estrogen receptor-mediated response of human lactoferrin gene promoter
  880. Synergistic Fungistatic Effects of lactoferrin in Combination with Antifungal Drugs against ClinicalCandida Isolates
  881. Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: identification of its active domain
  882. Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection
  883. Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells
  884. lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study
  885. The survival of ingested lactoferrin in the gastrointestinal tract of adult mice
  886. lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocytic cells
  887. Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae
  888. Production of human lactoferrin in transgenic tobacco plants
  889. Rapid assay of lactoferrin in keratoconjunctivitis sicca.
  890. lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein
  891. Interaction of lactoferrin with ceruloplasmin
  892. In vitro susceptibility of Candida species to lactoferrin
  893. Restricted spatiotemporal expression of lactoferrin during murine embryonic development
  894. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets
  895. Activation of rainbow trout, Oncorhynchus mykiss, phagocytic cells by administration of bovine lactoferrin
  896. lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea
  897. Influence of lactoferrin on iron absorption from human milk in infants
  898. lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells
  899. Antibacterial activity of peptides homologous to a loop region in human lactoferrin
  900. Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29
  901. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
  902. Immunoregulatory effects of a nutritional preparation containing bovine lactoferrin taken orally by healthy individuals.
  903. Binding of ruthenium (III) anti-tumor drugs to human lactoferrin probed by high resolution X-ray crystallographic structure analyses
  904. The mammalian neuroendocrine hormone norepinephrine supplies iron for bacterial growth in the presence of transferrin or lactoferrin
  905. Bovine lactoferrin and LactoferricinTM Inhibit Tumor Metastasis in Mice
  906. lactoferrin inhibits G1 cyclin‐dependent kinases during growth arrest of human breast carcinoma cells
  907. Antibiotic properties of bovine lactoferrin on Helicobacter pylori
  908. Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism
  909. lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 …
  910. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in …
  911. lactoferrin given in food facilitates dermatophytosis cure in guinea pig models
  912. Characterization of lbpA, the structural gene for a lactoferrin receptor in Neisseria gonorrhoeae
  913. lactoferrin in intrauterine infection, human parturition, and rupture of fetal membranes
  914. Effects of orally administered bovine lactoferrin on the immune system of healthy volunteers
  915. Paracrine regulation of epithelial progesterone receptor and lactoferrin by progesterone in the mouse uterus
  916. Structure of recombinant human lactoferrin expressed in Aspergillus awamori
  917. Antibacterial activity of bovine lactoferrin and its peptides against enterohaemorrhagic Escherichia coli O157: H7.
  918. The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis
  919. Ocular surface damage and tear lactoferrin in dry eye syndrome
  920. Expression of a human lactoferrin cDNA in tobacco cells produces antibacterial protein (s)
  921. Antiviral activity of lactoferrin
  922. Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus
  923. Properties of a heparin-binding peptide derived from bovine lactoferrin
  924. Effect of lactoferrin on proliferation and differentiation of the Jurkat human lymphoblastic T cell line.
  925. Advances in lactoferrin research
  926. lactoferrin binds to porins OmpF and OmpC in Escherichia coli
  927. Neutralization of heparin activity by neutrophil lactoferrin
  928. Molecular characterization of LbpB, the second lactoferrin‐binding protein of Neisseria meningitidis
  929. Biochemical analysis of lactoferrin receptors in the Neisseriaceae: identification of a second bacterial lactoferrin receptor protein
  930. Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation–modified proteins to a conserved motif
  931. Purification and characterization of lactoferrin, lactoperoxidase, lysozyme and immunoglobulins from camel’s milk
  932. Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry
  933. Measurement of urinary lactoferrin as a marker of urinary tract infection
  934. Estrogen regulation of lactoferrin expression in human endometrium
  935. Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and 2
  936. Activity of hydrolysed lactoferrin against foodborne pathogenic bacteria in growth media: the effect of EDTA
  937. Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents
  938. Amniotic fluid lactoferrin in intrauterine infection
  939. Inhibition of azoxymethane‐initiated colon tumor by bovine lactoferrin administration in F344 rats
  940. Structure of buffalo lactoferrin at 3.3 Å resolution at 277 K
  941. lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice
  942. Bovine lactoferrin peptidic fragments involved in inhibition of herpes simplex virus type 1 infection
  943. Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines
  944. A new role for lactoferrin: DNA binding and transcription activation
  945. Antifungal properties of lactoferricin B, a peptide derived from the N‐terminal region of bovine lactoferrin
  946. The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans
  947. The bovine lactoferrin gene (LTF) maps to chromosome 22 and syntenic group U12
  948. Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis
  949. Characteristic transport of lactoferrin from the intestinal lumen into the bile via the blood in piglets
  950. Possible chemopreventive effects of bovine lactoferrin on esophagus and lung carcinogenesis in the rat
  951. Characterization of recombinant human lactoferrin secreted in milk of transgenic mice
  952. Structures involved in the interaction of Porphyromonas gingivalis fimbriae and human lactoferrin
  953. Effects of lactoferrin and Lactoferricin® on the Release of Interleukin 8 from Human Polymorphonuclear Leukocytes
  954. Ability of lactoferrin to promote the growth of Bifidobacterium spp. in vitro is independent of receptor binding capacity and iron saturation level
  955. To culture or not to culture: fecal lactoferrin screening for inflammatory bacterial diarrhea
  956. The Therapeutic Effect of Bovine lactoferrin in the Host Infected with Helicobacter pylori
  957. Decreased tear lactoferrin concentration in patients with chronic hepatitis C
  958. Effect of lactoferrin on the production of tumor necrosis factor‐α and nitric oxide
  959. Acquisition of iron from transferrin and lactoferrin by the protozoan Leishmania chagasi
  960. Effects of lactoferrin and its peptides on proliferation of rat intestinal epithelial cell line, IEC-18, in the presence of epidermal growth factor
  961. lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep
  962. Structure of the human lactoferrin gene and its chromosomal localization.
  963. Human lactoferrin and Peptides Derived from a Surface-Exposed Helical Region Reduce Experimental Escherichia coli Urinary Tract Infection in Mice
  964. Antifungal spectrum and fungicidal mechanism of an N-terminal peptide of bovine lactoferrin
  965. Porins OmpC and PhoE of Escherichia coli as specific cell-surface targets of human lactoferrin: Binding characteristics and biological effects
  966. In vitro antiviral activity of lactoferrin and ribavirin upon hantavirus
  967. Estrogen receptor-related receptor α1 interacts with coactivator and constitutively activates the estrogen response elements of the human lactoferrin gene
  968. Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants
  969. Structure-Function Relationship of Antibacterial Synthetic Peptides Homologous to a Helical Surface Region on Human lactoferrin against Escherichia coli Serotype …
  970. Salivary lactoferrin and low‐Mr mucin MG2 in Actinobacillus actinomycetemcomitans‐associated periodontitis
  971. Regulation of epidermal Langerhans cell migration by lactoferrin
  972. Effect of lactoferrin on oxidative stability of corn oil emulsions and liposomes
  973. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA
  974. Transferrins: A mechanism for iron uptake by lactoferrin
  975. Examination of the immunomodulatory properties and the effect on disease resistance of dietary bovine lactoferrin and vitamin C fed to Atlantic salmon (Salmo salar) …
  976. lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin
  977. The effects of lactoferrin on gram-negative bacteria
  978. lactoferrin interaction with salmonellae potentiates antibiotic susceptibility in vitro
  979. Cooperative interactions between the amino-and carboxyl-terminal lobes contribute to the unique iron-binding stability of lactoferrin
  980. Inhibitory Effects of Bovine lactoferrin on the Adherence of Enterotoxigenic Escherichia coli to Host Cells
  981. lactoferrin and the inflammatory response
  982. lactoferrin inhibits HIV-1 replication in vitro and exhibits synergy when combined with zidovudine
  983. Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli
  984. Degradation of lactoferrin by periodontitis-associated bacteria
  985. Two ion-exchange chromatographic methods for the isolation of antibacterial peptides from lactoferrin: In situ enzymatic hydrolysis on an ion-exchange membrane
  986. lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen‐activated protein kinase in the human lymphoblastic T Jurkat cell line
  987. Tritrichomonas foetus: iron acquisition from lactoferrin and transferrin
  988. The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide
  989. High-level expression of human lactoferrin in milk of transgenic mice using genomic lactoferrin sequence
  990. lactoferrin expression in human breast cancer.
  991. Seminal plasma lactoferrin concentrations in normal and abnormal semen samples
  992. Enhancement of the activity of novobiocin against Escherichia coli by lactoferrin
  993. Myeloid transcription factor C/EBPɛ is involved in the positive regulation of lactoferrin gene expression in neutrophils
  994. Human milk lactoferrin binds two DNA molecules with different affinities
  995. lactoferrin inhibits the binding of lipopolysaccharides to L-selectin and subsequent production of reactive oxygen species by neutrophils
  996. Role of basic residues of human lactoferrin in the interaction with B lymphocytes
  997. Subthreshold UV radiation-induced peroxide formation in cultured corneal epithelial cells: the protective effects of lactoferrin
  998. Immunochemical detection of human lactoferrin in feces as a new marker for inflammatory gastrointestinal disorders and colon cancer
  999. Iron and lactoferrin in milk of anemic mothers given iron supplements
  1000. lactoferrin–its role in defense against infection and immunotropic properties
  1001. Direct activity of recombinant human lactoferrin against Helicobacter pylori
  1002. Characterization of human lactoferrin produced in the baculovirus expression system
  1003. Elevation of lactoferrin gene expression in developing, ductal, resting, and regressing parenchymal epithelium of the ruminant mammary gland
  1004. lactoferrin effects on the in vitro immune response in critically ill patients.
  1005. Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14 …
  1006. The role of lactoferrin as an anti-inflammatory molecule
  1007. Increased levels of lactoferrin in synovial fluid but not in serum from patients with rheumatoid arthritis
  1008. Expression of lactoferrin on human granulocytes: analysis with polyclonal and monoclonal antibodies
  1009. Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line
  1010. Inhibition of Hyphal Growth of Azole-Resistant Strains of Candida albicans by Triazole Antifungal Agents in the Presence of lactoferrin-Related Compounds
  1011. lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity
  1012. Primary and three-dimensional structure of lactotransferrin (lactoferrin) glycans
  1013. Correlation of lactoferrin with neutrophilic inflammation in body fluids
  1014. Metal substitution in transferrins: specific binding of cerium (IV) revealed by the crystal structure of cerium-substituted human lactoferrin
  1015. Impairment of circulating lactoferrin in HIV-1 infection.
  1016. lactoferrin increases the output of neutrophil precursors and attenuates the spontaneous production of TNF-alpha and IL-6 by peripheral blood cells.
  1017. … of Microbial Infection and Mortality in Medical Patients with Fever: Plasma Procalcitonin, Neutrophilic Elastase-α1-Antitrypsin, and lactoferrin Compared with Clinical …
  1018. lactoferrin inhibits proliferative response and cytokine production of TH1 but not TH2 cell lines.
  1019. Three-dimensional structure of lactoferrin in various functional states
  1020. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea
  1021. Internalization of human lactoferrin by the Jurkat human lymphoblastic T-cell line.
  1022. Structure of buffalo lactoferrin at 2.5 Å resolution using crystals grown at 303 K shows different orientations of the N and C lobes
  1023. Human lactoferrin binds and removes the hemoglobin receptor protein of the periodontopathogen Porphyromonas gingivalis
  1024. Immunomodulatory effect of bovine lactoferrin pepsin hydrolysate on murine splenocytes and Peyer’s patch cells
  1025. … and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane
  1026. Identification of the iroA gene product of Neisseria meningitidis as a lactoferrin receptor
  1027. Human lactoferrin proteolytic activity: analysis of the cleaved region in the IgA protease of Haemophilus influenzae
  1028. Recombinant Human lactoferrin is Effective in the Treatment of Helicobacter felis‐infected Mice
  1029. lactoferrin lowers serum interleukin 6 and tumor necrosis factor alpha levels in mice subjected to surgery.
  1030. Antimicrobial peptides of lactoferrin
  1031. Defining candidate genes for mastitis resistance in cattle: the role of lactoferrin and lysozyme
  1032. lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant …
  1033. Orally administered bovine lactoferrin inhibits bacterial translocation in mice fed bovine milk
  1034. Antibacterial system generated by lactoferrin in mice in vivo is primarily a killing system
  1035. Interaction of tear lipocalin with lysozyme and lactoferrin
  1036. Expression of Human lactoferrin cDNA Confers Resistance to Ralstonia solanacearum in Transgenic Tobacco Plants
  1037. Serum and milk lactoferrin concentration and the correlation with some blood components in lactating sows
  1038. Iron, lactoferrin and iron regulatory protein activity in the synovium; relative importance of iron loading and the inflammatory response
  1039. lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment
  1040. Respiratory epithelial cells demonstrate lactoferrin receptors that increase after metal exposure
  1041. Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice
  1042. Inhibition of azoxymethane initiated colon tumor and aberrant crypt foci development by bovine lactoferrin administration in F344 rats
  1043. Metal complexes of lactoferrin and their effect on the intracellular multiplication of Legionella pneumophila
  1044. Effects of heat treatment on structure and iron-binding capacity of bovine lactoferrin
  1045. Evaluation of the antimicrobial effect of lactoferrin on Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens
  1046. lactoferrin three-dimensional structure: a framework for interpreting function.
  1047. Cloning and Expression of the Moraxella catarrhalis lactoferrin Receptor Genes
  1048. Sp1 and C/EBP are necessary to activate the lactoferrin gene promoter during myeloid differentiation
  1049. Fractionation of lactoperoxidase and lactoferrin from bovine whey using a cation exchange membrane
  1050. Expression and characterization of recombinant murine lactoferrin
  1051. Characterization of Korean native goat lactoferrin
  1052. The Preterm Prediction Study: cervical lactoferrin concentration, other markers of lower genital tract infection, and preterm birth
  1053. Prevention of colon carcinogenesis and carcinoma metastasis by orally administered bovine lactoferrin in animals
  1054. Receptor-mediated binding of milk lactoferrin to nursing piglet enterocytes: a model for studies on absorption of lactoferrin-bound iron.
  1055. Activated human γδ T lymphocytes express functional lactoferrin receptors
  1056. lactoferrin can supply iron for the growth of Bifidobacterium breve
  1057. lactoferrin as a sensitive blood marker of neutrophil activation in normal pregnancies
  1058. Oral administration of bovine lactoferrin for treatment of intractable stomatitis in feline immunodeficiency virus (FIV)-positive and FIV-negative cats.
  1059. Bacteriostatic effect of orally administered bovine lactoferrin on proliferation of Clostridium species in the gut of mice fed bovine milk
  1060. Inhibitory effects of bovine lactoferrin on intestinal polyposis in the ApcMin mouse
  1061. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells
  1062. lactoferrin Protects Against UV-B Irradiation–Induced Corneal Epithelial Damage in Rats
  1063. Lipopolysaccharide‐inactivating activity of neutrophils is due to lactoferrin
  1064. Chemopreventive effect of bovine lactoferrin on 4‐nitroquinoline 1‐oxide‐induced tongue carcinogenesis in male F344 rats
  1065. Neoplastic transformation of the endocervix associated with downregulation of lactoferrin expression
  1066. lactoferrin suppresses loss of corneal epithelial integrity in a rabbit short-term dry eye model
  1067. Iron saturation alters the effect of lactoferrin on the proliferation and differentiation of human enterocytes (Caco-2 cells)
  1068. Gingival crevicular fluid lactoferrin levels in adult per iodontitis patients
  1069. Direct evidence for the secretion of lactoferrin and its binding to sperm in the porcine epididymis
  1070. A Helical Region on Human lactoferrin
  1071. Isolation of lactoperoxidase, lactoferrin, α-lactalbumin, β-lactoglobulin B and β-lactoglobulin A from bovine rennet whey using ion exchange chromatography
  1072. Ribonuclease, cell-free translation-inhibitory and superoxide radical scavenging activities of the iron-binding protein lactoferrin from bovine milk
  1073. Levels of antimicrobial molecules defensin and lactoferrin are elevated in the cerebrospinal fluid of children with meningitis
  1074. Effect of supplemental lactoferrin with ferrous iron on iron status of newborn calves
  1075. Glycation ligand binding motif in lactoferrin
  1076. Tumor necrosis factor‐α increases lactoferrin transcytosis through the blood‐brain barrier
  1077. Identification and Molecular Analysis oflbpBA, Which Encodes the Two-Component Meningococcal lactoferrin Receptor
  1078. Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas.
  1079. lactoferrin-lipid A-lipopolysaccharide interaction: inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14
  1080. Metal-dependent expression of ferritin and lactoferrin by respiratory epithelial cells
  1081. Neutrophil activation in preeclampsia. Are defensins and lactoferrin elevated in preeclamptic patients?
  1082. Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer’s disease
  1083. lactoferrin expression in mammary epithelial cells is mediated by changes in cell shape and actin cytoskeleton
  1084. Surface expression of lactoferrin by resting neutrophils
  1085. Use of a lactoferrin assay in the differential diagnosis of female genital tract infections and implications for the pathophysiology of bacterial vaginosis
  1086. Characterization of Moraxella(Branhamella) catarrhalis lbpB, lbpA, and lactoferrin Receptor orf3 Isogenic Mutants
  1087. Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin
  1088. Gastric Juice Levels of lactoferrin and Helicobacter pylori Infection
  1089. Chemopreventive Effects of Bovine lactoferrin on N‐Butyl‐N‐(4‐ hydroxybutyl)nitrosamine‐induced Rat Bladder Carcinogenesis
  1090. lactoferrin secretion into mouse milk
  1091. lactoferrin and interleukin-6 interaction in amniotic infection
  1092. Differential spatiotemporal regulation of lactoferrin and progesterone receptor genes in the mouse uterus by primary estrogen, catechol estrogen, and xenoestrogen
  1093. Effects of oral hygiene products containing lactoperoxidase, lysozyme, and lactoferrin on the composition of whole saliva and on subjective oral symptoms in patients …
  1094. Mouse lactoferrin gene: a marker for estrogen and epidermal growth factor.
  1095. Comparison of EDTA and apo-lactoferrin with lysozyme on the growth of foodborne pathogenic and spoilage bacteria
  1096. Cell proliferation effect of lactoferrin in human endometrial stroma cells
  1097. Comparative study of lactoferrin and other blood markers of inflammatory stress between preeclamptic and normal pregnancies
  1098. lactoferrin secretion into milk: comparison between ruminant, murine, and human milk
  1099. Involvement of vulnibactin and exocellular protease in utilization of transferrin-and lactoferrin-bound iron by Vibrio vulnificus
  1100. Molecular characterization of the structural gene for the lactoferrin receptor of the meningococcal strain H44/76.
  1101. Plasma lactoferrin levels are decreased in end-stage AIDS patients
  1102. Preparation and Characterization of Neisseria meningitidis Mutants Deficient in Production of the Human lactoferrin-Binding Proteins LbpA and LbpB
  1103. Recognition of lactoferrin and aminopeptidase M-modified lactoferrin by the liver: involvement of proteoglycans and the remnant receptor
  1104. The Bacteriostatic Effects of Orally Administered Bovine lactoferrin on Intestinal Enterobacteriaceae of SPF Mice Fed Bovine Milk
  1105. Inhibition of binding of lactoferrin to the human promonocyte cell line THP-1 by heparin: the role of cell surface sulphated molecules
  1106. Inhibitory effect of lactoferrin on the adhesion of Actinobacillus actinomycetemcotnitans and Prevotella intermedia to fibroblasts and epithelial cells
  1107. lactoferrin binding to the rat asialoglycoprotein receptor requires the receptor’s lectin properties
  1108. lactoferrin Interaction with Actinobacillus actinomycetemcomitans
  1109. Oral administration of bovine lactoferrin for treatment of tinea pedis. A placebo-controlled, double-blind study Orale Verabreichung von Rinder-Laktoferrin zur …
  1110. lactoferrin contains structural motifs of ribonuclease
  1111. A retinoic acid response element that overlaps an estrogen response element mediates multihormonal sensitivity in transcriptional activation of the lactoferrin gene
  1112. Polymorphic sequence of Korean native goat lactoferrin exhibiting greater antibacterial activity
  1113. Identification of lactoferrin-binding proteins in bovine mastitis-causing Streptococcus uberis
  1114. Fourier transform infrared spectroscopy and differential scanning calorimetry of transferrins: human serum transferrin, rabbit serum transferrin and human lactoferrin
  1115. The lactoferrin tear test in the diagnosis of Sjögren’s syndrome
  1116. Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme
  1117. The mechanism of in vivo bacteriostasis of bovine lactoferrin
  1118. Effects of lactoferrin and milk on adherence of Streptococcus uberisto bovine mammary epithelial cells
  1119. Elastase and lactoferrin in gingival crevicular fluid: possible indicators of a granulocyte‐associated specific host response
  1120. lactoferrin: structure, function and applications. Proceedings of the 4th International Conference on lactoferrin: Structure, Function and Applications, held in Sapporo …
  1121. Growth of Moraxella catarrhalis with human transferrin and lactoferrin: expression of iron-repressible proteins without siderophore production
  1122. Microheterogeneity of the oligosaccharides carried by the recombinant bovine lactoferrin expressed in Mamestra brassicae cells
  1123. Effects of orally administrated bovine lactoferrin on growth and blood properties of goldfish
  1124. Removal of lactoferrin from plasma is mediated by binding to low density lipoprotein receptor‐related protein/α 2‐macroglobulin receptor and transport to …
  1125. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
  1126. Identification of a Human lactoferrin-Binding Protein in Gardnerella vaginalis
  1127. Antibacterial activity of multiple antigen peptides homologous to a loop region in human lactoferrin
  1128. Production of human lactoferrin in transgenic plants.
  1129. Altered domain closure and iron binding in transferrins: the crystal structure of the Asp60Ser mutant of the amino-terminal half-molecule of human lactoferrin
  1130. Determination of the minor whey protein bovine lactoferrin in cheese whey concentrates with capillary electrophoresis
  1131. Regulation of lactoferrin gene expression by estrogen and epidermal growth factor
  1132. lactoferrin–metal interactions: first crystal structure of a complex of lactoferrin with a lanthanide ion (Sm3+) at 3.4 Å resolution
  1133. Antimicrobial properties of pepsin-digested lactoferrin added to carrot juice and filtrates of carrot juice
  1134. Anti-Invasive Activity of Bovine lactoferrin against Listeria monocytogenes
  1135. Structural Characterization of the lactoferrin Receptor from Neisseria meningitidis
  1136. Clostridium difficile toxin and faecal lactoferrin assays in adult patients
  1137. The physiological role of lactoferrin
  1138. Augmented inhibition of growth of Candida albicans by neutrophils in the presence of lactoferrin
  1139. Production of stable isotope enriched antimicrobial peptides in Escherichia coli: an application to the production of a 15N-enriched fragment of lactoferrin
  1140. Amonabactin-mediated iron acquisition from transferrin and lactoferrin by Aeromonas hydrophila: direct measurement of individual microscopic rate constants
  1141. Enhancement of the nonspecific defense activity of the skin mucus of red sea bream by oral administration of bovine lactoferrin
  1142. Hepatic and extrahepatic clearance of circulating human lactoferrin: an experimental study in rat
  1143. Selective extraction of lysozyme from a mixture with lactoferrin by ultrafiltration. Role of the physico-chemical environment
  1144. Anti-Candida Activity of Caiprotectin in Combination with Neutrophils or lactoferrin
  1145. Effect of lactoferrin on lipopolysaccharide (LPS) induced preterm delivery in mice
  1146. Modulation of the anti-Candida activity of apo-lactoferrin by dietary sucrose and tunicamycin in vitro
  1147. Defensive effect of orally administered bovine lactoferrin against Cryptocaryon irritans infection of red sea bream
  1148. Reduction of stress response in carp,Cyprinus carpioL., held under deteriorating environmental conditions, by oral administration of bovine lactoferrin
  1149. Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases
  1150. Commercial production of lactoferrin, a multifunctional iron-binding glycoprotein
  1151. Identification of lactoferrin complexes in bovine mammary secretions during mammary gland involution
  1152. Characterization of a mitogen-response unit in the mouse lactoferrin gene promoter.
  1153. Effect of iron-free and metal-bound forms of lactoferrin on the growth of bifidobacteria, E. coli and S. aureus
  1154. lactoferrin down-modulates the activity of the granulocyte macrophage colony-stimulating factor promoter in interleukin-1β-stimulated cells
  1155. Glycans of bovine lactoferrin function as receptors for the type 1 fimbrial lectin of Escherichia coli
  1156. Crystal structure of a complex formed between proteolytically‐generated lactoferrin fragment and proteinase K
  1157. Effect of intracellular iron depletion by picolinic acid on expression of the lactoferrin receptor in the human colon carcinoma cell subclone HT29-18-C1
  1158. Apical-to-basolateral transepithelial transport of human lactoferrin in the intestinal cell line HT-29cl. 19A
  1159. P‐selectin‐dependent leukocyte recruitment and intestinal mucosal injury induced by lactoferrin
  1160. Ontogeny of lactoferrin in the developing mouse uterus: a marker of early hormone response
  1161. CCAAT displacement protein (CDP/cut) recognizes a silencer element within the lactoferrin gene promoter
  1162. The ratio of albumin to lactoferrin in tear fluid as a diagnostic tool in primary Sjogren’s syndrome
  1163. Effects of pasteurization of colostrum on subsequent serum lactoferrin concentration and neutrophil superoxide production in calves
  1164. Structure of copper-and oxalate-substituted human lactoferrin at 2.0 Å resolution
  1165. Cumulative correlations of lysozyme, lactoferrin, peroxidase, S-IgA, amylase, and total protein concentrations with adherence of oral viridans streptococci to …
  1166. Cholinergic stimulation of lactoferrin and epidermal growth factor secretion by the human lacrimal gland.
  1167. Effect of lactoferrin on interaction of Prevotella intermedia with plasma and subepithelial matrix proteins
  1168. Plasma lactoferrin as a marker of white cell degranulation in venous disease
  1169. Ultrastructural Effects of lactoferrin Binding on Giardia lamblia Trophozoites
  1170. Relationship between antibacterial activity and cell surface binding of lactoferrin in species of genus Micrococcus
  1171. Inhibition of iron/ascorbate-induced lipid peroxidation by an N-terminal peptide of bovine lactoferrin and its acylated derivatives
  1172. Antimicrobial peptide of Korean native goat lactoferrin and identification of the part essential for this activity
  1173. Anion Binding by Transferrins:  Importance of Second-Shell Effects Revealed by the Crystal Structure of Oxalate-Substituted Diferric lactoferrin,
  1174. Mutagenicity of bovine lactoferrin in reverse mutation test
  1175. Growth inhibitory effects of bovine lactoferrin to Toxoplasma gondii parasites in murine somatic cells
  1176. Fecal lactoferrin, fecal leukocytes and occult blood in the diagnostic approach to childhood invasive diarrhea
  1177. Antibacterial effects of lactoferrin and a pepsin-generated lactoferrin peptide against Helicobacter pylori in vitro
  1178. In vitro inhibition of mammary cell growth by lactoferrin: a comparative study
  1179. Amniotic-fluid lactoferrin: a marker for subclinical intraamniotic infection prior to 32 weeks gestation
  1180. Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis
  1181. Phospholipase D-mediated diradylglycerol formation coincides with H2O2 and lactoferrin release in adherent human neutrophils.
  1182. Inhibition of tryptophan oxidation in the presence of iron–vitamin C by bovine lactoferrin
  1183. lactoferrin inhibits cholesterol accumulation in macrophages mediated by acetylated or oxidized low-density lipoproteins
  1184. lactoferrin as a suppressor of cell migration of gastrointestinal cell lines
  1185. Plasma clearance and liver uptake of chylomicron remnants generated by hepatic lipase lipolysis: evidence for a lactoferrin-sensitive and apolipoprotein E …
  1186. Regulatory effects of lactoferrin and lipopolysaccharide on LFA-1 expression on human peripheral blood mononuclear cells
  1187. Mutagenesis of the Histidine Ligand in Human lactoferrin:  Iron Binding Properties and Crystal Structure of the Histidine-253 → Methionine Mutant,
  1188. Biochemical and immunological properties of lactoferrin binding proteins fromMoraxella (Branhamella) catarrhalis
  1189. Pancreatic stone protein and lactoferrin in human pancreatic juice in chronic pancreatitis.
  1190. Physicochemical and antibacterial properties of lactoferrin and its hydrolysate produced by heat treatment at acidic pH
  1191. lactoferrin and anti-lactoferrin antibodies: effects of ironloading of lactoferrin on albumin extravasation in different tissues in rats.
  1192. MICs of rifampicin and chloramphenicol for mucoid Pseudomonas aeruginosa strains are lower when human lactoferrin is present.
  1193. Analysis of the Immunological Responses to Transferrin and lactoferrin Receptor Proteins fromMoraxella catarrhalis
  1194. Characterization of lactoferrin-binding proteins of human macrophage membrane: multiple species of lactoferrin-binding proteins with polylactosamine-binding ability
  1195. The chicken oocyte receptor for yolk precursors as a model for studying the action of receptor-associated protein and lactoferrin
  1196. Preparation and characterization of the N and C monoferric lobes of buffalo lactoferrin produced by proteolysis using proteinase K
  1197. lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin
  1198. Direct detection and quantitative determination of bovine lactoferricin and lactoferrin fragments in human gastric contents by affinity mass spectrometry
  1199. Iocalized amyloidosis of the seminal vesicle: Identification of lactoferrin immunoreactivity in the amyloid material
  1200. Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis
  1201. Protective effect of orally administrated bovine lactoferrin against experimental infection of goldfish Carassius auratus with Ichthyophthirius multifiliis
  1202. Characterization of the goat lactoferrin cDNA: assignment of the relevant locus to bovine U12 synteny group
  1203. Recovery of 15N-lactoferrin Is Higher Than That of 15N-Casein in the Small Intestine of Suckling, But Not Adult Miniature Pigs
  1204. Antioxidant properties of lactoferrin from human milk
  1205. The relationship between elastase and lactoferrin in healthy, gingivitis and periodontitis sites
  1206. Binding of human plasminogen and lactoferrin by Helicobacter pylori coccoid forms
  1207. Bovine lactoferrin is more efficient than bovine lactoferricin in inhibiting HSV-I/-II replication in vitro.
  1208. Cell-surface lactoferrin as a marker for degranulation of specific granules in bovine neutrophils
  1209. Characterization of lactoferrin binding to the MAC-T bovine mammary epithelial cell line using a biotin-avidin technique.
  1210. Physical characteristics and polymerization during iron saturation of lactoferrin, a myelopoietic regulatory molecule with suppressor activity
  1211. Calprotectin and lactoferrin levels in the gingival crevicular fluid of children
  1212. Reactions of denatured proteins with other cellular components to form insoluble aggregates and protection by lactoferrin
  1213. lactoferrin lowers the incidence of positive Coombs’ test in New Zealand black mice.
  1214. Comparison of tests for fecal lactoferrin and fecal occult blood for colorectal diseases: a prospective pilot study
  1215. Leucocyte activation by anti-lactoferrin antibodies bound to vascular endothelium
  1216. Interaction of human milk lactoferrin with ATP.
  1217. Isolation and expression of a porcine lactoferrin gene.
  1218. Salivary factors in children with recurrent parotitis. Part 2: Protein, albumin, amylase, IgA, lactoferrin lysozyme and kallikrein concentrations.
  1219. Isolated rat hepatocytes acquire iron from lactoferrin by endocytosis
  1220. Orally administered lactoferrin increases hepatic protein synthesis in formula-fed newborn pigs
  1221. Promoter-specific activation of mouse lactoferrin gene by epidermal growth factor involves two adjacent regulatory elements.
  1222. lactoferrin is an estrogen responsive protein in the uterus of mice and rats
  1223. Identification of lactoferrin in bovine tears.
  1224. Oral treatment of rats with bovine lactoferrin inhibits carrageenan-induced inflammation; correlation with decreased cytokine production.
  1225. The effect of human lactoferrin on the MICs of doxycycline and rifampicin for Burkholderia cepacia and Pseudomonas aeruginosa strains
  1226. The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin
  1227. Tear lactoferrin levels and ocular bacterial flora in HIV positive patients
  1228. Inhibition of poliovirus type 1 infection by iron-, manganese-and zinc-saturated lactoferrin
  1229. Comparison of fecal lactoferrin latex agglutination assay and methylene blue microscopy for detection of fecal leukocytes in Clostridium difficile-associated disease
  1230. Effect of trypsin on bovine lactoferrin and interaction between the fragments under different conditions
  1231. Structural determination of two N-linked glycans isolated from recombinant human lactoferrin expressed in BHK cells
  1232. Isolated rat hepatocytes differentially bind and internalize bovine lactoferrin N-and C-lobes
  1233. Human milk lactoferrin binds ATP and dissociates into monomers
  1234. Specific binding of cerium by human lactoferrin stimulates the oxidation of Ce3+ to Ce4+
  1235. … effect of bovine lactoferrin to Toxoplasma gondii tachyzoites in murine macrophages: tyrosine phosphorylation in murine macrophages induced by bovine lactoferrin
  1236. Binding and degradation of lactoferrin by Porphyromonas gingivalis Prevotella intermedia and Prevotella nigrescens
  1237. Familial subepithelial corneal amyloidosis (gelatinous drop-like corneal dystrophy): exclusion of linkage to lactoferrin gene
  1238. Complexes of human lactoferrin with vanadium in oxidation states+ 3,+ 4 and+ 5
  1239. Transport of lactoferrin from blood to bile in the rat
  1240. Distribution of lactoferrin and 60/65 kDa heat shock protein in normal and inflamed human intestine and liver.
  1241. Growth inhibitory effect of bovine lactoferrin on Toxoplasma gondii tachyzoites in murine macrophages: Role of radical oxygen and inorganic nitrogen oxide in …
  1242. Human lactoferrin: production at large scale, characterization and applications.
  1243. Pathogenic Neisseriae Can Use Hemoglobin, Transferrin, and lactoferrin Independently of the tonBLocus
  1244. lactoferrin in cervical mucus as a biochemical marker for inflammation
  1245. Isolation and structure-functional characterization of human colostral lactoferrin
  1246. Identification of a lactoferrin-binding protein in Prevotella nigrescens
  1247. lactoferrin in tears in contact lens wearers.
  1248. Crystal Structure and Iron-Binding Properties of the R210K Mutant of the N-Lobe of Human lactoferrin:  Implications for Iron Release from Transferrins,
  1249. The Antibacterial Activity of lactoferrin and Neonatal E. coli Infections
  1250. lactoferrin structure-function relationships
  1251. Evaluation of bovine lactoferrin as a topical therapy for chemotherapy-induced mucositis in the golden Syrian hamster
  1252. Binding characteristics of bovine lactoferrin to the cell surface of Clostridium species and identification of the lactoferrin-binding protein
  1253. Accuracy of fecal lactoferrin and other stool tests for diagnosis of invasive diarrhea at a Colombian pediatric hospital
  1254. Characterization of the lactoferrin‐dependent inhibition of the adhesion of Actinobacilllus actinomycetemcomitans, Prevotella intermedia and Prevotella nigrescens …
  1255. Effects of topical glucocorticoids on in vitro lactoferrin glandular secretion: comparison between human upper and lower airways
  1256. Rapid identification and cloning of bacterial transferrin and lactoferrin receptor protein genes
  1257. Effect of twinning and supplemental iron-saturated lactoferrin on iron status of newborn calves
  1258. Analysis of the human Ig isotype response to lactoferrin binding protein A from Neisseria meningitidis
  1259. Structure–biological activity relationships of 11‐residue highly basic peptide segment of bovine lactoferrin
  1260. lactoferrin and eosinophilic cationic protein in nasal secretions of patients with experimental rhinovirus colds, natural colds, and presumed acute community-acquired …
  1261. Evaluation of a new latex agglutination test for fecal lactoferrin in travelers’ diarrhea
  1262. Induction of lactoferrin expression in murine ES cells by retinoic acid and estrogen
  1263. Adhesion of nontypeable Haemophilus influenzae from blood and sputum to human tracheobronchial mucins and lactoferrin
  1264. Unique epitopes of lactoferrin expressed in human cytotrophoblasts involved in immunologic reactions
  1265. Expression of human lactoferrin in milk of transgenic mice using bovine β-casein/human lactoferrin cDNA fusion gene
  1266. The immunosuppressive mini‐domain of human lactoferrin
  1267. Isolation and characterization of a gene encoding human Kruppel-like factor 5 (IKLF): binding to the CAAT/GT box of the mouse lactoferrin gene promoter
  1268. Active peptides of lactoferrin
  1269. Identification of lactoferrin‐binding proteins from Treponema pallidum subspecies pallidum and Treponema denticola
  1270. Immunohistochemical study of ceruloplasmin, lactoferrin and secretory component expression in neoplastic and non-neoplastic thyroid gland diseases
  1271. Antitumor effect of human lactoferrin against newly established human pancreatic cancer cell line SPA
  1272. Comparison of heparin‐binding to lactoferrin from human milk and from human granulocytes by means of affinity capillary electrophoresis
  1273. Influence of lactoferrin on host-microbe interactions
  1274. Characterization of the protein and glycan moieties in different forms of bovine lactoferrin
  1275. Phagocytosis-enhancing effect of lactoferrin on bovine peripheral blood monocytes in vitro and in vivo.
  1276. On the molecular-replacement problem in the presence of merohedral twinning: structure of the N-terminal half-molecule of human lactoferrin
  1277. Transferrin: Interactions of lactoferrin with hydrogen carbonate
  1278. Sequence variability of the meningococcal lactoferrin-binding protein LbpB
  1279. Inhibition of in vitro replication of the oyster parasite Perkinsus marinus by the natural iron chelators transferrin, lactoferrin, and desferrioxamine
  1280. Identification and Analysis of a Ca2+-Dependent lactoferrin Receptor in Rat Liver
  1281. Expression of Human lactoferrin cDNA in Insect Cells.
  1282. Functional lactoferrin receptors on activated human lymphocytes
  1283. lactoferrin: A Marvelous Protein in Milk?
  1284. Tear lactoferrin levels in chronic meibomitis associated with acne rosacea
  1285. Bactericidal activity of different forms of lactoferrin
  1286. Role of diradylglycerol formation in H2O2 and lactoferrin release in adherent human polymorphonuclear leukocytes
  1287. lactoferrin as a gene delivery vehicle to hepatocytes
  1288. Occurrence of anti-lactoferrin antibodies in patients with systemic lupus erythematosus, hydralazine-induced lupus, and rheumatoid arthritis
  1289. Maternal serum lactoferrin and vertical transmission of HIV
  1290. Tissue and site-specific methylation correlates with expression of the mouse lactoferrin gene
  1291. Effects of topical application of free and liposome-encapsulated lactoferrin and lactoperoxidase on oral microbiota and dental caries in rats
  1292. Restricted spatiotemporal expression of lactoferrin during murine embryogenesis
  1293. Binding characteristics of human lactoferrin to the human monocytic leukemia cell line THP-1 differentiated into macrophages
  1294. Characterization of two kinds of lactotransferrin (lactoferrin) receptors on different target cells
  1295. lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment
  1296. Structural and immunochemical studies on bovine lactoferrin fragments
  1297. Enhanced Anti-Candida Activity of Neutrophils and Azole Antifungal Agents in the Presence of lactoferrin-Related Compounds
  1298. Synthesis of lactoferrin and casein by explants of bovine mammary tissue
  1299. Neutrophil lactoferrin release induced by IgA immune complexes differed from that induced by cross-linking of Fcα receptors (FcαR) with a monoclonal antibody …
  1300. … cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin …
  1301. Expression analysis of a bovine β-casein/human lactoferrin hybrid gene in transgenic mice
  1302. lactoferrin receptors in intestinal brush border membranes
  1303. Human lactoferrin receptor activity in non-encapsulated Haemophilus influenzae
  1304. Microparticle‐enhanced nephelometric immunoassay of lactoferrin in human milk
  1305. Regulation by lactoferrin of epidermal Langerhans cell migration
  1306. Effect of 1 human milk prostaglandins and lactoferrin on respiratory syncytial virus and rotavirus
  1307. Estrogenic effect on the expression of estrogen receptor, COUP‐TF, and lactoferrin mRNA in developing mouse tissues
  1308. Effects of lactoferrin on iron absorption in immature mice
  1309. Fecal lactoferrin assay as a cost-effective tool for intestinal inflammation
  1310. Aluminum site structure in serum transferrin and lactoferrin revealed by synchrotron radiation X-ray spectroscopy
  1311. A longitudinal study of unsaturated iron-binding capacity and lactoferrin in unstimulated parotid saliva
  1312. lactoferrin in thyroid lesions: immunoreactivity in fine needle aspiration biopsy samples.
  1313. The monocytic receptor for lactoferrin and its involvement in lactoferrin-mediated iron transport
  1314. Effect of some physical and chemical factors on the bactericidal activity of human lactoferrin and transferrin against Yersinia pseudotuberculosis.
  1315. Proposed mechanisms for the involvement of lactoferrin in the hydrolysis of nucleic acids
  1316. Serum eosinophilic cationic protein and lactoferrin related to smoking history and lung function
  1317. Isolation of lactoferrin by immunoaffinity chromatography using yolk antibodies
  1318. Salivary lactoferrin in neonates with chorioamnionitis
  1319. Effect of lactoferricin B, a pepsin-generated peptide of bovine lactoferrin, on Escherichia coli HB101 (pRI203) entry into HeLa cells
  1320. Characterization and functional analysis of the porcine lactoferrin gene promoter
  1321. Competitive ELISA of bovine lactoferrin with bispecific monoclonal antibodies
  1322. Spectroscopic studies on metal complexes of Aspergillus awamori-derived recombinant human lactoferrin
  1323. … blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 …
  1324. Insertional inactivation of the gene for the meningococcal lactoferrin binding protein
  1325. Immunological cross-reaction between lactoferrin and transferrin
  1326. Effect of substratum on growth, cell morphology and lactoferrin synthesis and secretion in bovine mammary cell culture
  1327. Prokaryotic expression of bovine lactoferrin deletion mutants that bind to the Ca2+-dependent lactoferrin receptor on isolated rat hepatocytes
  1328. Mechanisms of lactoferrin‐induced leukocyte‐endothelial cell adhesion in postcapillary venules
  1329. Iron‐loading of cultured adult rat hepatocytes reversibly enhances lactoferrin binding and endocytosis
  1330. Fecal lactoferrin as a marker of fecal leukocytes
  1331. Host defensive effects of orally administered bovine lactoferrin
  1332. Effects of a lactoperoxidase system and lactoferrin, added to a milk replacer diet, on severity of diarrhoea, intestinal morphology and microbiology of digesta and …
  1333. Effect of bovine lactoferrin on performance of Japanese flounder Paralichthys olivaceus.
  1334. Antiviral activity of lactoferrin-derived peptides.
  1335. Suppression of stress reactions of rainbow trout, Oncorhynchus mykiss, reared at high density by oral administration of bovine lactoferrin
  1336. Neutrophil lactoferrin release induced by IgA immune complexes can be mediated either by Fc alpha receptors or by complement receptors through different pathways …
  1337. Role of the First N-Terminal Basic Cluster of Human lactoferrin (R2R3R4R5) in the Interactions with the Jurkat Human Lymphoblastic T-Cells
  1338. Anti-inflammatory capacities of human milk: lactoferrin and secretory IgA inhibit endotoxin-induced cytokine release
  1339. Matrix attachment region sequences enhanced the expression frequency of a whey acidic protein/human lactoferrin fusion gene in the mammary gland of transgenic …
  1340. 13-Week oral repeated administration toxicity study of bovine lactoferrin in rats
  1341. Oral administration of lactoferrin enhances the productions of IFN-γ and IL-10 in spleen cells cultured with concanavalin A or lipopolysaccharide
  1342. Effect of Vibrio cholerae non-O1 protease on lysozyme, lactoferrin and secretory immunoglobulin A
  1343. Maternal lactoferrin in the urine of preterm infants
  1344. Anti-lactoferrin autoantibodies: relation between epitopes and iron-binding domain
  1345. Two spatially distant epitopes of human lactoferrin
  1346. Autoantibodies to lactoferrin and histone in systemic vasculitis identified by anti-myeloperoxidase solid phase assays
  1347. Identification and isolation of a 45-kDa calcium-dependent lactoferrin receptor from rat hepatocytes
  1348. Neutrophil β2-microglobulin and lactoferrin content in renal failure patients
  1349. Role of glycan chains in bovine lactoferrin.
  1350. X-ray structural analysis of bovine lactoferrin at 2.5 Å resolution
  1351. Apoptosis of Caco-2 intestinal cells invaded by Listeria monocytogenes: protective effect of lactoferrin
  1352. The Main Systemic, Highly Effective, and Quickly Acting Antimicrobial Mechanisms Generated by lactoferrin in Mammals in Vivo
  1353. Complete sequence analysis of rat transferrin and expression of transferrin but not lactoferrin in the digestive glands
  1354. lactoferrin inhibits Bacillus cereus growth and heme analogs recover its growth
  1355. Neutrophil lactoferrin release during open heart surgery is unrelated to complement activation.
  1356. Purification, crystallization and preliminary crystallographic analysis of mare lactoferrin
  1357. Purification of membrane-bound lactoferrin from the human milk fat globule membrane
  1358. lactoferrin gene promoter in human and mouse
  1359. lactoferrin inhibits the effector phase of the delayed type hypersensitivity to sheep erythrocytes and inflammatory reactions to M. bovis (BCG).
  1360. Lysozyme and lactoferrin in human uncinate process mucosa during chronic sinusitis
  1361. The anti-invasive effect of bovine lactoferrin requires an interaction with surface proteins of Listeria monocytogenes
  1362. Effect of orally administrated bovine lactoferrin on the survival rate of juvenile ayu, Plecoglossus altivelis, held under deteriorating environmental conditions
  1363. Concurrence of Clostridium difficile toxin A enzyme-linked immunosorbent assay, fecal lactoferrin assay, and clinical criteria with C. difficile cytotoxin titer in two patient …
  1364. Agglutination of Bacterial Cells of Clostridium innocuum, Bifidobacterium longum, and Micrococcus luteus by lactoferrin and Ovotransferrin
  1365. lactoferrin impedes epithelial cell adhesion in vitro
  1366. Elevated CSF lactoferrin in superficial siderosis of the central nervous system
  1367. Phosphatidic acid induces the release of β-glucuronidase but not lactoferrin from electropermeabilized human neutrophils
  1368. Antibodies to lactoferrin
  1369. Analysis of the expression of growth factor, interleukin-1, and lactoferrin genes and the distribution of inflammatory leukocytes in the preimplantation mouse oviduct
  1370. High immunoreactivity of lactoferrin contaminating commercially purified myeloperoxidase
  1371. Enhancement of cationic liposome-mediated transfection by lactoferrin
  1372. Immunological status of patients subjected to cardiac surgery: effect of lactoferrin on proliferation and production of interleukin 6 and tumor necrosis factor alpha by …
  1373. Presence of a glycan at a potential N-glycosylation site, Asn-281, of bovine lactoferrin
  1374. lactoferrin: similarity to diamine oxidase and purification by aminohexyl affinity chromatography
  1375. Iron transport across Caco-2 cell monolayers. Effect of transferrin, lactoferrin and nitric oxide
  1376. Siderophore-mediated utilization of transferrin-and lactoferrin-bound iron by Acinetobacter baumannii
  1377. Binding of porcine milk lactoferrin to piglet intestinal lactoferrin receptor
  1378. Augmentation by lactoferrin of host defense against Candida infection in mice.
  1379. Heterogeneity of seminal vesicle amyloid. Immunohistochemical detection of lactoferrin and amyloid of the prealbumin-transthyretin type
  1380. Inhibition of listeriolysin O-induced hemolysis by bovine lactoferrin
  1381. Three complement-type repeats of the low-density lipoprotein receptor-related protein define a common binding site for RAP, PAI-1, and lactoferrin
  1382. Structure of oxalate-substituted diferric mare lactoferrin at 2.7 Å resolution
  1383. Tear lactoferrin concentration during postoperative ocular inflammation in cataract surgery
  1384. Characterization of the post-translational biochemical processing of human lactoferrin expressed in transgenic tobacco
  1385. Suppressive effects of lactoferrin on bleomycin-dependent DNA damage by the iron ion and ascorbate
  1386. Comparison of immunomodulatory properties of purified lactoferrin, lactoperoxidase and β-casein in sheep
  1387. Analysis of bovine lactoferrin in whey using capillary electrophoresis (CE) and micellar electrokinetic chromatography (MEKC)
  1388. Inhibitory Activity of Human lactoferrin and Its Peptide on Chondroitin Sulfate A-, CD36-, and Thrombospondin-Mediated Cytoadherence ofPlasmodium falciparum …
  1389. Biliary lactoferrin concentrations are increased in active inflammatory bowel disease: a factor in the pathogenesis of primary sclerosing cholangitis?
  1390. Binding of lactoferrin to bacterial cells of the Clostridium species and their agglutination
  1391. Extraction of lactoperoxidase and lactoferrin from cheese whey using membrane cation exchangers
  1392. Iron uptake from lactoferrin by intestinal brush-border membrane vesicles of human neonates.
  1393. Effect of bovine and human lactoferrin on MA 104 cell infected with human rotavirus
  1394. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease and collagenous colitis: no association with lactoferrin, β-glucuronidase, myeloperoxidase, or …
  1395. Inhibitory effect of lactoferrin on the adhesion of Prevotella nigrescens ATCC 25261 to hydroxyapatite
  1396. Kinetic parameters for the heat denaturation of bovine lactoferrin in milk, and its effect on interaction with monocytes
  1397. Biochemical characterization of bovine lactoferrin as a glycyrrhizin-binding protein in vitro
  1398. A study of lactoferrin and antibodies against lactoferrin in neurological diseases
  1399. lactoferrin in infant formulas
  1400. lactoferrin improves physiological conditions of fish held under deteriorating states.
  1401. Immunohistochemical demonstration of lactoferrin in human neoplastic tissues
  1402. Metal substitution in lactoferrins: the crystal structure of manganese lactoferrin at 3.4 Å resolution
  1403. Processes Underlying Interactions of Human lactoferrin with the Jurkat Human Lymphoblastic T‐cell Line Receptor. II‐Comparative Molecular Field Analysis
  1404. In vivo and in vitro effects of lactoferrin on Yersinia pseudotuberculosis.
  1405. Mammary mechanisms for lactoferrin: interactions with IGFBP-3
  1406. Breast feeding and formulas: the role of lactoferrin?
  1407. Molecular cloning and sequence analysis of bubaline lactoferrin promoter
  1408. Cloning and expression of the C-terminal lobe of human lactoferrin
  1409. Study on the binding of lactotransferrin (lactoferrin) to human PHA-activated lymphocytes and non-activated platelets
  1410. Diagnostic value of lactoferrin analysis in pleural effusions
  1411. Measurement of fecal lactoferrin for diagnosis on pediatric gastrointestinal disease
  1412. lactoferrin and insult-induced metabolic imbalance in humans and other animals.
  1413. lactoferrin-Receptor Interaction
  1414. Recognition of lactoferrin and aminopeptidase M-modified lactoferrin by the liver: involvement of the remnant receptor.
  1415. Role of sialic acid residues in iron binding by human lactoferrin-α
  1416. Interaction of lactoferrin with Micrococcus spp. and Its Role in Antimicrobial Activity
  1417. Electrophoretic detection of myeloperoxidase, protease, lactoferrin and lysozyme in buffalo polymorphonuclear granular acid extracts
  1418. Iron‐Induced conformational change in human lactoferrin: Demonstration by sodium dodecyl sulfate‐polyacrylamide gel electrophoresis and analysis of effects of iron …
  1419. Anti-myeloperoxidase and anti-lactoferrin antibodies in patients with IgA nephropathy and Henoch-Schönlein purpura
  1420. lactoferrin and lysozyme-two mammalian antibiotics
  1421. Bioactive proteins in bovine milk-Studies on glutathione peroxidase, lactoferrin and immunoglobulins
  1422. Interaction of lactoferrin with ascorbate and the relationship with bleomycin-dependent DNA damage
  1423. Effect of lactoferrin on iron absorption in mice.
  1424. Interleukin-6, C-reactive protein, lactoferrin and white blood cell count in patients with S. aureus septicemia
  1425. Mutation of Arginine 121 in lactoferrin Destabilizes Iron Binding by Disruption of Anion Binding:  Crystal Structures of R121S and R121E Mutants,
  1426. An innate natural antibody is reactive with a cryptic sequence of lactoferrin exposed on sperm head surface
  1427. Biodistribution of human lactoferrin in the gastrointestinal tract.
  1428. Distribution of Lysozyme-and lactoferrin-Secreting Cells in Eustachian Tube of Normal BALB/c Mouse.
  1429. Effect of lactoferrin on the phagocytic activity of polymorphonuclear leucocytes isolated from blood of patients with autoimmune diseases and Staphylococcus aureus …
  1430. Crystallization and preliminary X-ray diffraction studies of the proteolytically engineered C-terminal half of buffalo lactoferrin in its iron-saturated form
  1431. … of a 76-kDa iron-binding protein from human seminal plasma by affinity chromatography specific for ribonuclease: structural and functional identity with milk lactoferrin
  1432. Regulation of lymphocyte proliferation by lactoferrin
  1433. Interaction of lactoferrin with mononuclear and colon carcinoma cells
  1434. Importance of pathogen-eliminating systems in host protection by lactoferrin feeding.
  1435. Expression of marker genes in muscle fibers after transfection in vivo, mediated by lactoferrin
  1436. Bacterial lactoferrin Receptors in the Neisseriaceae
  1437. Binding of Streptococcus mutans, Serotype c, to Saliva-coated Hydroxyapatite in the Presence and Absence of Human lactoferrin
  1438. Digestion of orally administered lactoferrin in adult rats.
  1439. The role of lactoferrin in the gastrointestinal tract
  1440. lactoferrin reverses respiratory abnormalities in respiratory syncytial virus (RSV) infection of mice
  1441. Processes Underlying Interactions of Human lactoferrin with the Jurkat Human Lymphoblastic T‐cell Line Receptor. I‐Quantitative Structure‐Affinity Relationships …
  1442. Clinical evaluation of fecal lactoferrin and α 1-antitrypsin in pediatric gastrointestinal infections
  1443. lactoferrin release in experimental venous hypertension
  1444. Immunohistochemical study of estrogen-induced lactoferrin-like protein in the mouse uterus: localization in the nucleolus and secretory pathway
  1445. Classification of acute myeloid leukaemia in trephine biopsies with special reference to lactoferrin.
  1446. Plasma lactoferrin concentration measured by ELISA in healthy and diseased cows.
  1447. Bovine lactoferrin protects mice against Escherichia coli: comparison of different ways of its application and effect of reticuloendothelial system blockade
  1448. Neutrophil activation subsequent to cardiopulmonary bypass: a sensitive method for determining neutrophil activation by quantification of lactoferrin concentrations
  1449. Variants and biotechnological use of the bovine lactoferrin-encoding gene
  1450. Construction of recombinant chimeric human lactoferrin/bovine transferrins
  1451. Effect of lactoferrin on growth, survival and tolerance to stress of kuruma prawn Penaeus japonicus.
  1452. A comparison of the three-dimensional structures of human lactoferrin in its iron free and iron saturated forms
  1453. Crystallographic studies on metal and anion substituted human lactoferrin
  1454. Functional significance of the binding of lactoferrin to DNA
  1455. Cryptic domains of a 60 kDa heat shock protein of Helicobacter pylori bound to bovine lactoferrin
  1456. Antiviral effects of plasma and milk proteins: lactoferrin shows potent antiviral activity on both HIV and HCMV replication in vitro in the same concentration range
  1457. lactoferrin promotes nerve growth factor synthesis/secretion in mouse fibroblast LM cells
  1458. Posttranscriptional Regulation of Bovine and Human lactoferrin
  1459. Clinical studies on lactoferrin added to infant formula.
  1460. Further evidence of different lactoferrin and transferrin binding sites on human HT29-D4 cells. Effects of lysozyme, fucose and cathepsin G. Comparison with …
  1461. Binding of human lactoferrin to Escherichia coli porins: a biochemical study.
  1462. The Impact of Phagocyte—lactoferrin Interactions on Inflammation
  1463. Structural and functional flexibility of lactoferrin
  1464. Genomic human lactoferrin sequence induced high levels of protein expression in milk of transgenic mice.
  1465. lactoferrin gene: methylation, expression and cancer.
  1466. Heterologous introns enhanced expression of human lactoferrin cDNA in mouse mammary epithelial cells
  1467. lactoferrin Almost Absent From Lactating Rat Mammary Gland Is Replaced by Transferrin
  1468. Prevention of carcinogenesis and metastasis by dietary bovine lactoferrin.
  1469. lactoferrin against oral Candidiasis.
  1470. Development of a two-site immunoassay using polyclonal antibodies for determination of lactoferrin in human blood
  1471. In vitro and in vivo antidermatophytic effects of lactoferrin.
  1472. Bacteriostatic effects of orally administered bovine lactoferrin on intestinal bacteria in the gut of mice fed bovine milk
  1473. Interaction of lactoferrin with calcium and its implications to application of lactoferrin in foods.
  1474. Essential metal ions alter the lactoferrin binding to the erythrocyte plasma membrane receptors
  1475. Estrogen regulation of human lactoferrin gene activity
  1476. Interaction of lactoferrin with sequestered transition metal ions
  1477. Inhibition of lactoferrin and vitronectin binding toStaphylococcus aureus by heparin
  1478. Role of sialic acid residues in iron binding by human lactoferrin-a
  1479. Antiviral activity of lactoferrin against HCV infection in human cultured cells.
  1480. High lactoferrin levels in disseminated intravascular coagulation and its possible negative role in coagulation
  1481. Radioimmunometric quantification of surface lactoferrin in blood mononuclear cells
  1482. Bovine milk lactoferrin modulates the proliferative lymphocyte response to phytohemagglutinin
  1483. Brain lactoferrin: Origins and mechanisms of accumulation in neurodegenerative disorders
  1484. Isolation of lactoferrin from bovine colostrum by chromatographic techniques
  1485. PRODUCTION OF RECOMBINANT HUMAN lactoferrin IN MILK OF TRANSGENIC COWS 24
  1486. Distribution of the iron-binding protein lactoferrin in the pathological lesions of neurodegenerative diseases
  1487. Clinico-diagnostic role of ferritin and lactoferrin assays in benign and malignant affections of lungs and pleura
  1488. Regulation of interleukin 6 (IL-6) and TNF-alpha through lactoferrin in mice
  1489. Expression and functional analysis of recombinant human lactoferrin
  1490. lactoferrin effects on immune response in critically ill
  1491. Is nitric oxide involved in the protective effect against Escherichia coli infection generated by lactoferrin in vivo?
  1492. Isolation and detection of human lactoferrin binding protein in human amniotic membrane
  1493. Cloning of human genomic lactoferrin sequence and expression in the mammary glands of transgenic animals
  1494. Establishment of a mouse hybrid-hybridoma secreting bispecific antibodies to bovine lactoferrin and horseradish peroxidase
  1495. lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C.
  1496. Expression of marker genes in muscular fibers after in vivo lactoferrin-mediated transfection.
  1497. Superoxide dismutase-like activity of metal substituted lactoferrin derivatives.
  1498. The action of lactoperoxidase, lactoferrin and lactoglobulin on Shigella sonnei in an in-vivo experiment
  1499. Is lactoferrin a transcription factor? Computer-assisted search for potential target genes and analysis of a sequence-specific DNA binding
  1500. lactoferrin in milk and its role in iron absorption.
  1501. Molecular characterization of Streptococcus uberis CAMP factor, lactoferrin binding protein and their upstream genes.
  1502. Recent development of lactoferrin (its active peptides and their physiological functions). II.
  1503. Bovine lactoferrin
  1504. Immunoenzyme method of determining human lactoferrin and its use for diagnosing purulent-septic complications
  1505. Zonal distribution of receptor binding of trypsin-activated α2-macroglobulin, α2-macroglobulin receptor-associated protein, lactoferrin and transferrin on rat liver …
  1506. Recombinant human lactoferrin and its variants
  1507. Observations on the impact of breast-feeding and of intestinal helminthiasis on a rapid agglutination assay for fecal lactoferrin in Nicaraguan children with diarrhea
  1508. Anti-microbiol and anti-inflammatory activities of human lactoferrin and its peptides
  1509. Antimicrobial and antitumor activities of lactoferrin in mouse model systems.
  1510. Bovine lactoferrin inhibits rat tongue carcinogenesis.
  1511. Enhanced Chemiluminescent Detection of Fluorescein-Labeled Nucleic Acids Compared to 32P Labeling Methods: lactoferrin as a Marker
  1512. lactoferrin (LT) Levels in Term (T) and Preterm (PT) Milk. 1401
  1513. Altered domain closure and iron binding in lactoferrin mutants
  1514. Expression of human lactoferrin in transfected rat mammary epithelial cells
  1515. Observations on the metabolism and cellular interactions of lactoferrin
  1516. … intestinal microbiological and morphological observations in young calves fed milk replacers enriched with a combination of lactoperoxidase system and lactoferrin
  1517. Antiviral effect of bovine lactoferrin on feline herpesvirus infection.
  1518. Structure-function analysis of the hepatocyte binding domain of lactoferrin
  1519. Identification of an active domain of bovine lactoferrin that enhances the phagocytic activity of human neutrophils.
  1520. Studies on the Antibacterial Activity of Enzymatic Hydrolyzates of lactoferrin Derived from Bovine Colostrum
  1521. Clinical evaluation of orally administered bovine lactoferrin for treatment of tinea pedis.
  1522. Fecal lactoferrin screening assay for inflammatory bacterial diarrhea
  1523. Immunoenzyme method of lactoferrin analysis
  1524. The Effect of Lysosomal pH on lactoferrin-Dependent Iron Uptake in Tritrichomonas foetus
  1525. Rat intestinal epithelial cells modify the reactivity of bovine milk lactoferrin to concanavalin A
  1526. Relationship between metaplastic changes and occurrence of endocrin cells, lysozyme and lactoferrin in gallbladder carcinoma
  1527. lactoferrin characterization in milk from different animal species [donkey-mare-goat-sow]
  1528. DEFENSIN AND lactoferrin, CIRCULATING ENDOGENOUS ANTIMICROBIALS, ARE INCREASED IN PEDIATRIC SEPSIS
  1529. lactoferrin: Structure, Function and Applications
  1530. A modification of lactoferrin isolation method
  1531. Separation of lactoferrin and clinical application of its radioimmunoassay
  1532. Separation of lactoferrin and clinical application of its radioimmunoassay
  1533. lactoferrin in duodenal aspirates during childhood
  1534. Mutagenesis of Human lactoferrin and Expression in Baby Hamster Kidney Cells
  1535. Measurement of Urinary lactoferrin as
  1536. lactoferrin as a Possible Transcriptional Regulator
  1537. Structure of mare lactoferrin at 4.0 A [ring] resolution
  1538. Has lactoferrin a Role in Hereditary Hemochromatosis?
  1539. Recent development of lactoferrin (structure, properties and methods of preparation).
  1540. RESTRICTED SPATIOTEMPORAL EXPRESSION OF lactoferrin DURING MURINE
  1541. Negative Regulation of Activated Granulocytes in Number and Function by lactoferrin
  1542. Use of lactoferrin assay in the diagnosis of different vaginal pathogens
  1543. Direct evidence of the generation of lactoferricin from ingested lactoferrin
  1544. CA2+-DEPENDENT lactoferrin RECEPTOR
  1545. Estrogen regulates expression of lactoferrin in human endometrium.
  1546. Separation of tryptic fragments of bovine lactoferrin and their ability to bind to Trypanosoma cruzi
  1547. Functional domains of human lactoferrin involved in antibacterial activities
  1548. The bovine lactoferrin gene: defining the minimal promotor region: a thesis presented to Massey University in partial fulfilment of the requirements for the degree of …
  1549. lactoferrin and Eosinophilic Cationic
  1550. Expression of recombinant mouse lactoferrin in insect cells.
  1551. Development of Secretory Activity, the Localization of lactoferrin in the Secretory Pathway, and Interactions of
  1552. PROTECTIVE ROLE OF HUMAN lactoferrin AGAINST INVASION OF Shigella flexneri M90T.♦ 707
  1553. Purification of lactoferrin and its RIA application in diagnosis of lung cancer
  1554. Iron acquisition from lactoferrin by pathogenic members of the neisseriaceae
  1555. Development of an Antibacterial MAP Homologous to a Loop Region in Human lactoferrin
  1556. Expression of Human lactoferrin Gene and Secretion in Saccharomyces diastaticus YIY345
  1557. lactoferrin Impairs the Initial Steps of Shigella flexneri-induced Phagocytosis in HeLaCells♦ 842
  1558. Human lactoferrin receptor activity in non-encapsulated Haemophilus
  1559. Inhibitory properties of pepsin digested lactoferrin in apple and carrot juice
  1560. Characterization of lactoferrin gene 5′ flanking region of Korean native goat.
  1561. Identification of two molecular species in human milk-derived lactoferrin.
  1562. Effect of peptides from lactoferrin on some food spoilage bacteria
  1563. lactoferrin iron uptake pathway of Trichomonas vaginalis
  1564. Identification and isolation of lactoferrin-binding proteins purified from rat hepatocytes
  1565. An evaluation of lactoferrin latex agglutination assay as a new marker for inflammatory diarrhea in pediatric patients.
  1566. Ocular Bacteria and Concentration of lactoferrin in Poodle Dogs with Tear Staining Syndrome
  1567. Enteral lactoferrin Mitigates Gut-Associated Neonatal Infection
  1568. Biological Functions of lactoferrin and Antigenic Determinants of Lactoferricin
  1569. The responsiveness of the bovine lactoferrin promoter to cytokines and glucocorticoids: a thesis presented in partial fulfilment of the requirements for the degree of …
  1570. Characterization of the binding of human milk lactoferrin to iron and DNA
  1571. lactoferrin Inhibits Bacillus cereus Growth and Heme Analogs Recover
  1572. Effect of leupeptin, TLCK and lactoferrin on tryptase release from human colon mast cells
  1573. Determination of Antigenic Determinant (Epitope) of lactoferrin-B Recognized by Monoclonal Antibody
  1574. Regulation of epidermal Langerhans cell migration by lactoferrin and dexamethasone
  1575. Bovine lactoferrin down-regulate T-cell function during SEB-induced septicemia
  1576. The Standardization and Utilization of a Spot Plate Assay to Help Define the Mechanism of lactoferrin-mediated Killing of S. mutans
  1577. A mutational analysis of the hinge region of the N-lobe of lactoferrin: a thesis presented in partial fulfilment of the requirements for the degree of Master of Science in …
  1578. Antibacterial factors in cows’ milk and colostrum: immunoglobulins and lactoferrin
  1579. Digestive tract cell activating agent of EGF and lactoferrin
  1580. Influence of Lys-residue deletion on the immunomodulatory activity of peptides related to immunosuppressive region of lactoferrin.
  1581. Thermal behaviour of bovine lactoferrin in relation to bacterial interaction and antibacterial activity [application of differential scanning colorimetry]
  1582. Protection against Invasion of Various Enteric Pathogens in HeLa Cells by Human lactoferrin
  1583. Inhibition by lactoferrin of allergen-induced dendritic cell migration to draining lymph nodes
  1584. lactoferrin Modulates Endotoxin-Mediated Activation of Pulmonary Alveolar Macrophages
  1585. Levels of Antimicrobial Molecules Defensin and lactoferrin are elevated in the Cerebrospinal Fluid of Children with Bacterial Meningitis• 384
  1586. Effect of lactoferrin digest and ozone treatments on Penicillium spp. isolated from bottled water
  1587. Comparison of secondary structure and antibacterial activity of bactericidal peptides derived from bovine and Korean native goat lactoferrin
  1588. Prostatic markers, lactoferrin and infertility in chronic non bacterial prostatitis
  1589. Effects of lactoferrin and Lysozyme on Ciliary Motility in Rabbit Tracheal Epithelium
  1590. Crystallographic and physicochemical studies on anion-binding and deglycosylation of human lactoferrin: a thesis presented in partial fulfilment of the requirements …
  1591. lactoferrin Increases the Output of Neutrophil Precursors and Attenuates the Spontaneous Production of TNF-a and IL-6 by Peripheral Blood Cells
  1592. The importance of trypsin inhibitor, lactoferrin, and bovine colostral cells in the immunity of newborn calves.
  1593. Relationship between lymphocytic infiltration grading in lacrimal glands and concentration of tear lactoferrin of the patients with sjogren’s syndrome
  1594. Crystallographic studies of folypolyglutamate synthetase and recombinant human lactoferrin: a dissertation submitted in partial fulfilment of the requirements for the …
  1595. Direct Cloning and Expression of Full Length cDNA and the N-lobe DNA Fragment of Human lactoferrin in Escherichia coli
  1596. Some Properties of Bispecific Antibodies to Bovine lactoferrin and Horseradish Peroxidase Secreted by a Hybrid-Hybridoma HH1-4-3
  1597. … -LIKE GROWTH FACTOR-I (IGF-I) ALLEVIATE THE GROWTH SUPPRESSIVE EFFECT OF IRON-UNSATURATED lactoferrin ON HUMAN ENTEROCYTES …
  1598. Effect of human lactoferrin (hLf) and epidermal growth factor (hEGF) on caco-2 cell monolayer barrier function
  1599. Spatio-temporal localization of lactoferrin-like immunoreactivity in the rat hippocampus after transient forebrain ischemia
  1600. A study on the correlations between salivary levels of lysozyme, lactoferrin and secretory Immunoglobulin A to Streptococcus mutans and caries susceptibility
  1601. Enhanced release of lactoferrin and IL-8 following the upregulation of neutrophil-mediated ADCC by GM-CSF: A comparison between image analysis and chromium …
  1602. Affinity purification of bovine lactoferrin and bovine transferrin from whey using immobilized gangliosides
  1603. … MEMBRANE PROTEIN BY MORAXELLA CATARRHALIS IS REGULATED BY IRON AND AFFECTS IRON ACQUISITION FROM TRANSFERRIN AND lactoferrin …
  1604. Familial sub-epithelial corneal amyloidosis (gelatinous drop-like cor-neal dystrophy): exclusion of linkage to lactoferrin gene
  1605. … -232) AN EVALUATION OF THE TOUCH SCIENTIFIC lactoferrin MICROASSAY SYSTEM: REPEATABILITY OF TEAR lactoferrin MEASUREMENTS: 3: 20 …
  1606. An analysis of the rat hepatic lectin-1 (RHL-1) recognition domain of bovine lactoferrin
  1607. Cardiac surgery induces increased production of interleukin-10 and lactoferrin
  1608. lactoferrin
  1609. lactoferrin
  1610. lactoferrin
  1611. lactoferrin
  1612. lactoferrin
  1613. lactoferrin research, technology and applications
  1614. lactoferrin and its biological functions
  1615. Antiinflammatory activities of lactoferrin
  1616. Antiviral activities of lactoferrin
  1617. The antimicrobial activity of lactoferrin: current status and perspectives
  1618. lactoferrin—a multifunctional protein with antimicrobial properties
  1619. lactoferrin–a novel bone growth factor
  1620. Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application
  1621. Cancer prevention by bovine lactoferrin and underlying mechanisms a review of experimental and clinical studies
  1622. lactoferrin functions: current status and perspectives
  1623. lactoferrin and iron: structural and dynamic aspects of binding and release
  1624. Human lactoferrin: a novel therapeutic with broad spectrum potential
  1625. lactoferrin and host defence: an overview of its immuno-modulating and anti-inflammatory properties
  1626. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation
  1627. The therapeutic potential of lactoferrin
  1628. Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin
  1629. Biological properties of lactoferrin: an overview
  1630. Bovine lactoferrin: benefits and mechanism of action against infections
  1631. Bovine lactoferrin and lactoferricin derived from milk: production and applications
  1632. lactoferrin: a multifunctional protein
  1633. lactoferrin and bone; structure–activity relationships
  1634. lactoferrin promotes bone growth
  1635. Interactions of lactoferrin with cells involved in immune function
  1636. lactoferrin and transferrin: functional variations on a common structural framework
  1637. Pharmacokinetics and brain uptake of lactoferrin in rats
  1638. Gastric digestion of bovine lactoferrin in vivo in adults
  1639. lactoferrin Is a Potent Regulator of Bone Cell Activity and Increases Bone Formation in Vivo
  1640. Antibiotic properties and applications of lactoferrin.
  1641. Activated lactoferrin– A New Approach to Meat Safety
  1642. Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months
  1643. Molecular cloning and functional expression of a human intestinal lactoferrin receptor
  1644. Effect of lactoferrin on Enteroaggregative E. coli (EAEC)
  1645. Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease
  1646. Large scale production of recombinant human lactoferrin in the milk of transgenic cows
  1647. Uptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues
  1648. Relationship between fecal lactoferrin and inflammatory bowel disease
  1649. lactoferrin concentrations in milk from normal and subclinical mastitic cows
  1650. lactoferrin reduces in vitro osteoclast differentiation and resorbing activity
  1651. Growth-promoting effects of lactoferrin on L. acidophilus and Bifidobacterium spp.
  1652. Multiple enzymic activities of human milk lactoferrin
  1653. A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants
  1654. Expression, characterization, and biologic activity of recombinant human lactoferrin in rice
  1655. Use of bovine lactoferrin for Helicobacter pylori eradication
  1656. lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB
  1657. lactoferrin in Sjögren’s syndrome
  1658. lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation
  1659. Use of lactoferrin forHelicobacter pyloriEradication
  1660. Cellular internalization of lactoferrin in intestinal epithelial cells
  1661. Protection against infections by oral lactoferrin: evaluation in animal models
  1662. Lactoferricin derived from milk protein lactoferrin
  1663. Antimicrobial actions of lactoferrin
  1664. Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis
  1665. Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin
  1666. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin
  1667. Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice
  1668. Characterization of binding of human lactoferrin to pneumococcal surface protein A
  1669. Antiadenovirus activity of milk proteins: lactoferrin prevents viral infection
  1670. Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo
  1671. A structural comparison of human serum transferrin and human lactoferrin
  1672. Fecal lactoferrin: a new parameter to monitor infliximab therapy
  1673. Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion
  1674. Mother’s iron status, breastmilk iron and lactoferrin–are they related?
  1675. Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy
  1676. Oral lactoferrin treatment of experimental oral candidiasis in mice
  1677. Camel lactoferrin, a transferrin-cum-lactoferrin: crystal structure of camel apolactoferrin at 2.6 Å resolution and structural basis of its dual role
  1678. Enhancement of nisin, lysozyme, and monolaurin antimicrobial activities by ethylenediaminetetraacetic acid and lactoferrin
  1679. Human lactoferrin Impairs Virulence of Shigella flexneri
  1680. lactoferrin: role in iron homeostasis and host defense against microbial infection
  1681. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria
  1682. Iron status in mice carrying a targeted disruption of lactoferrin
  1683. Expression of human lactoferrin in transgenic rice grains for the application in infant formula
  1684. Perspectives on interactions between lactoferrin and bacteria
  1685. Liposomalization of lactoferrin enhanced it’s anti-inflammatory effects via oral administration
  1686. Amoebicidal activity of milk, apo-lactoferrin, sIgA and lysozyme
  1687. lactoferrin protects neonatal rats from gut-related systemic infection
  1688. Rice expressing lactoferrin and lysozyme has antibiotic-like properties when fed to chicks
  1689. Effects of the lactoferrin (LF) on the growth performance, intestinal microflora and morphology of weanling pigs
  1690. Functional fragments of ingested lactoferrin are resistant to proteolytic degradation in the gastrointestinal tract of adult rats
  1691. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance
  1692. lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance
  1693. lactoferrin inhibits human papillomavirus binding and uptake in vitro
  1694. lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts
  1695. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells
  1696. Both lactoferrin and iron influence aggregation and biofilm formation in Streptococcus mutans
  1697. lactoferrin activates macrophages via TLR4-dependent and-independent signaling pathways
  1698. Process development and economic evaluation of recombinant human lactoferrin expressed in rice grain
  1699. lactoferrin immunomodulation of DTH response in mice
  1700. Oral lactoferrin Results in T Cell–Dependent Tumor Inhibition of Head and Neck Squamous Cell Carcinoma In vivo
  1701. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease
  1702. Growth characteristics of calves fed an intensified milk replacer regimen with additional lactoferrin
  1703. Characterization of the infection-responsive bovine lactoferrin promoter
  1704. Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice
  1705. lactoferrin Impairs Type III Secretory System Function in Enteropathogenic Escherichia coli
  1706. Bovine lactoferrin inhibits tumor‐induced angiogenesis
  1707. Oral administration of lactoferrin increases hemoglobin and total serum iron in pregnant women
  1708. Neonatal small bowel epithelia: enhancing anti-bacterial defense with lactoferrin and Lactobacillus GG
  1709. In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice
  1710. lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes
  1711. Nasal mucosa expression of lactoferrin in patients with chronic rhinosinusitis
  1712. Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells
  1713. Antiviral activity of lactoferrin towards naked viruses
  1714. Bovine lactoferrin is effective to suppress Helicobacter pylori colonization in the human stomach: a randomized, double-blind, placebo-controlled study
  1715. Effect of dietary lactoferrin on the immune functions and serum iron level of weanling piglets
  1716. lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes
  1717. Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes
  1718. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn’s disease
  1719. The mode of oral bovine lactoferrin administration influences mucosal and systemic immune responses in mice
  1720. Identification of an import signal for, and the nuclear localization of, human lactoferrin
  1721. Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with interferon and ribavirin
  1722. Heat-induced aggregation of bovine lactoferrin at neutral pH: Effect of iron saturation
  1723. Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain
  1724. Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety
  1725. Supplemental lactoferrin improves health and growth of Holstein calves during the preweaning phase
  1726. Secretion of lactoferrin and lysozyme by cultures of human airway epithelium
  1727. Orally administered bovine lactoferrin systemically inhibits VEGF165‐mediated angiogenesis in the rat
  1728. Factors regulating lactoferrin gene expression
  1729. lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors
  1730. lactoferrin supplementation to dairy calves
  1731. In Vitro Characterization of lactoferrin Aggregation and Amyloid Formation
  1732. High pressure increases bactericidal activity and spectrum of lactoferrin, lactoferricin and nisin
  1733. Antibacterial effect of bovine lactoferrin against udder pathogens
  1734. Susceptibilities against bovine lactoferrin with microorganisms isolated from mastitic milk
  1735. Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides
  1736. Opposing selective forces for expression of the gonococcal lactoferrin receptor
  1737. Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells
  1738. Effect of lactoferrin in combination with penicillin on the morphology and the physiology of Staphylococcus aureus isolated from bovine mastitis
  1739. The role of N‐linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis
  1740. Solution structures and model membrane interactions of lactoferrampin, an antimicrobial peptide derived from bovine lactoferrin
  1741. lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane-treated rats
  1742. lactoferrin potently inhibits osteoblast apoptosis, via an LRP1-independent pathway
  1743. Interactions of Bismuth with Human lactoferrin and Recognition of the BiIII−lactoferrin Complex by Intestinal Cells
  1744. Effect of lactoferrin on the growth performance, intestinal morphology, and expression of PR-39 and protegrin-1 genes in weaned piglets
  1745. Helicobacter pylori Eradication: A Randomized Prospective Study of Triple Therapy: Versus: Triple Therapy Plus lactoferrin and Probiotics
  1746. lactoferrin and immunoglobulin contents in camel’s milk (Camelus bactrianus, Camelus dromedarius, and Hybrids) from Kazakhstan
  1747. Structure and Association of Human lactoferrin Peptides with Escherichia coli Lipopolysaccharide
  1748. Iron sequestration by human lactoferrin stimulates P. aeruginosa surface motility and blocks biofilm formation
  1749. Associations between bovine lactoferrin gene polymorphism and somatic cell count in milk
  1750. Experimental immune-mediated pancreatitis in neonatally thymectomized mice immunized with carbonic anhydrase II and lactoferrin
  1751. Dose‐response trial of lactoferrin in patients with chronic hepatitis C
  1752. Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases
  1753. In vitro evaluation of the anticancer effect of lactoferrin and tea polyphenol combination on oral carcinoma cells
  1754. Changes in lactoferrin and lysozyme levels in human milk during the first twelve weeks of lactation
  1755. Peptides from the N-terminal end of bovine lactoferrin induce apoptosis in human leukemic (HL-60) cells
  1756. Availability of lactoferrin as a natural solubilizer of iron for food products
  1757. lactoferrin regulates the immune responses in post-surgical patients.
  1758. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans
  1759. Iron status of infants fed low-iron formula: no effect of added bovine lactoferrin or nucleotides
  1760. lactoferrin works as a new LPS-binding protein in inflammatory activation of macrophages
  1761. Absorption of iron from recombinant human lactoferrin in young US women
  1762. Effects of orally administered bovine lactoferrin and lactoperoxidase on influenza virus infection in mice
  1763. Different Anti-Candida Activities of Two Human lactoferrin-Derived Peptides, Lfpep and Kaliocin-1
  1764. lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells
  1765. Dietary bovine lactoferrin induces changes in immunity level and disease resistance in Asian catfish Clarias batrachus
  1766. Study on the polymorphism of bovine lactoferrin gene and its relationship with mastitis
  1767. Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis
  1768. Exogenous topical lactoferrin inhibits allergen‐induced Langerhans cell migration and cutaneous inflammation in humans
  1769. Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: a possible explanation for inhibition of carcinogenesis …
  1770. lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir
  1771. Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study
  1772. The investigation of glutathione peroxidase, lactoferrin, myeloperoxidase and interleukin‐1β in gingival crevicular fluid: implications for oxidative stress in human …
  1773. Assessment of plasma lactoferrin in Parkinson’s disease
  1774. lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN—gp120 interaction
  1775. The synergistic effect of nisin and lactoferrin on the inhibition of Listeria monocytogenes and Escherichia coli O157:H7
  1776. lactoferrin sequestration and its contribution to iron‐deficiency anemia in Helicobacter pylori‐infected gastric mucosa
  1777. Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin
  1778. Efficacy of rice-based oral rehydration solution containing recombinant human lactoferrin and lysozyme in Peruvian children with acute diarrhea
  1779. Orally ingested human lactoferrin is digested and secreted in the upper gastrointestinal tract in vivo in women with ileostomies
  1780. Isolation of bovine lactoferrin, lactoperoxidase and enzymatically prepared lactoferricin from proteolytic digestion of bovine lactoferrin using adsorptive membrane …
  1781. lactoferrin Down-Regulates G1 Cyclin-Dependent Kinases during Growth Arrest of Head and Neck Cancer Cells
  1782. Orally administered lactoferrin restores humoral immune response in immunocompromised mice
  1783. Anti‐HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface
  1784. Proteolytic activity of bovine lactoferrin
  1785. Binding of lactoferrin and free secretory component to enterotoxigenic Escherichia coli
  1786. lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells
  1787. One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis
  1788. Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides
  1789. Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in the small intestine
  1790. Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease
  1791. lactoferrin inhibits lipid peroxidation in patients with chronic hepatitis C
  1792. lactoferrin, amylase and mucin MUC5B and their relation to the oral microflora in hyposalivation of different origins
  1793. Structural origin of endotoxin neutralization and antimicrobial activity of a lactoferrin-based peptide
  1794. lactoferrin and other markers from gingival crevicular fluid and saliva before and after periodontal treatment
  1795. Receptor-mediated transport of lactoferrin into the cerebrospinal fluid via plasma in young calves
  1796. Synergistic Activity of the N-Terminal Peptide of Human lactoferrin and Fluconazole against Candida Species
  1797. A novel localized amyloidosis associated with lactoferrin in the cornea
  1798. Heparin‐interacting sites of bovine lactoferrin are involved in anti‐adenovirus activity
  1799. Enhancement of antibacterial and lipopolysaccharide binding activities of a human lactoferrin peptide fragment by the addition of acyl chain
  1800. Involvement of bovine lactoferrin metal saturation, sialic acid and protein fragments in the inhibition of rotavirus infection
  1801. Anti-complement effects of lactoferrin-derived peptides
  1802. Enhanced antitumor activity and selectivity of lactoferrin‐derived peptides
  1803. Genetic variability of lactoferrin content estimated by mid-infrared spectrometry in bovine milk
  1804. Randomized, double‐blind, placebo‐controlled trial of bovine lactoferrin in patients with chronic hepatitis C
  1805. Isolation of lactoferrin from acid whey by magnetic affinity separation
  1806. lactoferrin decreases pollen antigen‐induced allergic airway inflammation in a murine model of asthma
  1807. Bacteriostatic activity of human lactoferrin against Staphylococcus aureus is a function of its iron-binding properties and is not influenced by antibiotic resistance
  1808. Antiviral activity of human lactoferrin: Inhibition of alphavirus interaction with heparan sulfate
  1809. lactoferrin in the preterm infants’ diet attenuates iron-induced oxidation products
  1810. lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells
  1811. Human lactoferrin activates transcription of IL-1β gene in mammalian cells
  1812. A novel bovine lactoferrin peptide, FKCRRWQWRM, suppresses Candida cell growth and activates neutrophils
  1813. Usefulness of fecal lactoferrin and hemoglobin in diagnosis of colorectal diseases
  1814. Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis
  1815. A one-enzyme strategy to release an antimicrobial peptide from the LFampin-domain of bovine lactoferrin
  1816. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells
  1817. lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro
  1818. Effects of bovine lactoferrin on in vitro replication of feline herpesvirus
  1819. lactoferrin Protects Rabbits from Shigella flexneri-Induced Inflammatory Enteritis
  1820. lactoferrin-protector against oxidative stress and regulator of glycolysis in human erythrocytes
  1821. Determination of lactoferrin in bovine milk, colostrum and infant formulas by optical biosensor analysis
  1822. Differential expression and estrogen response of lactoferrin gene in the female reproductive tract of mouse, rat, and hamster
  1823. MG2 and lactoferrin form a heterotypic complex in salivary secretions
  1824. Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine‐rich sites
  1825. Anti‐inflammatory activities of human lactoferrin in acute dextran sulphate‐induced colitis in mice
  1826. lactoferrin Glu561Asp facilitates secondary amyloidosis in the cornea
  1827. Potential implications of lactoferrin as a therapeutic agent
  1828. Effects of high pressure homogenization on the activity of lysozyme and lactoferrin against Listeria monocytogenes
  1829. The molecular characterisation and antimicrobial activity of amidated bovine lactoferrin
  1830. Determination of bovine lactoferrin concentrations in cheese with specific monoclonal antibodies
  1831. Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanism
  1832. lactoferrin inhibits growth of malignant tumors of the head and neck
  1833. lactoferrin: mechanism of action, clinical significance and therapeutic relevance.
  1834. Antifungal Effects of Lysozyme and lactoferrin against Genetically Similar, Sequential Candida albicansIsolates from a Human Immunodeficiency Virus-Infected …
  1835. lactoferrin and immunologic dissonance: clinical implications
  1836. Anti herpes simplex virus activity of lactoferrin/lactoferricin–an example of antiviral activity of antimicrobial protein/peptide
  1837. Growth, immune function, and disease and stress resistance of juvenile Nile tilapia (Oreochromis niloticus) fed graded levels of bovine lactoferrin
  1838. Effects of iron-unsaturated human lactoferrin on hydrogen peroxide-induced oxidative damage in intestinal epithelial cells
  1839. lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive Escherichia coli strains
  1840. Influence of dietary vitamin C and bovine lactoferrin on blood chemistry and non-specific immune responses of Japanese eel, Anguilla japonica
  1841. Evidence of lactoferrin transportation into blood circulation from intestine via lymphatic pathway in adult rats
  1842. Inhibition of Penicillium commune by Edible Whey Protein Films Incorporating lactoferrin, Lacto‐ferrin Hydrolysate, and Lactoperoxidase Systems
  1843. Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein
  1844. Comparison of the effects of acylation and amidation on the antimicrobial and antiviral properties of lactoferrin
  1845. Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer
  1846. The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures
  1847. Characterization of glycans in a lactoferrin isoform, lactoferrin-a
  1848. Modulation of In Vitro Fungicidal Activity of Human lactoferrin against Candida albicans by Extracellular Cation Concentration and Target Cell Metabolic Activity
  1849. Expression, characterization, and purification of recombinant porcine lactoferrin in Pichia pastoris
  1850. Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model
  1851. Characterization of in vitro and in vivo antiviral activity of lactoferrin and ribavirin upon hantavirus
  1852. Structural characterization of the ceruloplasmin: lactoferrin complex in solution
  1853. lactoferrin-a multipotential protein.
  1854. Effect of lactoferrin on selected immune system parameters and the gastrointestinal morphology in growing calves
  1855. Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli
  1856. New functions of lactoferrin and β-casein in mammalian milk as cysteine protease inhibitors
  1857. The synthetic N-terminal peptide of human lactoferrin, hLF (1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter …
  1858. lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection
  1859. Effects of lactoferrin on non-specific immune responses of gilthead seabream (Sparus auratus L.)
  1860. Pepsin-digested bovine lactoferrin induces apoptotic cell death with JNK/SAPK activation in oral cancer cells
  1861. Histatin and lactoferrin derived peptides: antimicrobial properties and effects on mammalian cells
  1862. In vitro growth responses of bifidobacteria and enteropathogens to bovine and human lactoferrin
  1863. High prevalence of autoantibodies against carbonic anhydrase II and lactoferrin in type 1 diabetes: concept of autoimmune exocrinopathy and endocrinopathy of the …
  1864. Baculovirus expression of mouse lactoferrin receptor and tissue distribution in the mouse
  1865. N-glycosylation potential of maize: the human lactoferrin used as a model
  1866. Capture of lactoferrin and lactoperoxidase from raw whole milk by cation exchange chromatography
  1867. Adsorption behaviour of lactoferrin in oil-in-water emulsions as influenced by interactions with β-lactoglobulin
  1868. Formulation and evaluation of lactoferrin bioadhesive tablets
  1869. The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type 1
  1870. Bovine lactoferrin peptidic fragments involved in inhibition of Echovirus 6 in vitro infection
  1871. Prevention of carcinogenesis and cancer metastasis by bovine lactoferrin
  1872. Surface-induced unfolding of human lactoferrin
  1873. lactoferrin against staphylococcus aureus mastitis: lactoferrin alone or in combination with penicillin G on bovine polymorphonuclear function and mammary …
  1874. Recombinant human lactoferrin treatment for global health issues: iron deficiency and acute diarrhea
  1875. Plasma concentrations of defensins and lactoferrin in children with severe sepsis
  1876. Methylation and expression of the lactoferrin gene in human tissues and cancer cells
  1877. Comparable Efficacies of the Antimicrobial Peptide Human lactoferrin 1-11 and Gentamicin in a Chronic Methicillin-Resistant Staphylococcus aureus Osteomyelitis …
  1878. Interaction of human lactoferrin with cell adhesion molecules through RGD motif elucidated by lactoferrin-binding epitopes
  1879. lactoferrin receptors in gram-negative bacteria: insights into the iron acquisition process
  1880. lactoferrin iron levels are reduced in saliva of patients with localized aggressive periodontitis
  1881. The efficacy of bovine lactoferrin in the treatment of cows with experimentally induced Escherichia coli mastitis
  1882. High expression of a human lactoferrin in transgenic tobacco cell cultures
  1883. Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB
  1884. Lactoferrampin, an antimicrobial peptide of bovine lactoferrin, exerts its candidacidal activity by a cluster of positively charged residues at the C-terminus in …
  1885. Simulated moving bed technology with a simplified approach for protein purification: separation of lactoperoxidase and lactoferrin from whey protein concentrate
  1886. Dietary bovine lactoferrin enhances tolerance to high temperature stress in Japanese flounder Paralichthys olivaceus
  1887. lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis
  1888. Polymorphisms within the lactoferrin Gene Promoter in Various Cattle Breeds
  1889. Characterization of a bovine lactoferrin binding protein of Streptococcus uberis
  1890. Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates
  1891. Interaction of ceruloplasmin, lactoferrin, and myeloperoxidase
  1892. lactoferrin Feeding Augments Peritoneal Macrophage Activities in Mice Intraperitoneally Injected with Inactivated Candida albicans
  1893. Effects of lactoferrin on the immune response modified by the immobilization stress
  1894. Human apo-lactoferrin enhances angiogenesis mediated by vascular endothelial growth factor A in vivo
  1895. Human lactoferrin-Derived Peptide’s Antifungal Activities against Disseminated Candida albicans Infection
  1896. Functional Domain of Bovine Milk lactoferrin Which Inhibits the Adherence of Streptococcus mutans Cells to a Salivary Film
  1897. Fluorometric study on the interaction between lomefloxacin and bovine lactoferrin
  1898. Downstream processing of bovine lactoferrin from sweet whey
  1899. Expression of bovine lactoferrin cDNA confers resistance to Erwinia amylovora in transgenic pear
  1900. lactoferrin expression in the canine uterus during the estrous cycle and with pyometra
  1901. A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico
  1902. Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers
  1903. Introduction of the human lactoferrin gene into grass carp (Ctenopharyngodon idellus) to increase resistance against GCH virus
  1904. High-level expression of human lactoferrin in the milk of goats by using replication-defective adenoviral vectors
  1905. Increase of lactoferrin concentration in mastitic goat milk
  1906. lactoferrin and free secretory component of human milk inhibit the adhesion of enteropathogenic Escherichia coli to HeLa cells
  1907. Distinct bactericidal activities of bovine lactoferrin peptides LFampin 268–284 and LFampin 265–284: Asp-Leu-Ile makes a difference
  1908. Potassium efflux induced by a new lactoferrin-derived peptide mimicking the effect of native human lactoferrin on the bacterial cytoplasmic membrane
  1909. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV …
  1910. Salivary micelles: identification of complexes containing MG2, sIgA, lactoferrin, amylase, glycosylated proline-rich protein and lysozyme
  1911. lactoferrin Modulation of Antigen-Presenting-Cell Response to BCG Infection: Wpływ laktoferryny na odpowiedź komórek prezentujących antygen …
  1912. Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin
  1913. Expression, purification, and characterization of equine lactoferrin in Pichia pastoris
  1914. lactoferrin gene expression is estrogen responsive in human and rhesus monkey endometrium
  1915. Reconstitution of the cellular immune response by lactoferrin in cyclophosphamide-treated mice is correlated with renewal of T cell compartment
  1916. Detection and quantitation of lactoferrin in bovine whey samples by reversed-phase high-performance liquid chromatography on polystyrene–divinylbenzene
  1917. Blood lactoferrin release induced by running exercise in normal volunteers: antibacterial activity
  1918. Leishmania chagasi: uptake of iron bound to lactoferrin or transferrin requires an iron reductase
  1919. Inhibitory effect of bovine milk lactoferrin on the interaction between a streptococcal surface protein antigen and human salivary agglutinin
  1920. Neutrophil lactoferrin upregulates the human p53 gene through induction of NF-κB activation cascade
  1921. Suppressive effects of milk-derived lactoferrin on psychological stress in adult rats
  1922. Bovine lactoferrin reduces plasma triacylglycerol and NEFA accompanied by decreased hepatic cholesterol and triacylglycerol contents in rodents
  1923. Bovine lactoferrin has a nitric oxide-dependent hypotensive effect in rats
  1924. lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor …
  1925. Single nucleotide polymorphism in the promoter region of the lactoferrin gene and its associations with milk performance traits in Polish Holstein-Friesian cows
  1926. Microbicidal action of lactoferrin and lactoferricin and their synergistic effect with metronidazole in Entamoeba histolytica
  1927. Oral lactoferrin prevents body weight loss and increases cytokine responses during herpes simplex virus type 1 infection of mice
  1928. lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins
  1929. lactoferrin Stimulates A Staphylococcus aureus Killing Activity of Bovine Phagocytes in the Mammary Gland
  1930. lactoferrin protects against development of hepatitis caused by sensitization of Kupffer cells by lipopolysaccharide
  1931. The detection of bovine lactoferrin binding protein on Trypanosoma brucei
  1932. Isolation of lactoferrin from bovine colostrum by ultrafiltration coupled with strong cation exchange chromatography on a production scale
  1933. Human lactoferrin transgenic rabbits produced efficiently using dimethylsulfoxide–sperm-mediated gene transfer
  1934. Effects of natural phenolic compounds on the antioxidant activity of lactoferrin in liposomes and oil-in-water emulsions
  1935. Effect of lactoferrin on the ferroxidase activity of ceruloplasmin
  1936. lactoferrin disruption of bacterial type III secretion systems
  1937. Effects of lactoferrin, phytic acid, and EDTA on oxidation in two food emulsions enriched with long-chain polyunsaturated fatty acids
  1938. Bacterial lactoferrin-binding protein A binds to both domains of the human lactoferrin C-lobe
  1939. The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin
  1940. Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study
  1941. Human lactoferrin in the milk of transgenic mice increases intestinal growth in ten-day-old suckling neonates
  1942. Effect of bovine lactoferrin against Carnobacterium viridans
  1943. Single nucleotide polymorphisms (SNPs) in human lactoferrin gene
  1944. Immobilized lactoferrin is a stimulus for eosinophil activation
  1945. Antimicrobial effects of lactoferrin, lysozyme, and the lactoperoxidase system and edible whey protein films incorporating the lactoperoxidase system against …
  1946. Electrically-enhanced crossflow microfiltration for separation of lactoferrin from whey protein mixtures
  1947. Enteric‐formulated lactoferrin was more effectively transported into blood circulation from gastrointestinal tract in adult rats
  1948. Effect of infusing lactoferrin hydrolysate into bovine mammary glands with subclinical mastitis
  1949. Crystal structure of the Tp34 (TP0971) lipoprotein of Treponema pallidum: implications of its metal-bound state and affinity for human lactoferrin
  1950. One-step lactoferrin purification from bovine whey and colostrum by affinity membrane chromatography
  1951. Antibacterial activity of pepsin‐digested lactoferrin on foodborne pathogens in buffered broth systems and ultra‐high temperature milk with EDTA
  1952. Role of endogenous interferon and LPS in the immunomodulatory effects of bovine lactoferrin in murine peritoneal macrophages
  1953. A milk protein lactoferrin enhances human T cell leukemia virus type I and suppresses HIV-1 infection
  1954. High concentrations of lactoferrin in the follicular fluid correlate with embryo quality during in vitro fertilization cycles
  1955. lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b
  1956. Effect of lactoferrin on the methotrexate-induced suppression of the cellular and humoral immune response in mice
  1957. Comparative analysis of the site‐specific N‐glycosylation of human lactoferrin produced in maize and tobacco plants
  1958. Antitumour activity and specificity as a function of substitutions in the lipophilic sector of helical lactoferrin‐derived peptide
  1959. Antiproliferative and apoptosis inducing effect of lactoferrin and black tea polyphenol combination on hamster buccal pouch carcinogenesis
  1960. Preparation and in vitro characteristics of lactoferrin-loaded chitosan microparticles
  1961. lactoferrin inhibits early steps of human BK polyomavirus infection
  1962. Binding interactions of pefloxacin mesylate with bovine lactoferrin and human serum albumin
  1963. Liposomal lactoferrin induced significant increase of the interferon‐alpha (IFN‐α) producibility in healthy volunteers
  1964. Cloning of a pig homologue of the human lactoferrin receptor: expression and localization during intestinal maturation in piglets
  1965. Formation of multilayers at the interface of oil-in-water emulsion via interactions between lactoferrin and β-lactoglobulin
  1966. Safety determination for the use of bovine milk-derived lactoferrin as a component of an antimicrobial beef carcass spray
  1967. Effects on Escherichia coli O157: H7 and meat starter cultures of bovine lactoferrin in broth and microencapsulated lactoferrin in dry sausage batters
  1968. Human recombinant lactoferrin is ineffective in the treatment of human Helicobacter pylori infection
  1969. Pulsed ELDOR determination of the intramolecular distance between the metal binding sites in dicupric human serum transferrin and lactoferrin
  1970. An intronic alternative promoter of the human lactoferrin gene is activated by Ets
  1971. No detectable transfer of dietary lactoferrin or its functional fragments to portal blood in healthy adult rats
  1972. lactoferrin expression by bovine ocular surface epithelia: a primary cell culture model to study lactoferrin gene promoter activity
  1973. Effect of dietary bovine lactoferrin on growth response, tolerance to air exposure and low salinity stress conditions in orange spotted grouper Epinephelus coioides
  1974. Viral load in breast milk correlates with transmission of human cytomegalovirus to preterm neonates, but lactoferrin concentrations do not
  1975. Human neutrophil lactoferrin trans-activates the matrix metalloproteinase 1 gene through stress-activated MAPK signaling modules
  1976. Immunoregulatory activities of lactoferrin in the delayed type hypersensitivity in mice are mediated by a receptor with affinity to mannose
  1977. lactoferrin of camel milk of Kazakhstan
  1978. Optical biosensor analysis of the heat denaturation of bovine lactoferrin
  1979. lactoferrin interaction with retinoid signaling: cell growth and apoptosis in mammary cells
  1980. Influences of orally administered lactoferrin on IFN-γ and IL-10 production by intestinal intraepithelial lymphocytes and mesenteric lymph-node cells
  1981. Detection of lactoferrin in bovine and goat milk by enzyme-linked immunosorbent assay
  1982. Crystal structure of a proteolytically generated functional monoferric C-lobe of bovine lactoferrin at 1.9 Å resolution
  1983. Camel (Camelus dromedarius) immunoglobulin G, α-lactalbumin, serum albumin and lactoferrin in colostrum and milk during the early post partum period
  1984. lactoferrin in the central nervous system
  1985. Purification and quantification of lactoferrin in equine seminal plasma
  1986. Adjuvant effect of mushroom glucan and bovine lactoferrin upon Aeromonas hydrophila vaccination in catla, Catla catla (Hamilton)
  1987. Treatment of enterogenic endotoxinemia with lactoferrin in rats
  1988. Expression of delta-lactoferrin induces cell cycle arrest
  1989. Human delta‐lactoferrin is a transcription factor that enhances Skp1 (S‐phase kinase‐associated protein) gene expression
  1990. Immobilised peptide displaying phages as affinity ligands: Purification of lactoferrin from defatted milk
  1991. Technology evaluation: rh lactoferrin, Agennix.
  1992. Human lactoferrin controls the level of retinoblastoma protein and its activity
  1993. Inhibitory effect of lactoferrin on in vitro growth of Babesia caballi
  1994. lactoferrin: antimicrobial and diagnostic properties
  1995. Plasma total transcobalamin I: Ethnic/Racial patterns and comparison with lactoferrin
  1996. Utilization of lactoferrin as an iron‐stabilizer for soybean and fish oil
  1997. Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection.
  1998. lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis
  1999. Protective effects of lactoferrin in Escherichia coli-induced bacteremia in mice: relationship to reduced serum TNF alpha level and increased turnover of neutrophils
  2000. Human lactoferrin upregulates expression of KDR/Flk-1 and stimulates VEGF-A-mediated endothelial cell proliferation and migration
  2001. lactoferrin enhances opioid-mediated analgesia via nitric oxide in the rat spinal cord
  2002. The inhibition of mast cell activation by neutrophil lactoferrin: uptake by mast cells and interaction with tryptase, chymase and cathepsin G
  2003. High level expression of functionally active human lactoferrin in silkworm larvae
  2004. Cleaved inflammatory lactoferrin peptides in parotid saliva of periodontitis patients
  2005. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells
  2006. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study
  2007. Dietary administration of bovine lactoferrin influences the immune ability of the giant freshwater prawn Macrobrachium rosenbergii (de Man) and its resistance against …
  2008. Partial resistance to bacterial wilt in transgenic tomato plants expressing antibacterial lactoferrin gene
  2009. Expression and Purification of Goat lactoferrin from Pichia pastoris Expression System
  2010. Preventive effect of recombinant human lactoferrin in a rabbit preterm delivery model
  2011. lactoferrin enhances peripheral opioid-mediated antinociception via nitric oxide in rats
  2012. Foam fractionation of a dilute solution of bovine lactoferrin
  2013. Potential antimicrobial effects of human lactoferrin against oral infection with Listeria monocytogenes in mice
  2014. The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured …
  2015. Prophylaxis with lactoferrin, a novel antimicrobial agent, in a neonatal rat model of coinfection
  2016. A nonconservative, coding single-nucleotide polymorphism in the N-terminal region of lactoferrin is associated with aggressive periodontitis in an African-American …
  2017. Production and characterization of recombinant human lactoferrin in transgenic Javanica rice
  2018. A complex of lactoferrin with monophosphoryl lipid A is an efficient adjuvant of the humoral and cellular immune response in mice
  2019. Efficacy of a lactoferrin-penicillin combination to treat β-lactam-resistant Staphylococcus aureus mastitis
  2020. Production of recombinant bovine lactoferrin N-lobe in insect cells and its antimicrobial activity
  2021. Anti-inflammatory effects of orally ingested lactoferrin and glycine in different zymosan-induced inflammation models: evidence for synergistic activity
  2022. Seminal plasma lactoferrin but not transferrin reflects gonadal function in dogs
  2023. The relationship between the levels of SigA, lactoferrin and α1 proteinase inhibitor in saliva and permanent dentition caries in 15‐year‐olds
  2024. Effects of lactoferrin feeding on growth, feed intake and health of calves
  2025. Inhibitory activity of bovine lactoferrin against echovirus induced programmed cell death in vitro
  2026. Ontogenic changes in lactoferrin receptor and DMT1 in mouse small intestine: implications for iron absorption during early life
  2027. The antihypertensive activity of angiotensin-converting enzyme inhibitory peptide containing in bovine lactoferrin
  2028. Recovery of lactoferrin and lactoperoxidase from sweet whey using colloidal gas aphrons (CGAs) generated from an anionic surfactant, AOT
  2029. Antibacterial activity of bovine lactoferrin hydrolysate against mastitis pathogens and its effect on superoxide production of bovine neutrophils
  2030. Identification and isolation from breast milk of ceruloplasmin-lactoferrin complex
  2031. lactoferrin: the conductor of the immunological system?
  2032. Interactions between adsorbed lactoferrin layers measured directly with the atomic force microscope
  2033. In vitro effects of bovine lactoferrin, mushroom glucan and Abrus agglutinin on Indian major carp, catla (Catla catla) head kidney leukocytes
  2034. … in vitro antifungal activity of lactoferrin combined with antimycotics against clinical isolates of Candida Impact on the development of buccal preparations of lactoferrin
  2035. Transgenic ginseng cell lines that produce high levels of a human lactoferrin
  2036. lactoferrin and Citrate Concentrations at Drying‐off and During Early Mammary Involution of Dairy Cows
  2037. lactoferrin-induced up-regulation of zeta (zeta) chain expression in peripheral blood T lymphocytes from cervical cancer patients.
  2038. Recombinant human lactoferrin prevents NSAID-induced intestinal bleeding in rodents
  2039. lactoferrin from canine neutrophils: isolation and physicochemical and antimicrobial properties
  2040. Release of surface‐expressed lactoferrin from polymorphonuclear neutrophils after contact with CD4+T cells and its modulation on Th1/Th2 cytokine production
  2041. Human lactoferrin exerts bi-directional actions on PC12 cell survival via ERK1/2 pathway
  2042. Transgenic Cows That Produce Recombinant Human lactoferrin in Milk Are Not Protected from Experimental Escherichia coli Intramammary Infection
  2043. Recombinant human lactoferrin has preventive effects on lipopolysaccharide-induced preterm delivery and production of inflammatory cytokines in mice
  2044. Modulation of innate and adaptive immunity by lactoferrin in human immunodeficiency virus (HIV)-infected, antiretroviral therapy-naïve children
  2045. Bovine lactoferrin inhibits echovirus endocytic pathway by interacting with viral structural polypeptides
  2046. Identification of Toxoplasma gondii proteins binding human lactoferrin: a new aspect of rhoptry proteins function
  2047. Expression of a human lactoferrin N-lobe in Nicotiana benthmiana with potato virus X-based agroinfection
  2048. Effects of human lactoferrin on the cytoplasmic membrane of Candida albicans cells related with its candidacidal activity
  2049. Recombinant porcine lactoferrin expressed in the milk of transgenic mice enhances offspring growth performance
  2050. Modulation of xenobiotic-metabolizing enzymes and redox status during chemoprevention of hamster buccal carcinogenesis by bovine lactoferrin
  2051. Antioxidative properties of lactoferrin from bovine colostrum before and after its lyophilization
  2052. Direct capture of lactoferrin from whey using magnetic micro-ion exchangers in combination with high-gradient magnetic separation
  2053. Low density lipoprotein receptor-related protein (LRP) is required for lactoferrin-enhanced collagen gel contractile activity of human fibroblasts
  2054. Enhancing the antimicrobial effects of bovine lactoferrin against Escherichia coli O157:H7 by cation chelation, NaCl and temperature
  2055. Effects of lactoferrin on collagen gel contractile activity and myosin light chain phosphorylation in human fibroblasts
  2056. Tandem Repeats of lactoferrin‐Derived Anti‐Hepatitis C Virus Peptide Enhance Antiviral Activity in Cultured Human Hepatocytes
  2057. Design and fungicidal activity of mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis
  2058. Immunolocalization of lactoferrin in healthy and inflamed gingival tissues
  2059. Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin
  2060. Antiviral activity of lactoferrin against canine herpesvirus
  2061. Effect of iron saturation on the recovery of lactoferrin in rennet whey coming from heat-treated skim milk
  2062. Immunoregulatory function of lactoferrin in immunosuppressed and autoimmune animals Wpływ laktoferryny na status immunologiczny zwierząt poddanych …
  2063. Normalization of peripheral blood cell composition by lactoferrin in cyclophosphamide-treated mice
  2064. lactoferrin is the major deoxyribonuclease of human milk
  2065. Enhanced resistance to Aeromonas hydrophila infection and enhanced phagocytic activities in human lactoferrin-transgenic grass carp (Ctenopharyngodon idellus)
  2066. Characteristics of lactoferrin receptor in bovine intestine: higher binding activity to the epithelium overlying Peyer’s patches
  2067. Opioid mediated suppressive effect of milk-derived lactoferrin on distress induced by maternal separation in rat pups
  2068. Angiogenin: a novel inhibitor of neutrophil lactoferrin release during extracorporeal circulation
  2069. lactoferrin Peptide Increases the Survival ofCandida albicans- Inoculated Mice by Upregulating Neutrophil and Macrophage Functions, Especially in Combination …
  2070. Hematological, metabolic, and endocrine effects of feeding vitamin A and lactoferrin in neonatal calves
  2071. Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: a pilot study of eight stool markers
  2072. Novel function of bovine milk-derived lactoferrin on antinociception mediated by μ-opioid receptor in the rat spinal cord
  2073. “Dilysine Trigger” in Transferrins Probed by Mutagenesis of lactoferrin:  Crystal Structures of the R210G, R210E, and R210L Mutants of Human lactoferrin,
  2074. lactoferrin Iron Levels Affect Attachment of Actinobacillus actinomycetemcomitans to Buccal Epithelial Cells
  2075. New sensitive method for the measurement of lysozyme and lactoferrin for the assessment of innate mucosal immunity. Part I: time-resolved immunofluorometric assay …
  2076. lactoferrin expression in the horse endometrium: relevance in persisting mating-induced endometritis
  2077. Small molecule lactoferrin with an inflammatory effect but no apparent antibacterial activity in mastitic mammary gland secretion
  2078. The role of lactoferrin in cancer prevention
  2079. Variable expression of human lactoferrin gene in mice milk driven by its 90 KB upstream flanking sequences
  2080. lactoferrin promotes collagen gel contractile activity of fibroblasts mediated by lipoprotein receptors
  2081. Unveiling molecular mechanisms of pneumococcal surface protein A interactions with antibodies and lactoferrin
  2082. Induction of lactoferrin and IL‐8 release from human neutrophils by tryptic enzymes via proteinase activated receptor‐2
  2083. Persorption of bovine lactoferrin from the intestinal lumen into the systemic circulation via the portal vein and the mesenteric lymphatics in growing pigs
  2084. The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29-18-C1 cells is mediated through basic residues located in the N-terminus
  2085. Constitutive expression of human lactoferrin and its N-lobe in rice plants to confer disease resistance
  2086. Developmental gene expression of lactoferrin in duodenum and effect of weaning age on gene expression of lactoferrin in piglets
  2087. Effects of bovine lactoferrin by the intramammary infusion in cows with staphylococcal mastitis during the early non-lactating period
  2088. A calorimetric study of thermal denaturation of recombinant human lactoferrin from rice
  2089. Anti-lactoferrin toxicity and elevated iron: The environmental prerequisites which activate susceptibility to tuberculosis infection?
  2090. Coadsorption of human milk lactoferrin into the dipalmitoylglycerolphosphatidylcholine phospholipid monolayer spread at the air/water interface
  2091. Breast milk lactoferrin regulates gene expression by binding bacterial DNA CpG motifs but not genomic DNA promoters in model intestinal cells
  2092. Structure of the zinc-saturated C-terminal lobe of bovine lactoferrin at 2.0 Å resolution
  2093. Effects of supplemental lactoferrin on serum lactoferrin and IgG concentrations and neutrophil oxidative metabolism in Holstein calves
  2094. Effects of feeding vitamin A and lactoferrin on epithelium of lymphoid tissues of intestine of neonatal calves
  2095. lactoferrin accelerates reconstitution of the humoral and cellular immune response during chemotherapy-induced immunosuppression and bone marrow transplant in …
  2096. Protective Role of Human lactoferrin Against Invasion ofShigella Flexneri M90t
  2097. Expression of Bovine lactoferrin C-lobe in Rhodococcus erythropolis and Its Purification and Characterization
  2098. Modulation of expression of superantigens by human transferrin and lactoferrin: a novel mechanism in host-Streptococcus interactions
  2099. Milk-derived lactoferrin may block tolerance to morphine analgesia
  2100. Patterning of lactoferrin using functional SAMs of iron complexes
  2101. Activated lactoferrin
  2102. Characterization of monoclonal antibodies against human lactoferrin
  2103. lactoferrin-enhanced anoikis: a defense against neonatal necrotizing enterocolitis
  2104. The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells
  2105. A randomized controlled trial of consensus interferon with or without lactoferrin for chronic hepatitis C patients with genotype 1b and high viral load
  2106. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study
  2107. Expression of lactoferrin on neutrophil granulocytes from synovial fluid and peripheral blood of patients with rheumatoid arthritis.
  2108. … (ChIP) studies indicate a role for CCAAT enhancer binding proteins alpha and epsilon (C/EBPα and C/EBPε) and CDP/cut in myeloid maturation-induced lactoferrin …
  2109. Bovine lactoferrin protects lipopolysaccharide-induced diarrhea modulating nitric oxide and prostaglandin E2 in mice
  2110. Expression of pulmonary lactoferrin in sudden-onset and slow-onset asthma with fatal outcome
  2111. Analytical cation-exchange chromatography to assess the identity, purity, and N-terminal integrity of human lactoferrin
  2112. lactoferrin-BINDING PROTEINS OF TRITRICHOMONAS FOETUS
  2113. Preventive effect of recombinant human lactoferrin on lipopolysaccharide-induced preterm delivery in mice
  2114. Simultaneous assays for Clostridium difficile and faecal lactoferrin in ulcerative colitis.
  2115. Differential modulation of human lactoferrin activity against both R5 and X4-HIV-1 adsorption on epithelial cells and dendritic cells by natural antibodies
  2116. Antibiotic Susceptibility of Stenotrophomonas maltophilia in the Presence of lactoferrin
  2117. Effect of lactoferrin addition on the dialysability of iron from infant formulas
  2118. CXC-chemokine stimulation of neutrophils correlates with plasma levels of myeloperoxidase and lactoferrin and contributes to clinical outcome after pediatric cardiac …
  2119. Continuous-release or burst-release of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11) from calcium phosphate bone substitutes
  2120. A peptide domain of bovine milk lactoferrin inhibits the interaction between streptococcal surface protein antigen and a salivary agglutinin peptide domain
  2121. Effect of combination therapy with lactoferrin and antibiotics against staphylococcal mastitis on drying cows
  2122. The effects of lactoferrin on myelopoiesis: can we resolve the controversy?
  2123. Post-initiation chemopreventive effects of dietary bovine lactoferrin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in female A/J mice
  2124. lactoferrin Blocks the Initial Host Cell Attachment Mechanism of Enteropathogenic E. Coli (EPEC)
  2125. Temperature‐Sensitive Microcapsules Containing lactoferrin and Their Action Against Carnobacterium viridans on Bologna
  2126. Safety of milk and milk derivatives in relation to BSE: the lactoferrin example
  2127. Antimicrobial activity of lactoferrin and lactoperoxidase in milk
  2128. Randomized placebo-controlled trial of interferon alpha-2b plus ribavirin with and without lactoferrin for chronic hepatitis C
  2129. Production of recombinant porcine lactoferrin exhibiting antibacterial activity in methylotrophic yeast, Pichia pastoris
  2130. Recent advances of basic research and clinical application of lactoferrin as an antiviral reagent against chronic hepatitis C
  2131. Antiviral activities of lactoferrin.
  2132. Bovine lactoferrin decreases histopathological changes in the liver and regulates cytokine production by splenocytes of obstructive jaundiced rats
  2133. Immunoexpression of lactoferrin in human sporadic renal cell carcinomas
  2134. lactoferrin ameliorates symptoms of experimental encephalomyelitis in Lewis rats
  2135. lactoferrin and its possible role in iron enrichment of infant formulas
  2136. Serum lactoferrin and immunoglobulin G concentrations in healthy or ill neonatal foals and healthy adult horses
  2137. Effect of lactoferrin feeding on the host antifungal response in guinea-pigs infected or immunised with Trichophyton mentagrophytes
  2138. lactoferrin for gut GVHD
  2139. Bovine lactoferrin binds to insulin-like growth factor-binding protein-3
  2140. Involvement of bovine lactoferrin moieties in the inhibition of herpes simplex virus type 1 infection.
  2141. Production of lactoferricin and other cationic peptides from food grade bovine lactoferrin with various iron saturation levels
  2142. Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro
  2143. lactoferrin supplementation to holstein calves during the preweaning and postweaning phases
  2144. Oral lactoferrin in HIV-1 vertically infected children: an observational follow-up of plasma viral load and immune parameters
  2145. Effect of short-term dietary intake of bovine lactoferrin on intestinal lymphocyte apoptosis in healthy mice
  2146. Determination of bovine lactoferrin in lactoferrin-supplemented dairy products and raw milk by an automated latex assay
  2147. The detection of bovine lactoferrin binding protein on Toxoplasma gondii
  2148. Variation of lactoferrin and lactoperoxidase in bovine milk and the impact of level of pasture intake
  2149. Ultrafiltration of mixed protein solutions of lysozyme and lactoferrin: role of modified inorganic membranes and ionic strength on the selectivity
  2150. … of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin
  2151. Effects of an enhanced vitamin A intake during the dry period on retinoids, lactoferrin, IGF system, mammary gland epithelial cell apoptosis, and subsequent …
  2152. lactoferrin regulates proliferative response of human peripheral blood mononuclear cells to phytohemagglutinin and mixed lymphocyte reaction
  2153. The bovine lactoferrin region responsible for promoting the collagen gel contractile activity of human fibroblasts
  2154. Correction of the iron overload defect in β-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis
  2155. Composition of pH-sensitive triad in C-lobe of human serum transferrin. Comparison to sequences of ovotransferrin and lactoferrin provides insight into functional …
  2156. Expression of porcine lactoferrin by using recombinant baculovirus in silkworm, Bombyx mori L., and its purification and characterization
  2157. lactoferrin reduces methotrexate-induced small intestinal damage, possibly through inhibition of GLP-2-mediated epithelial cell proliferation
  2158. Remarkable attachment of lactoferrin to Streptococcus pyogenes during acute pharyngotonsillitis
  2159. Elevated free tear lactoferrin levels in leprosy are associated with Type 2 reactions
  2160. Effects of bovine lactoferrin hydrolysate on the in vitro antimicrobial susceptibility of Escherichia coli strains isolated from baby pigs
  2161. Differential pattern in circulating nitrogen derivatives, lactoferrin, and anti-lactoferrin antibodies in HIV type 1 and HIV type 2 infections
  2162. Ultrastructural and cytochemical study of cell wall modification by lactoferrin, lactoferricin and penicillin G against Staphylococcus aureus
  2163. Deficiency of the specific granule proteins, R‐binder/transcobalamin I and lactoferrin, in plasma and saliva: A new disorder
  2164. Recombinant human lactoferrin has a potential to suppresses uterine cervical ripening in preterm delivery in animal model
  2165. Relationship between seminal plasma lactoferrin and gonadal function in horses
  2166. Molecular cloning and expression of yak (Bos grunniens) lactoferrin cDNA in Pichia pastoris
  2167. The adjuvant activity of lactoferrin in the generation of DTH to ovalbumin can be inhibited by bovine serum albumin bearing alpha-D-mannopyranosyl residues
  2168. Production of human lactoferrin in transgenic cell suspension cultures of sweet potato
  2169. Human and bovine lactoferrins in the milk of recombinant human lactoferrin‐transgenic dairy cows during lactation
  2170. Detection of bovine lactoferrin binding protein on Jurkat human lymphoblastic T cell line
  2171. The cytotoxic effects of human neutrophil peptide-1 (HNP1) and lactoferrin on oral squamous cell carcinoma (OSCC) in vitro
  2172. Developmental gene expression of lactoferrin and effect of dietary iron on gene regulation of lactoferrin in mouse mammary gland
  2173. A distinct role of neutrophil lactoferrin in RelA/p65 phosphorylation on Ser536 by recruiting TNF receptor-associated factors to IκB kinase signaling complex
  2174. … trapped by the simultaneous crystallization process: crystal structure of an iron-saturated intermediate in the Fe3+ binding pathway of camel lactoferrin at 2.7 Å …
  2175. Effect of nucleotides on the oligomeric state of human lactoferrin
  2176. Variations in concentrations of lactoferrin in human milk: a nine country survey
  2177. Bovine lactoferrin pepsin hydrolysate exerts inhibitory effect on angiotensin I-converting enzyme-dependent vasoconstriction
  2178. Changes in antioxidative properties of lactoferrin from women’s milk during deamidation
  2179. Isolation of immunoglobulin in yolk (IgY) and rabbit serum immunoglobulin G (IgG) specific against bovine lactoferrin by immunoaffinity chromatography
  2180. Mycobacterium leprae infection and serum lactoferrin levels
  2181. A non-invasive quantitative assay to measure murine intestinal inflammation using the neutrophil marker lactoferrin
  2182. Short‐term Effects on Pro‐inflammatory Cytokine, lactoferrin and CD14 mRNA Expression Levels in Bovine Immunoseparated Milk and Blood Cells Treated by LPS
  2183. Impact of lysozyme and lactoferrin on oral Candida isolates exposed to polyene antimycotics and fluconazole
  2184. Toxoplasma gondii binds human lactoferrin but not transferrin
  2185. Characterization of lactoferrin (LF) from Colostral Whey Using Anti‐LF Antibody Immunoaffinity Chromatography
  2186. lactoferrin: bioactive properties and applications
  2187. Evaluation of lysozyme and lactoferrin in lacrimal and other ocular glands of bison and cattle and in tears of bison
  2188. IL-1β-induced Langerhans’ cell migration and TNF-α production in human skin: regulation by lactoferrin
  2189. Faecal lactoferrin assay as an adjunct to Clostridium difficile diarrhoea.
  2190. Antimicrobial effect of lactoferrin digest on spores of a Penicillium sp. isolated from bottled water
  2191. N-Linked Glycan Structures of Human lactoferrin Produced by Transgenic Rice
  2192. Purification and biochemical characterization of a fibroblast growth factor-binding protein (FGF-BP) from the lactoferrin fraction of bovine milk
  2193. Influence of pectins on preparation characteristics of lactoferrin bioadhesive tablets
  2194. … and antibacterial genes are upregulated in early involution of the mouse mammary gland: sharp increase of ceruloplasmin and lactoferrin in accumulating breast milk
  2195. Role of lactoferrin in development of inflammation
  2196. Construction of expression vector of human lactoferrin and its expression in bovine mammary epithelial cells
  2197. Electrostatic Interactions between lactoferrin and b-Lactoglobulin in Oil-in-Water Emulsions
  2198. High-yield production of functional human lactoferrin in transgenic cell cultures of Siberian ginseng (Acanthopanax senticosus)
  2199. lactoferrin interacts with nucleotides
  2200. Effects of lactoferrin on IL-6 production by peritoneal and alveolar cells in cyclophosphamide-treated mice
  2201. Preliminary observations on the Echinacea-induced lactoferrin production in goat milk
  2202. Detection and characterization of PCR-SSCP markers of the bovine lactoferrin gene for clinical mastitis
  2203. Significance of fecal lactoferrin in evaluation of disease activity in ulcerative colitis
  2204. Immunolocalization of lactoferrin in surgically resected pigmented skin lesions
  2205. Influence of bovine lactoferrin and lactoferricin on cytokine expression in LPS‐treated cultivated bovine blood cells
  2206. Faecal lactoferrin as a predictor of positive faecal culture in south Indian children with acute diarrhoea
  2207. Human lactoferrin and its polyfunctional biological functions.
  2208. Apoptotic Death of Listeria Monocytogenes-Infected Human Macrophages Induced by Lactoferricin B, A Bovine lactoferrin-Derived Peptide
  2209. Multivalent metal-induced iron acquisition from transferrin and lactoferrin by myeloid cells
  2210. ANTIOXIDATIVE AND ANTIMICROBIAL PROPERTIES OF lactoferrin IN HOT‐BONED GROUND PORK DURING STORAGE
  2211. In vitro reconstitution of antimicrobial pathogen activity by expressed recombinant bovine lactoferrin N-terminal peptide in Escherichia coli
  2212. Potential usefulness of bovine lactoferrin for adjunctive immunotherapy for mucosal Candida infections
  2213. Does human lactoferrin in the milk of transgenic mice deliver iron to suckling neonates?
  2214. Influence of pH in the recovery of lactoferrin from whey with ceramic membranes
  2215. Serum lactoferrin concentrations in colostrum-fed calves
  2216. lactoferrin: a tamoxifen-responsive protein in normal and malignant human endometrial cells in culture
  2217. Comparison of growth promoting effects on Bifidobacterium spp. by bovine lactoferrin hydrolysates
  2218. Targeting of stabilized plasmid lipid particles to hepatocytes in vivo by means of coupled lactoferrin
  2219. Estrogen response element and the promoter context of the human and mouse lactoferrin genes influence estrogen receptor α-mediated transactivation …
  2220. Regulation of fungal infection by a combination of amphotericin B and peptide 2, a lactoferrin peptide that activates neutrophils
  2221. 1H NMR relaxometric characterization of bovine lactoferrin
  2222. Salivary lactoferrin is recognized by the human herpesvirus-8
  2223. Consistent downregulation of human lactoferrin gene, in the common eliminated region 1 on 3p21. 3, following tumor growth in severe combined immunodeficient …
  2224. Effect of sodium dodecyl sulphate and cross-flow velocity on membrane fouling during cross-flow microfiltration of lactoferrin solutions
  2225. Study of Structural Changes of lactoferrin Using Flow Injection Analysis with Electrochemical Detection on Glassy Carbon Electrode.
  2226. Evaluation of faecal occult blood test and lactoferrin latex agglutination test in screening hospitalized patients for diagnosing inflammatory and non-inflammatory …
  2227. Downregulation of lactoferrin by PPARα ligands: Role in perturbation of hepatocyte proliferation and apoptosis
  2228. Antibacterial effects of the milk protein lactoferrin
  2229. Disposition kinetics of lactoferrin in milk after intramammary administration
  2230. A probe for capture and Fe3+-induced conformational change of lactoferrin selected from phage displayed peptide libraries
  2231. Producing human lactoferrin by high-density fermentation recombinant Pichia pastoris
  2232. lactoferrin-induced reduction of vanB vancomycin resistance in enterococci
  2233. Down‐regulation of 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline (MeIQx)‐induced CYP1A2 Expression Is Associated with Bovine lactoferrin Inhibition of MeIQx …
  2234. Inv-mediated apoptosis of epithelial cells infected with enteropathogenic Yersinia: a protective effect of lactoferrin
  2235. Interleukin-8, tumor necrosis factor-α, and lactoferrin in immunocompetent hosts with experimental and Brazilian children with acquired cryptosporidiosis
  2236. Presence of autoantibodies to carbonic anhidrase II and lactoferrin in type 1 diabetes: proposal of the concept of autoimmune exocrinopathy and endocrinopathy of …
  2237. Prevalence of autoantibodies to carbonic anhydrase II and lactoferrin in patients with type 1 diabetes
  2238. Effects of defensin and lactoferrin on functional activity of endothelial cells in vitro
  2239. Factors contributing to the potency of antimicrobial cationic peptides from the N-terminal region of human lactoferrin
  2240. Effect on bovine lactoferrin on the activation of the enteroinvasive bacterial type III secretion system
  2241. A sideways glance: Take it or leave it? The role of lactoferrin in iron sequestration and delivery within the body
  2242. lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and …
  2243. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
  2244. New sensitive method for the measurement of lysozyme and lactoferrin to explore mucosal innate immunity. Part II: time-resolved immunofluorometric assay used in …
  2245. Comparative evaluation of pulmonary lactoferrin and lysozyme immunoreactivity for the postmortem diagnosis of death due to sepsis
  2246. Reduction of concanavalin A-induced expression of interferon-γ by bovine lactoferrin in feline peripheral blood mononuclear cells
  2247. lactoferrin and bone: an overview of recent progress
  2248. Muramidase and lactoferrin in adenoidal hypertrophies, hypertrophic and chronic infected tonsil tissue–a quantitative analysis
  2249. The utility of lactoferrin in differentiating parasitic from bacterial infections.
  2250. Full length and delta lactoferrin display differential cell localization dynamics, but do not act as tumor markers or significantly affect the expression of other genes
  2251. Sub-chronic (13-week) oral toxicity study in rats with recombinant human lactoferrin produced in the milk of transgenic cows
  2252. The antiviral protein human lactoferrin is distributed in the body to cytomegalovirus (CMV) infection-prone cells and tissues
  2253. Protein synthesis in jejunum and liver of neonatal calves fed vitamin A and lactoferrin
  2254. Intraperitoneal injection of lactoferrin ameliorates severe albumin extravasation and neutrophilia in LPS-induced inflammation in neonatal rats
  2255. Effect of bovine lactoferrin on the immune responses of captive bottlenosed dolphins (Tursiops truncatus) being transported over long distances
  2256. Rapid determination of bovine lactoferrin in dairy products by an automated quantitative agglutination assay based on latex beads coated with F (ab′) 2 fragments
  2257. Human milk lactoferrin hydrolyzes nucleoside-5′-triphosphates
  2258. Separation of lactoferrin from model whey protein mixture by reverse micelles formed by cationic surfactant
  2259. Inflammatory effect of cleaved bovine lactoferrin by elastase on staphylococcal mastitis
  2260. lactoferrin stimulates killing and clearance of bacteria but does not prevent mortality of diabetic mice.
  2261. Lethality in LPS-induced endotoxemia in C3H/HeCr mice is associated with prevalence of proinflammatory cytokines: lack of protective action of lactoferrin
  2262. The status of lactoferrin and total iron binding capacity of human parotid saliva in Sjögren’s syndrome.
  2263. lactoferrin, a glycoprotein with immunomodulatory and mast cell stabilising properties, in skin of horses suffering from Culicoides hypersensitivity
  2264. Induction of lactoferrin gene expression in myeloid or mammary gland cells by human T-cell leukemia virus type 1 (HTLV-1) tax: implications for milk-borne …
  2265. Potent antimicrobial effects of the glycosylated lactoferrin
  2266. Antibiotic Tolerance Induced by lactoferrin in Clinical Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
  2267. Effect of a derivatized tetrapeptide from lactoferrin on nitric oxide mediated matrix metalloproteinase-2 production by synovial fibroblasts in collagen-induced arthritis in …
  2268. Antioxidants ceruloplasmin and lactoferrin in the prevention and treatment of postoperative complications in cancer patients
  2269. Decreased lactoferrin levels in peritoneal fluid of women with minimal endometriosis
  2270. Identification of lactoferrin-binding proteins in Streptococcus dysgalactiae subsp. dysgalactiae and Streptococcus agalactiae isolated from cows with mastitis
  2271. Antinociceptive and antipyretic effects of a derivatized tetrapeptide from lactoferrin in rats
  2272. Effects of lactoferrin, soya germ and polyamine on 2‐amino‐1‐methyl‐6‐ phenylimidazo[4,5‐b]‐pyridine(PhIP)‐ induced breast carcinogenesis in rats
  2273. Recombinant functional human lactoferrin expressed in baculovirus system
  2274. lactoferrin-Supplementierung bei neonatalen Hundewelpen-Wirkung auf Immunsystem und Blutbild
  2275. … from crystals of a membrane-protein complex: bacterial outer membrane protein OmpC complexed with the antibacterial eukaryotic protein lactoferrin
  2276. Arginine 25 and arginine 28 of lactoferrin are critical for effective heparin neutralization in blood
  2277. Assessing the estrogenicity of environmental chemicals with a stably transfected lactoferrin gene promoter reporter in HeLa cells
  2278. Structure of a domain-opened mutant (R121D) of the human lactoferrin N-lobe refined from a merohedrally twinned crystal form
  2279. Effects of lactoferrin supplementation on ileal and total tract nutrient digestibility, gastrointestinal microbial populations, and immune characteristics of ileal cannulated …
  2280. Dynamics of expression of cytokines and lactoferrin in patients with chronic alcohol pancreatitis and chronic relapsing pancreatitis
  2281. lactoferrin–melanin interaction and its possible implications in melanin polymerization: Crystal structure of the complex formed between mare lactoferrin and melanin …
  2282. Detection of lactoferrin in feces for differential diagnosis in diarrhea
  2283. Bovine lactoferrin stimulates anchorage-independent cell growth via membrane-associated chondroitin sulfate and heparan sulfate proteoglycans in PC12 cells
  2284. Affinity enrichment of bovine lactoferrin in whey
  2285. A new tool for distinguishing of different structural forms of lactoferrin
  2286. Role of lactoferrin in treatment of bovine mastitis
  2287. Evaluation of in vitro endocytosis and antibody synthesis by rainbow trout head kidney cells treated with bovine lactoferrin
  2288. New method for the determination of anti-lactoferrin activity of microorganisms
  2289. lactoferrin: Natural, Multifunctional, Antimicrobial.
  2290. cDNA microarray analysis of lactoferrin expression in non-neoplastic human hepatocyte PH5CH8 cells
  2291. A novel apoptosis cascade mediated by lysosomal lactoferrin and its participation in hepatocyte apoptosis induced by D-galactosamine
  2292. A new diagnostic indicator using concanavalin A low-affinity lactoferrin levels in mammary gland secretion in mastitic drying cows
  2293. Expression of recombinant porcine lactoferrin N-lobe in Pichia methanolica and its antibacterial activity
  2294. Anti-lactoferrin antibodies in patients with connective tissue diseases.
  2295. Zinc, iron, copper, selenium, lactoferrin, and ferritin in human pus
  2296. A preliminary analysis of the goat lactoferrin encoding gene
  2297. Use of lactoferrin forHelicobacter pyloriEradication
  2298. Analysis on the partial sequence of bovine lactoferrin gene by PCR-SSCP
  2299. Fecal lactoferrin measurements are useful in the interval assessment of patients with active and inactive inflammatory bowel disease
  2300. Concentration of lactoferrin and interleukin‐6 in cervical mucus from patients being treated for infertility
  2301. Effect of iron solubilized by lactoferrin on iron status in adult women
  2302. Use of fecal lactoferrin to diagnose irritable pouch syndrome: a word of caution
  2303. Product quality of low-fat/salt sausages containing lactoferrin and antimicrobial activity against Escherichia coli O157: H7
  2304. lactoferrin elicits opioid-mediated antinociception without development of tolerance: central nNOS-1 set off duty?
  2305. Activated lactoferrin: A look at the Science
  2306. Effect of bovine lactoferrin on utilization of orally administered iron in suckling piglets
  2307. A case of corneal lactoferrin amyloidosis secondary to trichiasis
  2308. lactoferrin reduces physiological dysfunctions of goldfish induced by chemotherapeutic agents
  2309. lactoferrin and its role in the pathogenesis of tick-borne encephalitis
  2310. Visualization of bovine lactoferrin binding to bifidobacteria
  2311. Direct detection of the binding of avidin and lactoferrin fluorescent probes to heparinized surfaces
  2312. lactoferrin (Lf): Retinoid interactions in the mammary glands of transgenic mice overexpressing human Lf
  2313. Antimicrobial activities of lactoferrin and its hydrolysate obtained from the colostrum of Hanwoo and Holstein cattle
  2314. Characterization of protein disulfide isomerase during lactoferrin polypeptide structural maturation in the endoplasmic reticulum
  2315. Oral recombinant human lactoferrin (rhLF) slows tumor growth in metastatic NSCLC and other advanced incurable cancers: Results of a Phase II study
  2316. Level of lactoferrin in serum and cerebrospinal fluid of patients with meningitis
  2317. Nuclear transfer of goat somatic cells transgenic for human lactoferrin
  2318. lactoferrin-mechanisms for antiviral activity.
  2319. Do lactoferrin, lysozyme and the lactoperoxidase-thiocyanate-hydrogen peroxide-system cause negative microbiological results in mastitis secretions?
  2320. Purification of lactoferrin by expanded-bed column chromatography
  2321. Cancer prevention and anti-metastatic effect by oral administration of bovine lactoferrin.
  2322. Expression of human lactoferrin in Bacteroides uniformis and its effect on azoxymethane-induced aberrant crypt focus formation in the rat colon
  2323. Effect of bovine lactoferrin on a transmissible AIDS-like disease in mice
  2324. Transcription and mRNA splicing of the human lactoferrin gene controlled by the regulatory region of the bovine α S1 casein gene in the mammary gland of transgenic …
  2325. The effect of punctal occlusion on tear lactoferrin in aqueous deficient dry eye patients
  2326. Growth behavior of Clostridium perfringens cells aggregated by bovine lactoferrin in the presence of lipoteichoic acid
  2327. lactoferrin stimulates erythrocyte Na+/K+-adenosine triphosphatase: effect of some modulators of membrane phosphorylation
  2328. Biochemical characterization of lactoferrin (LF)-binding proteins involved in the multiple physiological functions of LF in vitro
  2329. On the molecular interaction between lactoferrin and the dye Red HE-3b. A novel approach for docking a charged and highly flexible molecule to protein surfaces
  2330. Essential of proline and valine residues in the peptide derived from lactoferrin for angiotensin converting enzyme inhibition
  2331. Gene clone and Escherichia coli expression of murine lactoferrin
  2332. A novel synthetic peptide derivative from lactoferrin exhibiting antimicrobial activity
  2333. A preliminary study on genetic transformation of carrot with human lactoferrin gene
  2334. 211 lactoferrin INHIBITS BOVINE HERPESVIRUS-1 IN CELL CULTURE AND ALLOWS NORMAL DEVELOPMENT OF IN VITRO-PRODUCED EMBRYOS
  2335. In vivo expression of the antimicrobial defensin and lactoferrin proteins allowed by the strategic insertion of introns adequately spliced
  2336. Antimicrobial activity of lactoferrin and lactoferrin derived peptides
  2337. Production and characterization of recombinant human lactoferrin in transgenic Javanica rice cv Rojolele
  2338. Effect of dietary bovine lactoferrin on lipid peroxidation and activities, and mRNA levels of antioxidant enzymes in piglets
  2339. Does bovine lactoferrin inhibit Helicobacter pylori?
  2340. Effect of bovine lactoferrin on enamel demineralization and acid fermentation by Streptococcus mutans
  2341. Affinity measurement of lactoferrin (LF)-anti-LF immunoglobulin in yolk (IgY) complexes by competitive indirect enzyme-linked immunosorbent assay (CI-ELISA)
  2342. cDNA cloning and sequence analysis of human lactoferrin
  2343. ANTIOXIDANT PROPERTIES OF BOVINE COLOSTRUM AND ITS MAIN BIOACTIVE CONSTITUENTS OF lactoferrin AND LACTOPEROXIDASE
  2344. The role of anti-lactoferrin activity of bacteria in their persistence
  2345. Study progress of human lactoferrin transgene
  2346. Efficacy of a Rice Based Oral Rehydration Solution Containing Human Recombinant lactoferrin and Lysosyme in Children with Acute Diarrhea: P102
  2347. Structural and bioactivity determinants of the nutritional value of lactoferrin
  2348. … RESISTANCE AGAINST THE FIRE BLIGHT PATHOGEN IN APPLE CULTIVARS´ ELSTAR´ AND´ ROYAL GALA´ BY EXPRESSION OF HUMAN lactoferrin
  2349. CHARACTERIZATION OF THE HUMAN lactoferrin (HLF) CELL LINE HLFK1, GENERATED IN CBA MICE
  2350. Transmission of Bovine lactoferrin Fusion Gene in Transgenic Cattle
  2351. Double blind, placebo controlled trial of oral lactoferrin in combination therapy for first line non-small cell lung cancer (NSCLC)
  2352. Correlation of the gradient diffusion coefficients of human lactoferrin with interparticle interactions validated by photon correlation spectroscopy
  2353. Papillomavirus binding and entry: The heparan sulfate receptor and inhibition by lactoferrin
  2354. Effects of lactoferrin on rat dermal interstitial fluid pressure (Pif) and in vitro endothelial barrier function
  2355. Effect of bovine lactoferrin on the MICs of ampicillin/sulbactam (UNASYN), amoxicillin/clavulanic acid (Augmentin), ticarcillin clavulanate (Timentin), and piperacillin …
  2356. Influence of Activated lactoferrin as a Microbial Blocking Agent on Sensory and Shelf Life Characteristics of Case-Ready Fresh Beef
  2357. Potential of lactoferrin in the Prevention of Preterm Delivery
  2358. Effect of lactoferrin on the viability of Arn8 and HaCaT cell lines.
  2359. Assessing Intestinal Inflammation Using a New Rapid In Vitro Assay That Detects lactoferrin: 1082
  2360. Fecal lactoferrin distinguishes inflammatory from non-inflammatory causes of symptoms in patients with ileal-pouch anal anastomosis (IPAA)
  2361. Effect of lactoferrin on the development of acute and chronic adjuvant arthritis
  2362. Ultra-cleansing of lactoferrin: Nutraceutical implications
  2363. Anti-infectious and anti-inflammatory activities of lactoferrin and fragments thereof
  2364. Tear function and ocular surface alterations with lactoferrin treatment in severe dry eyes
  2365. Stimulating effect of bovine lactoferrin (bLF) on the level of lipopolisaccharide-binding protein (LBP) during experimental diabetes in mice
  2366. lactoferrin assay in urethritis and urethral prostatitis
  2367. Serum lactoferrin concentrations in calves fed fresh or frozen colostrum
  2368. Folding and Unfolding of Human lactoferrin at Interfaces: Expected X-ray Reflectivity Profiles
  2369. Effects of supersonic treatment on lactoferrin separation from whey waste using reversed micellar system
  2370. Antiviral activity of lactoferrin against bovine viral diarrhea virus
  2371. Specific reactions of polyfunctional proteins of the family of macroglobulins and lactoferrin with receptors and ligands in the protection of the body from pathogens
  2372. Deep Candida infections. Serology for laboratory diagnosis and antifungal activity of lactoferrin derived fragments
  2373. Evaluation of the Combination of Fecal lactoferrin and Fecal Anti-Saccharomyces Cerevesiae Antibodies To Detect Active Crohn’s Disease: 1001
  2374. Safety and efficacy of rice‐based ORS containing recombinant human lactoferrin and lysozyme in Peruvian children with diarrhea
  2375. Expression and antibacterial activity of recombinant human lactoferrin in methylotrophic yeast, Pichia pastoris
  2376. TERTIARY STRUCTURE OF lactoferrin PEPTIDE IN COMPLEX WITH LPS FOR DESIGN OF NOVEL ENDOTOXIN-NEUTRALIZING PEPTIDES: 248
  2377. … for Developing Methods of Diagnosis and Examination of the Function of Salivary Glands: Existence and Characterization of BMP and lactoferrin and Their Receptors …
  2378. Does the inclusion of moderate amounts of red meat in the diet of exercising older women impact on faecal markers of bowel health, including faecal lactoferrin?
  2379. Viral load and not lactoferrin concentrations in breast milk correlates with the transmission of Human Cytomegalovirus (HCMV) to preterm neonates.
  2380. Recent development and physiological functions of lactoferrin
  2381. Analysis of the 5′-region of bovine lactoferrin gene
  2382. Biological Function of lactoferrin in Milk
  2383. Comparative Study of Glycans in lactoferrin-a and lactoferrin-b
  2384. Adenoviruses Use lactoferrin as a Bridge
  2385. CompoundsWhich Mediate Gaffium-67Transferfrom lactoferrin to Ferritin
  2386. RP-HPLC Determination of Bovine lactoferrin
  2387. Content of protein lactoferrin in precancer laryngeal disease
  2388. One of Two Human lactoferrin Variants
  2389. Cloning of lactoferrin gene of mice and the difference of lactoferrin gene expression in mammary gland at different lactation stages
  2390. Effect of lactoferrin on production of tumor necrosis factor-α
  2391. 321 Immunological and Virological Effects of Bovine lactoferrin in HIV-1 Vertically Infected Children
  2392. Research on HPCE Determination of Content and Related Proteins of Bovine lactoferrin
  2393. Comparison of Amino Acid and Carbohydrate Compositions of Bovine, Goat and Sheep lactoferrin
  2394. PERITONEAL FLUID lactoferrin LEVELS IN ENDOMETRIOTIC PATIENTS
  2395. Antiviral Activity of Human lactoferrin
  2396. < The> utility of lactoferrin in differentiating parasitic from bacterial infections
  2397. Characterization of the human lactoferrin (HLF) cell line HLFK1, generated in CBA mice.
  2398. The effect of horse milk lactoferrin on mice cellular immune response
  2399. Oral lactoferrin Treatment of Experimental
  2400. Fine structures of epitopic sites in human and bovine lactoferrin recognized by anti-bovine lactoferrin C-lobe monoclonal antibody
  2401. lactoferrin AS A MARKER OF SYSTEMIC INFLAMMATORY RESPONSE
  2402. lactoferrin Peptide Increases the Survival
  2403. lactoferrin as a Marker of Systemic Inflammatory Response
  2404. Proceedings-lactoferrin as a Marker of Systemic Inflammatory Response
  2405. Fecal lactoferrin in Children with Gastrointestinal Symptoms
  2406. Elucidating the mechanism of a multifunctional protein: lactoferrin
  2407. Ejaculate microflora sensitivity to lactoferrin in chronic prostatitis
  2408. Cancer prevention by bovine lactoferrin and underlying mechanisms a review of experimental and clinical studies
  2409. Expression of Recombinant Bovine lactoferrin and lactoferrin N-lobe in Rhodococcus erythropolis at Low Temperature
  2410. The charakterization of a human lactoferrin [HLF] cell line-HLF K1
  2411. lactoferrin Impairs Type III Secretory
  2412. lactoferrin Binds CpG-Containing
  2413. Radioprotection of lactoferrin in Sub-Lethally X-ray irradiated mice
  2414. Antibiotic Tolerance Induced by lactoferrin
  2415. lactoferrin Levels are Elevated in Inflammatory Genital Infections
  2416. Fecal lactoferrin in Children with Gastrointestinal Symptoms: 1044
  2417. The effect of dietary lactoferrin on bone status in the ovariectomized mice
  2418. Health Promoting Effect of lactoferrin from Milk
  2419. Intestinal Absorption of lactoferrin Molecules, an Immunohistochemical Study in Rats
  2420. Abstracts of the 7th International Conference on lactoferrin/Résumés de la 7e Conférence internationale sur la lactoferrine
  2421. Development Strategy for functional rice improved with human lactoferrin and enhancement of nutrient compounds
  2422. Isolation and purification of lactoferrin from cationic proteins of goat polymorphonuclear cells
  2423. Human lactoferrin and Peptides Derived
  2424. 14 MOTILITY AND FERTILITY OF BULL SPERMATOZOA FROZEN IN EGG YOLK EXTENDER SUPPLEMENTED WITH lactoferrin
  2425. Identification of lactoferrin-binding proteins in human serum
  2426. X-ray study of ceruloplasmin-lactoferrin complex
  2427. P1053 FECAL lactoferrin IN PAEDIATRIC PATIENTS TREATED FOR MALIGNANT DISEASES
  2428. < The> role of lactoferrin supplementation of infant formulas on some physiological and biological parameters in rats
  2429. Neutrophil lactoferrin Levels in Inflammatory Bowel D’isease (71)
  2430. Curative Effect of lactoferrin on Repeated Respiratory Infection in Children
  2431. Fecal lactoferrin: Reliable Inflammatory Marker in Pediatric IBD
  2432. Development of a Molecularly Imprinted Polymer (MIP) for the Recovery of lactoferrin
  2433. Intestinal Absorption of lactoferrin Molecules, an Immunohistochemical Study in Rats
  2434. Effect of hydrolysed lactoferrin in Helicobacter pylori-infected mice
  2435. The effects of lactoferrin on superoxide anion production by HL-60 cells
  2436. Secondary Corneal Amyloidosis Proving an Association with lactoferrin
  2437. Bovine lactoferrin specifically binds to human monocytic THP-1 cells
  2438. Expression of human lactoferrin cDNA in tomato plant
  2439. A Putative Source of lactoferrin Deposited at Secondary Corneal Amyloidosis
  2440. Possible receptors for bovine lactoferrin on human monocytic THP-1 cells
  2441. … of non-steroidal anti-inflammatory drugs (NSAIDS) to lactoferrin: Crystal structure of the complex of the C-terminal lobe of bovine lactoferrin with diclofenac at …
  2442. AB0022 lactoferrin–a potent anti-inflammatory agent for treatment of adjuvant arthritis
  2443. Effect of lipopolysaccharides on bovine lactoferrin mRNA expression by mammary epithelial cells in vitro
  2444. Preparation and Identification of Anti-lactoferrin Single Chain Fv Antibody
  2445. THU0073 Elastase and lactoferrin as indicators of functional activity of polymorphonuclear cells in rheumatoid arthritis
  2446. A study of the expression of glycosylation mutants of bovine lactoferrin
  2447. Expression and Characterization of the Human lactoferrin in the Milk of Transgenic Mice
  2448. Isolation and characterization of the bioactive fractions from carabao (Bubalus bubalis L.) milk lactoferrin
  2449. lactoferrin: An adjuvant to enhance the efficacy of the BCG vaccine
  2450. lactoferrin is localised at the two sides of the mouse mammary epithelium
  2451. Antibacterial Effect of Bovine lactoferrin Against Udder Pathogens
  2452. Effects of lipopolysacharide, interleukin-l and lactoferrin on intake of sweet sołutions by mice
  2453. Measurement of ASCA, lactoferrin and Clostridium Difficile in Feces of Patients with IBD
  2454. Study on secretion of lactoferrin erhualian sow milk during lactation
  2455. lactoferrin Glu561Asp Polymorphism Is Involved in Susceptibility to Herpes Simplex Keratitis
  2456. Expression and Characterization of the Human lactoferrin in the Milk of Transgenic Mice
  2457. Bovine lactoferrin suppresses ConA-induced T cell activation in mice
  2458. Antiviral Activity of Human Colostral lactoferrin Against Herpes Simplex Virus Type 1
  2459. Biochemical Properties and Antibacterial Activity of lactoferrin from Korean Native Cow
  2460. Molecular cloning and functional expression of an intestinal lactoferrin receptor and feasibility of using recombinant human lactoferrin expressed in rice in …
  2461. Early endocytotic events associated with lactoferrin and its receptor in trophoblast cells.
  2462. Changes of lactoferrin concentration in cow_s milk in housing and grazing period and its correlation with the mammary gland health status
  2463. Cellular responses resulting from the interactions between lactoferrin and its receptor in human placental cells.
  2464. lactoferrin concentrations in cervical mucus of pregnant women with and without infection
  2465. Structural Characterization of the Ceruloplasmin: lactoferrin Complex in Solution
  2466. THE DETECTION OF lactoferrin, ASCA, AND ANCA IN FECES IS USEFUL FOR ASSESSING PEDIATRIC IBD PATIENTS: 962
  2467. Structural Characterization of the Ceruloplasmin: lactoferrin Complex in Solution
  2468. A series of in vitro studies investigating the role of lactoferrin in calf innate immunity
  2469. lactoferrin Assessment of Rectal Effluent as an Aid to Colonoscopy for Determining Intestinal Inflammation: 1024
  2470. A Comparison of Two Methods for the Extraction of lactoferrin-binding Proteins from Streptococcus uberis
  2471. Effect of Lyophilized lactoferrin on Cell Culture Arn8 in Normal Conditions and after Ultraviolet Irradiation
  2472. Treatment of Cytomegalovirus-infected rats with recombinant human lactoferrin.
  2473. Detection of lactoferrin in the Neutrophils and Plasma of the Patients Suffering from Hepatitis C
  2474. Expression of Human lactoferrin Gene in Transgenic Rice (Oryza sativa L.)
  2475. Transgenic Rice Plants Expressing Human lactoferrin
  2476. Use of milk protein lactoferrin as a natural antimicrobial in meat products
  2477. Histological observations on the structural changes in rat lacrimal gland by oral administration of lactoferrin
  2478. Transgenic rice plants producing human lactoferrin
  2479. Variation of lactoferrin (LTF) content predicted by mid-infrared spectrometry (MIR)
  2480. Structural characterization of the lactoferrin/ceruloplasmin complex by Small Angle X-Ray Scattering
  2481. Enhanced antitumor activity and selectivity of lactoferrin-derived peptides
  2482. Role of the lactoferrin-binding protein in pathogenesis of streptococcus uberis
  2483. P0663 THE EVALUATION OF FAECAL CALPROTECTIN AND lactoferrin LEVELS IN THE DIAGNOSIS OF CHILDREN WITH INFLAMMATORY BOWEL …
  2484. Cloning lactoferrin gene in a novel expression vector and its expression/secretion in bovine mammary cells
  2485. Anti lactoferrin antibody and serum ferritin in juvenile rheumatoid artheritis
  2486. Preventive effect of recombinant human lactoferrin in a rabbit preterm delivery model
  2487. THE ROLE OF lactoferrin, INTERLEUKIN-1 BETA AND INTERLEUKIN-8 IN PATHOGENESIS AND TREATMENT OF CHRONIC RHINOSINUSITIS.
  2488. Evaluation of CRP, Fecal lactoferrin and Clinical Activity Indices for Assessing the Presence of Intestinal Inflammation in IBD and IBS Patients
  2489. Expression of human lactoferrin gene transformed rice (Oryza sativa L.) via Agrobacterium
  2490. Interaction of lactoferrin with plasmid DNA studied by laser correlation spectroscopy
  2491. Immunological changes in colostrogenesis in bovine mammary gland during dry period and the function of lactoferrin (Lf)
  2492. lactoferrin Stimulates Killing and Clearance of Bacteria but Does Not Prevent Mortality of Diabetic Mice
  2493. Identification of low-molecular weight prostate-specific antigen (PSA) and lactoferrin in the prostatic secretion of benign prostatic hyperplasia
  2494. Decreased pulmonary lactoferrin activity facilitates Pseudomonas biofilm formation in CF
  2495. lactoferrin Sequestration and Its Contribution to Iron Deficiency Anemia in Helicobacter pylori Infected Gastric Mucosa
  2496. Recombinant Porcine lactoferrin Expressed in the Milk of Transgenic Mice Enhances Offspring Growth Performance
  2497. Evaluation of lactoferrin Concentrations in Goat Milk from Udder Inoculated with Staphylococcus aureus
  2498. Correlation between Human lactoferrin Binding and Colicin Susceptibility in Escherichia coli
  2499. Anti-cytomegalovirus applications of the intrinsically active drug carrier lactoferrin
  2500. Effect of NMDA receptor on analgesic effect of bovine milk-derived lactoferrin (BLF)
  2501. Fecal lactoferrin in newborns, infants and toddlers-Evaluation in asymptomatic children and patients with functional disorders
  2502. Studies on the antiviral activity of lactoferrin and ribavirin upon hantavirus
  2503. lactoferrin restoration of lymphocyte and macrophage content in cyclophosphamide-treated mice
  2504. FECAL lactoferrin IS A SENSITIVE AND SPECIFIC NON-INVASIVE SURROGATE MARKER FOR THE DIAGNOSIS AND MANAGEMENT OF PEDIATRIC …
  2505. Oral recombinant human lactoferrin (RhLF) in a non-human primate model of asthma
  2506. lactoferrin Gene Mutation in Gelatinous Drop–like Corneal Dystrophy
  2507. Physiological correlation between lactoferrin (LF), LF-binding proteins and glycyrrhizin (GL) in vitro
  2508. Associations between lactoferrin gene polymorphism and somatic cell count in milk and milk production traits in Jersey cws
  2509. Coupling of monolithic column sample preparation and flow injection analysis-Electrochemical detection for determination of lactoferrin: easy, low cost and structural …
  2510. Bovine lactoferrin suppresses T cell activation induced by concanavalin A
  2511. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: A…
  2512. Heterologous expression of biologically active porcine lactoferrin in yeast Pichia pastoris
  2513. Germ Line Transformation of the Silkworm, Bombyx mori L. with a piggyBac Vector Harboring the Human lactoferrin Gene
  2514. Enhancement of thermogenesis by milk-derived lactoferrin in cold exposure and restraint rats
  2515. In vitro Effects of lactoferrin and Other Tear Proteins on Lysozyme Deposition and Activity on Silicone Hydrogel Contact Lenses
  2516. Production, characterization, and elucidation of structure-function relationship of lactoferricin and other peptides derived from food-grade bovine lactoferrin
  2517. lactoferrin Increases the Output of Neutrophil Precursors and Attenuates the Spontaneous Production of TNF-α and IL-6 by Peripheral Blood Cells
  2518. H. pylori eradication with either quadruple therapy with lactoferrin or low-dose levofloxacin-based triple therapy: results of a multicenter study
  2519. Direct Capture of lactoferrin and Lactoperoxidase from Raw Whole Milk by Cation Exchange Chromatography
  2520. lactoferrin purification from bovine whey and colostrum by affinity membrane chromatography
  2521. Veterinary medicine sciences immunoglobulins and lactoferrin concentration in milk and bacteria causing subclinical mastitis in dairy cows.
  2522. Serum IgG concentrations of neonatal calves fed colostrum replacer supplemented with lactoferrin
  2523. Human lactoferrin enhances angiogenesis via upregulating expression of KDR/Flk-1, a receptor for vascular endothelial growth factor in human endothelial cells
  2524. … in spontaneus and lipopolysaccharide-induced production of tumor necrosis factor alpha by peripheral blood mononuclear cells: regulatory effects of lactoferrin
  2525. Measurement of lactoferrin, IgA, IgG1, IgG2, Antibacterial Activity, and Lactic Acid Bacterial Growth in Holstein Colostrum
  2526. DO SILICONE PUNCTAL PLUGS IMPACT TEAR lactoferrin LEVELS FOLLOWING LASIK?: Poster# 135
  2527. Effect of lactoferrin Derived from Bovine Colostrum on the Intensity of Peroxidative Processes in Liver Fragments Under their Hypothermic Storage
  2528. High Expression of a Human lactoferrin in Transgenic Siberian Ginseng (Acanthopanax senticosus) Cell Cultures
  2529. TREATMENT OF METHICILINE RESISTANT STAPHYLOCCOCUS AUREUS (MRSA) OSTEOMYELITIS IN RABBITS WITH HUMAN lactoferrin 1-11 (HLF1-11) …
  2530. Production of antimicrobial human lactoferrin in transgenic rice (Oryza sativa L.) using Agrobacterium tumefaciens
  2531. Colicin production, colicin sensitivity and lactoferrin binding of dysentery causing bacteria
  2532. Effects of dietary bovine lactoferrin on non-specific immune response and disease resistance of Indian major carp, catla, Catla catla (Hamilton)
  2533. Anti-lactoferrin (LF) auto-antibodies, 88 α1-antitrypsin, 90 Antiviral state, and interferons, 106–107 Antiviral treatment HCV-related cirrhosis, 216–218
  2534. Production of lactoferrin-producing Bacteroides uniformis and its effect on preneoplastic lesion of rat colon cancer induced by Azoxymethane
  2535. The effect of bovine viral diarrhea virus and lipopolysaccharide on the expression of defensins and secretion of lactoferrin by bovine tracheal epithelial cells
  2536. Efficiency of two cation exchange methods for isolating lactoperoxidase and lactoferrin from Gouda and Cheddar cheese whey
  2537. Afffinity measurement of lactoferrin (LF)-anti-LF immunoglobulin in Yolk (IgY) complexes by competitive indirect enzyme-linked immunosorbent assay (CI-ELISA)
  2538. O0120 lactoferrin STIMULATES ENTEROCYTE GROWTH AND DIFFERENTIATION THROUGH MAP KINASE-ERK AND RESTORES INTESTINAL …
  2539. Evaluation of lactoferrin (Latex agglutination-Leuko-Test and a new dip stick-Leuko-Stick-Test) and modified guaiac-test (Colo-Rectal-Test) as screening tests in …
  2540. Effect of probiotic and lactoferrin-supplemented diets on daily gain, feed intake, feed conversion rate, mean weekly faecal scores, lymphcyte to neutrophil ratio …
  2541. Efficacy of electrostatically sprayed Activin™(activated lactoferrin), hot water, high pressure water and lactic acid individually and used in a multi-hurdle …
  2542. … enterica serovar Typhimurium in murine macrophages Marian Kruzel, Attila Bacsi, Barun Choudhury, Sanjiv Sur, Istvan Boldogh: lactoferrin decreases pollen antigen …
  2543. PD2-2-5: lactoferrin is associated with the sexual difference in the incidence of lung adenocarcinogenesis
  2544. … 1 Current Status of Hormone-Induced Lactation, by K. Larry Smith, LB Willett, DR Redman, and FL Schanbacher 8 Concentration of lactoferrin in Milk and …
  2545. Serum and Cerebrospinal Fluid (CSF) Nitric Oxide, Macrophage Inflammatory Protein-1 α and lactoferrin Levels in Aseptic Meningitis
  2546. 273 THE EFFECTS OF lactoferrin ON THE ANTIMICROBIAL ACTIVITY OF PASTEURIZED HUMAN MILK.
  2547. D-2. Effects of bovine lactoferrin on the motile activity of fibroblasts (Abstracts of the International Symposium on Recent Advances in Animal Science (IS-RAAS), Joint …
  2548. 2P588 Characterization of the complex for procaspase-3 with lactoferrin and caspase-3 with cathechin derivatives (55. Drug design and delivery, Poster Session …
  2549. lactoferrin: structure, function and applications
  2550. lactoferrin structure and functions
  2551. lactoferrin–50 years on
  2552. lactoferrin: a review
  2553. Antimicrobial properties of lactoferrin
  2554. Twenty-five years of research on bovine lactoferrin applications
  2555. Nutritional roles of lactoferrin
  2556. A structural perspective on lactoferrin function
  2557. lactoferrin as a natural immune modulator
  2558. lactoferrin a multiple bioactive protein: an overview
  2559. lactoferrin, a bird’s eye view
  2560. A structural framework for understanding the multifunctional character of lactoferrin
  2561. Effect of lactoferrin on enteric pathogens
  2562. lactoferrin and cancer disease prevention
  2563. Factors affecting the lactoferrin concentration in bovine milk
  2564. Antiviral properties of lactoferrin—a natural immunity molecule
  2565. A critical review of the roles of host lactoferrin in immunity
  2566. Clinical studies of lactoferrin in children
  2567. Role of lactoferrin in the tear film
  2568. Bovine lactoferrin can be taken up by the human intestinal lactoferrin receptor and exert bioactivities
  2569. lactoferrin, a key molecule in immune and inflammatory processes
  2570. lactoferrin and cancer in different cancer models
  2571. Isolation of lactoferrin from milk of different species: calorimetric and antimicrobial studies
  2572. Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin
  2573. Immunomodulatory effects of lactoferrin on antigen presenting cells
  2574. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
  2575. Roles of lactoferrin on skin wound healing
  2576. lactoferrin: an alternative view of its role in human biological fluids
  2577. Co-acervates of lactoferrin and caseins
  2578. lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses
  2579. Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease
  2580. Bovine lactoferrin supplementation supports immune and antioxidant status in healthy human males
  2581. The effect of lactoferrin on oral bacterial attachment
  2582. The effect of bovine milk lactoferrin on human breast cancer cell lines
  2583. Cancer prevention by bovine lactoferrin: from animal studies to human trial
  2584. lactoferrin in Relation to Biological Functions and Applications: A
  2585. Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)
  2586. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings
  2587. lactoferrin as an effector molecule in the skeleton
  2588. Formation of protein nanoparticles by controlled heat treatment of lactoferrin: Factors affecting particle characteristics
  2589. Inhibition of eosinophil migration by lactoferrin
  2590. lactoferrin and oral diseases: current status and perspective in periodontitis
  2591. Novel lactoferrampin antimicrobial peptides derived from human lactoferrin
  2592. Crohn’s disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn’s disease activity index and endoscopic findings
  2593. lactoferrin in gastrointestinal disease
  2594. Periodontitis, periodontopathic bacteria and lactoferrin
  2595. Biochemical and molecular impacts of lactoferrin on small intestinal growth and development during early life
  2596. lactoferrin-conjugated PEG–PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations
  2597. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial
  2598. Discovery and development of a synthetic peptide derived from lactoferrin for clinical use
  2599. lactoferrin-lipopolysaccharide (LPS) binding as key to antibacterial and antiendotoxic effects
  2600. Effect of dietary bovine lactoferrin on performance and antioxidant status of piglets
  2601. Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine
  2602. Expression of active recombinant human lactoferrin in the milk of transgenic goats
  2603. Fecal markers: calprotectin and lactoferrin
  2604. Production of human lactoferrin in animal milk
  2605. Characterization of the interaction between human lactoferrin and lomefloxacin at physiological condition: Multi-spectroscopic and modeling description
  2606. Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis
  2607. Determination of lactoferrin and immunoglobulin G in animal milks by new immunosensors
  2608. The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain
  2609. Electroseparation of bovine lactoferrin from model and whey solutions
  2610. Bioinformatics analysis of lactoferrin gene for several species
  2611. lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery
  2612. lactoferrin for prevention of neonatal infections
  2613. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli
  2614. Oral bovine lactoferrin improves bone status of ovariectomized mice
  2615. Electrochemical immunosensor detection of urinary lactoferrin in clinical samples for urinary tract infection diagnosis
  2616. Relationship between milk lactoferrin and etiological agent in the mastitic bovine mammary gland
  2617. Recombinant human lactoferrin: a valuable protein for pharmaceutical products and functional foods
  2618. lactoferrin concentrations in goat milk throughout lactation
  2619. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans
  2620. Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin
  2621. Formation and characterization of lactoferrin/pectin electrostatic complexes: Impact of composition, pH and thermal treatment
  2622. Immunoregulatory role of lactoferrin-lipopolysaccharide interactions
  2623. Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological …
  2624. Apo‐and holo‐lactoferrin are both internalized by lactoferrin receptor via clathrin‐mediated endocytosis but differentially affect ERK‐signaling and cell proliferation in …
  2625. Reduced levels of lactoferrin in biofilm‐associated chronic rhinosinusitis
  2626. lactoferrin delivery systems: approaches for its more effective use
  2627. lactoferrin is a survival factor for neutrophils in rheumatoid synovial fluid
  2628. Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn’s disease
  2629. Dietary effect of lactoferrin-enriched fermented milk on skin surface lipid and clinical improvement of acne vulgaris
  2630. Inhibitory Effects of lactoferrin on Growth and Biofilm Formation of Porphyromonas gingivalis and Prevotella intermedia
  2631. Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn’s disease treatment
  2632. Growth promotion and cell binding ability of bovine lactoferrin to Bifidobacterium longum
  2633. lactoferrin: the path from protein to gene
  2634. Influence of bovine lactoferrin on selected probiotic bacteria and intestinal pathogens
  2635. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial
  2636. Antimicrobial activity of lysozyme and lactoferrin incorporated in cellulose-based food packaging
  2637. Elevated levels of salivary lactoferrin, a marker for chronic periodontitis?
  2638. Bactericidal effect of lactoferrin and lactoferrin chimera against halophilic Vibrio parahaemolyticus
  2639. Cattle mammary bioreactor generated by a novel procedure of transgenic cloning for large-scale production of functional human lactoferrin
  2640. Brain-targeting mechanisms of lactoferrin-modified DNA-loaded nanoparticles
  2641. lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson’s disease
  2642. Influence of oral lactoferrin on Mycobacterium tuberculosis induced immunopathology
  2643. lactoferrin: a biologically active molecule for bone regeneration
  2644. An antimicrobial protein, lactoferrin exists in the sweat: proteomic analysis of sweat
  2645. Meta‐analysis: efficacy of bovine lactoferrin in Helicobacter pylori eradication
  2646. Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease
  2647. Human lactoferrin stimulates skin keratinocyte function and wound re‐epithelialization
  2648. Liposomalization of lactoferrin enhanced its anti-tumoral effects on melanoma cells
  2649. Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model
  2650. Bovine lactoferrin counteracts Toll-like receptor mediated activation signals in antigen presenting cells
  2651. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn’s disease
  2652. Iron‐saturated’lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy
  2653. Luminescent quantum clusters of gold in transferrin family protein, lactoferrin exhibiting FRET
  2654. A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency
  2655. The lactoferrin receptor complex in Gram negative bacteria
  2656. Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin
  2657. Reciprocal interactions between lactoferrin and bacterial endotoxins and their role in the regulation of the immune response
  2658. Impact of lactoferrin Supplementation on Growth and Prevalence of Giardia Colonization in Children
  2659. lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection
  2660. lactoferrin: structure and function
  2661. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase …
  2662. In vivo diffusion of lactoferrin in brain extracellular space is regulated by interactions with heparan sulfate
  2663. A comparison of effects of pH on the thermal stability and conformation of caprine and bovine lactoferrin
  2664. lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells
  2665. Utilization of lactoferrin to fight antibiotic-resistant mammary gland pathogens,
  2666. lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas
  2667. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers
  2668. Physicochemical properties of lactoferrin stabilized oil-in-water emulsions: Effects of pH, salt and heating
  2669. Genetic analysis of lactoferrin content in bovine milk
  2670. Decreased circulating lactoferrin in insulin resistance and altered glucose tolerance as a possible marker of neutrophil dysfunction in type 2 diabetes
  2671. lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model
  2672. Proadipogenic effects of lactoferrin in human subcutaneous and visceral preadipocytes
  2673. Elucidation of the mechanism by which catecholamine stress hormones liberate iron from the innate immune defense proteins transferrin and lactoferrin
  2674. lactoferrin efficacy versus ferrous sulfate in curing iron disorders in pregnant and non-pregnant women
  2675. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome
  2676. Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women
  2677. Trichomoniasis and lactoferrin: future prospects
  2678. Effect of heat treatment on the antibacterial activity of bovine lactoferrin against three foodborne pathogens
  2679. Transgenic milk containing recombinant human lactoferrin modulates the intestinal flora in piglets
  2680. Glycosylation of human milk lactoferrin exhibits dynamic changes during early lactation enhancing its role in pathogenic bacteria-host interactions
  2681. Delta-lactoferrin, an intracellular lactoferrin isoform that acts as a transcription factor
  2682. Molecular evidence of stereo-specific lactoferrin dimers in solution
  2683. Development of poly (ethylene glycol) conjugated lactoferrin for oral administration
  2684. Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts
  2685. lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo
  2686. lactoferrin increases 172ThrAMPK phosphorylation and insulin-induced p473SerAKT while impairing adipocyte differentiation
  2687. Levels of lactoferrin, secretory IgA and serum albumin in the tear film of people with keratoconus
  2688. Extraction of lactoferrin with hydrophobic ionic liquids
  2689. Molecular mechanisms of the inhibitory effects of bovine lactoferrin on lipopolysaccharide-mediated osteoclastogenesis
  2690. Orally administered lactoferrin preserves bone mass and microarchitecture in ovariectomized rats
  2691. Interaction of lactoferrin and lysozyme with casein micelles
  2692. Relationships among salivary immunoglobulin A, lactoferrin and cortisol in basketball players during a basketball season
  2693. Faecal lactoferrin–a novel test to differentiate between the irritable and inflamed bowel?
  2694. Effects of dietary bovine lactoferrin on growth, physiological performance, iron metabolism and non-specific immune responses of Siberian sturgeon Acipenser baeri
  2695. lactoferrin modulation of BCG-infected dendritic cell functions
  2696. Association of Circulating lactoferrin Concentration and 2 Nonsynonymous LTF Gene Polymorphisms with Dyslipidemia in Men Depends on Glucose-Tolerance …
  2697. lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo
  2698. Scientific Opinion on bovine lactoferrin
  2699. Staphylococcus aureus and Escherichia coli cause deviating expression profiles of cytokines and lactoferrin messenger ribonucleic acid in mammary …
  2700. Fabrication and morphological characterization of biopolymer particles formed by electrostatic complexation of heat treated lactoferrin and anionic polysaccharides
  2701. Mid-infrared prediction of lactoferrin content in bovine milk: potential indicator of mastitis
  2702. Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus
  2703. lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women
  2704. Effect of Orally Administered Bovine lactoferrin on the Growth of Adenomatous Colorectal Polyps in a Randomized, Placebo-Controlled Clinical TrialEffect of bLF on …
  2705. Human lactoferrin activates NF‐κB through the Toll‐like receptor 4 pathway while it interferes with the lipopolysaccharide‐stimulated TLR4 signaling
  2706. Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea
  2707. Inhibitory effects of lactoferrin on biofilm formation in clinical isolates of Pseudomonas aeruginosa
  2708. Impact of electrostatic deposition of anionic polysaccharides on the stability of oil droplets coated by lactoferrin
  2709. lactoferrin protects against acetaminophen‐induced liver injury in mice
  2710. lactoferrin-conjugated dendritic nanoconstructs for lung targeting of methotrexate
  2711. Antihypertensive effect of a bovine lactoferrin pepsin hydrolysate: Identification of novel active peptides
  2712. In vitro susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lactoferrin and xylitol
  2713. Effects of lactoferrin on the differentiation of pluripotent mesenchymal cells
  2714. The human lactoferrin-derived peptide hLF1-11 exerts immunomodulatory effects by specific inhibition of myeloperoxidase activity
  2715. Bovine lactoferrin inhibits influenza A virus induced programmed cell death in vitro
  2716. Anti‐biofilm efficacy of a lactoferrin/xylitol wound hydrogel used in combination with silver wound dressings
  2717. Self-assembled polymersomes conjugated with lactoferrin as novel drug carrier for brain delivery
  2718. Influence of lactoferrin in preventing preterm delivery: A pilot study Corrigendum in/mmr/7/4/1366
  2719. Helicobacter pylori Infection in Clinical Practice: Probiotics and a Combination of Probiotics + lactoferrin Improve Compliance, But Not Eradication, in Sequential …
  2720. lactoferrin and prevention of late-onset sepsis in the pre-term neonates
  2721. Protective effects of lactoferrin against intestinal mucosal damage induced by lipopolysaccharide in human intestinal Caco-2 cells
  2722. The N1 domain of human lactoferrin is required for internalization by caco-2 cells and targeting to the nucleus
  2723. Antimicrobial and DNA-binding activities of the peptide fragments of human lactoferrin and histatin 5 against Streptococcus mutans
  2724. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway
  2725. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein
  2726. Thermodynamic characterization of the interactions between the immunoregulatory proteins osteopontin and lactoferrin
  2727. Potential activity of camel milk-amylase and lactoferrin against hepatitis C virus infectivity in HepG2 and lymphocytes
  2728. Recombinant human intelectin binds bovine lactoferrin and its peptides
  2729. lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats
  2730. Fecal lactoferrin as a noninvasive biomarker in inflammatory bowel diseases.
  2731. lactoferrin for the prevention of post-antibiotic diarrhoea
  2732. Human lactoferrin Induces Apoptosis-Like Cell Death in Candida albicans: Critical Role of K+-Channel-Mediated K+ Efflux
  2733. lactoferrin in chronic pancreatitis
  2734. Bovine lactoferrin improves bone status of ovariectomized mice via immune function modulation
  2735. Transgenic expression of lactoferrin imparts enhanced resistance to head blight of wheat caused by Fusarium graminearum
  2736. Interaction between lactoferrin and casein micelles in skimmed milk
  2737. Dietary lactoferrin alleviates age-related lacrimal gland dysfunction in mice
  2738. Inhibition of Epstein-Barr virus infection by lactoferrin
  2739. Probiotic Lactobacillus casei expressing human lactoferrin elevates antibacterial activity in the gastrointestinal tract
  2740. lactoferrin and its role in wound healing
  2741. Analysis of the spectroscopic characteristics on the binding interaction between tosufloxacin and bovine lactoferrin
  2742. Combined treatment of Pseudomonas aeruginosa biofilm with lactoferrin and xylitol inhibits the ability of bacteria to respond to damage resulting from lactoferrin iron …
  2743. Fungicidal activity of human lactoferrin-derived peptides based on the antimicrobial αβ region
  2744. Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and …
  2745. Bovine lactoferrin gene polymorphism and expression in relation to mastitis resistance-a review.
  2746. Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone
  2747. Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease
  2748. Decrease in salivary lactoferrin output in chronically intoxicated alcohol-dependent patients
  2749. Adsorption and spectroscopic characterization of lactoferrin on hydroxyapatite nanocrystals
  2750. Signal transduction and metabolism in chondrocytes is modulated by lactoferrin
  2751. Fecal lactoferrin and Clostridium spp. in stools of autistic children
  2752. Development and characterization of lactoferrin nanoliposome: cellular uptake and stability
  2753. Studies of the structure of multiferric ion-bound lactoferrin: a new antianemic edible material
  2754. Nano-lactoferrin in diagnostic, imaging and targeted delivery for cancer and infectious diseases
  2755. Utilization of lactoferrin-Bound and Transferrin-Bound Iron by Campylobacter jejuni
  2756. Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1
  2757. Stimulus-dependent impairment of the neutrophil oxidative burst response in lactoferrin-deficient mice
  2758. Effect of lactoferrin-embedded collagen membrane on osteogenic differentiation of human osteoblast-like cells
  2759. Effect of high-pressure treatment on denaturation of bovine lactoferrin and lactoperoxidase
  2760. Effect of lactoferrin on osteogenic differentiation of human adipose stem cells
  2761. Inhibition of tumor growth by recombinant adenovirus containing human lactoferrin through inducing tumor cell apoptosis in mice bearing EMT6 breast cancer
  2762. lactoferrin as a natural regimen for selective decontamination of the digestive tract: recombinant porcine lactoferrin expressed in the milk of transgenic mice protects …
  2763. lactoferrin inhibits E. coli O157: H7 growth and attachment to intestinal epithelial cells
  2764. The dominant expression of functional human lactoferrin in transgenic cloned goats using a hybrid lactoferrin expression construct
  2765. Efficacy and tolerability of oral bovine lactoferrin compared to ferrous sulfate in pregnant women with iron deficiency anemia: a prospective controlled randomized …
  2766. Bovine lactoferrin: involvement of metal saturation and carbohydrates in the inhibition of influenza virus infection
  2767. The influence of lactoferrin, orally administered, on systemic iron homeostasis in pregnant women suffering of iron deficiency and iron deficiency anaemia
  2768. The role of fecal calprotectin and lactoferrin in the diagnosis of necrotizing enterocolitis
  2769. Antifungal and antiparasitic activities of lactoferrin
  2770. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer’s disease
  2771. Lactoferricin but not lactoferrin inhibit herpes simplex virus type 2 infection in mice
  2772. Effect of pulsed electric field and thermal treatment on the physicochemical properties of lactoferrin with different iron saturation levels
  2773. Structural characterization of the interaction of human lactoferrin with calmodulin
  2774. Application of thermally responsive elastin-like polypeptide fused to a lactoferrin-derived peptide for treatment of pancreatic cancer
  2775. Relationship between metabolic status and the milk concentrations of haptoglobin and lactoferrin in dairy cows during early lactation
  2776. lactoferrin suppress the adipogenic differentiation of MC3T3-G2/PA6 cells
  2777. Antibacterial activity of recombinant human lactoferrin from rice: effect of heat treatment
  2778. Utility of fecal lactoferrin in identifying Crohn disease activity in children
  2779. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin
  2780. Modulation of physicochemical properties of lipid droplets using β-lactoglobulin and/or lactoferrin interfacial coatings
  2781. An evaluation of the expression profiles of salivary proteins lactoferrin and lysozyme and their association with caries experience and activity
  2782. Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune …
  2783. Effect of lactoferrin and iron on the growth of human pathogenic Candida species.
  2784. Fecal lactoferrin, myeloperoxidase and serum C‐reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic …
  2785. lactoferrin receptor mediates apo-but not holo-lactoferrin internalization via clathrin-mediated endocytosis in trophoblasts
  2786. Human trial of liposomal lactoferrin supplementation for periodontal disease
  2787. Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis
  2788. Characterisation of single nucleotide polymorphisms identified in the bovine lactoferrin gene sequences across a range of dairy cow breeds
  2789. Effect of bovine lactoferrin on extracellular matrix calcification by human osteoblast-like cells
  2790. Isolation and purification of Bovine lactoferrin
  2791. NalP-mediated proteolytic release of lactoferrin-binding protein B from the meningococcal cell surface
  2792. Study on use of lactoferrin for the biopreservation of paneer
  2793. Antimicrobial activity of lactoferrin against foodborne pathogenic bacteria incorporated into edible chitosan film
  2794. lactoferrin concentrations in bovine milk prior to dry-off
  2795. Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial α-helix of human lactoferrin
  2796. Growth comparison of several Escherichia coli strains exposed to various concentrations of lactoferrin using linear spline regression
  2797. Microbicidal effect of the lactoferrin peptides lactoferricin17–30, lactoferrampin265–284, and lactoferrin chimera on the parasite Entamoeba histolytica
  2798. Evaluation of the clinical efficacy of a mouthwash and oral gel containing the antimicrobial proteins lactoperoxidase, lysozyme and lactoferrin in elderly patients with …
  2799. Trans-endothelial and trans-epithelial transfer of lactoferrin into the brain through BBB and BCSFB in adult rats
  2800. Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO-β for the treatment of anemia in advanced cancer patients undergoing …
  2801. Antioxidant enzyme activities of iron-saturated bovine lactoferrin (Fe-bLf) in human gut epithelial cells under oxidative stress
  2802. Polymorphisms in the bovine lactoferrin promoter are associated with reproductive performance and somatic cell count
  2803. Multifunctional thin films of lactoferrin for biochemical use deposited by MAPLE technique
  2804. lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity
  2805. Enhanced leishmanicidal activity of cryptopeptide chimeras from the active N1 domain of bovine lactoferrin
  2806. lactoferrin inhibits neutrophil apoptosis via blockade of proximal apoptotic signaling events
  2807. lactoferrin increases both resistance to Salmonella typhimurium infection and the production of antibodies in mice
  2808. Novel alginate-enclosed chitosan–calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy
  2809. Impact of surface deposition of lactoferrin on physical and chemical stability of omega-3 rich lipid droplets stabilised by caseinate
  2810. lactoferrin in human tumours: immunohistochemical investigations during more than 25 years
  2811. Multiplex immunoassay of lower genital tract mucosal fluid from women attending an urban STD clinic shows broadly increased IL1ß and lactoferrin
  2812. Purification of lactoferrin using hydroxyapatite
  2813. Bovine lactoferrin serves as a molecular bridge for internalization of Streptococcus uberis into bovine mammary epithelial cells
  2814. Bovine lactoferrin stimulates human corneal epithelial alkali wound healing in vitro
  2815. Association between lactoferrin gene polymorphisms and aggressive periodontitis among Taiwanese patients
  2816. Effect of lactoferrin on oxidative features of ceruloplasmin
  2817. The pH-dependent formation of PEGylated bovine lactoferrin by branched polyethylene glycol (PEG)-N-hydroxysuccinimide (NHS) active esters
  2818. Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages
  2819. Effect of bovine lactoferrin addition to milk in yogurt manufacturing
  2820. Bovine lactoferrin in preventing preterm delivery associated with sterile inflammation
  2821. Binding of lactoferrin to IGBP1 triggers apoptosis in a lung adenocarcinoma cell line
  2822. Fat overload induces changes in circulating lactoferrin that are associated with postprandial lipemia and oxidative stress in severely obese subjects
  2823. Immune modulation by lactoferrin and curcumin in children with recurrent respiratory infections.
  2824. Comprehensive characterization of the site-specific N-glycosylation of wild-type and recombinant human lactoferrin expressed in the milk of transgenic cloned cattle
  2825. Effect of lactoferrin-and transferrin-conjugated polymersomes in brain targeting: in vitro and in vivo evaluations
  2826. Study of lactoferrin gene polymorphism in Iranian Holstein cattle using PCR-RFLP technique.
  2827. Apo-and holo-lactoferrin stimulate proliferation of mouse crypt cells but through different cellular signaling pathways
  2828. Discrimination and evaluation of lactoferrin and delta-lactoferrin gene expression levels in cancer cells and under inflammatory stimuli using TaqMan real-time PCR
  2829. DNA‐Bound lactoferrin Is the Major Target for Antineutrophil Perinuclear Cytoplasmic Antibodies in Ulcerative Colitis
  2830. Single nucleotide polymorphisms, haplotypes and combined genotypes of lactoferrin gene and their associations with mastitis in Chinese Holstein cattle
  2831. Bone regeneration by lactoferrin released from a gelatin hydrogel
  2832. Preventive effect of lactoferrin intake on anemia in female long distance runners
  2833. lactoferrin is a novel predictor of fatal ischemic heart disease in diabetes mellitus type 2: long-term follow-up of the HUNT 1 study
  2834. Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women
  2835. Effect of bovine lactoferrin in a therapeutic hamster model of hepatic amoebiasis
  2836. Recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonatal mice from a lethal challenge with enterovirus type 71
  2837. Impact of interfacial composition on physical stability and in vitro lipase digestibility of triacylglycerol oil droplets coated with lactoferrin and/or caseinate
  2838. A rice‐derived recombinant human lactoferrin stimulates fibroblast proliferation, migration, and sustains cell survival
  2839. Inhibitory effects of native and recombinant full-length camel lactoferrin and its N and C lobes on hepatitis C virus infection of Huh7. 5 cells
  2840. The effect of nisin and bovine lactoferrin on the microbiological quality of Turkish‐style meatball (Tekirdağ Köfte)
  2841. Effect of bovine lactoferrin in Salmonella ser. Typhimurium infection in mice
  2842. lactoferrin conjugated with 40-kDa branched poly (ethylene glycol) has an improved circulating half-life
  2843. lactoferrin for human health
  2844. lactoferrin isolation using monolithic column coupled with spectrometric or micro-amperometric detector
  2845. Human apo-lactoferrin as a physiological mimetic of hypoxia stabilizes hypoxia-inducible factor-1 alpha
  2846. Antimicrobial efficacy of pepsin-digested bovine lactoferrin on spoilage bacteria contaminating traditional Mozzarella cheese
  2847. Protective proteins in mammalian milks: lactoferrin steps forward
  2848. Charge reversal by salt-induced aggregation in aqueous lactoferrin solutions
  2849. Protective effects of lactoferrin chimera and bovine lactoferrin in a mouse model of enterohaemorrhagic Escherichia coli O157:H7 infection
  2850. lactoferrin targets T cells in the small intestine
  2851. Bioactive recombinant human lactoferrin, derived from rice, stimulates mammalian cell growth
  2852. Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida …
  2853. Effect of lactoferrin on consequences of acute experimental hemorrhagic anemia in rats
  2854. Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis
  2855. lactoferrin binding to transglutaminase cross-linked casein micelles
  2856. Differential immunolocalization between lingual antimicrobial peptide and lactoferrin in mammary gland of dairy cows
  2857. Antiradiation effects of lactoferrin
  2858. Oral lactoferrin treatment resolves amoebic intracecal infection in C3H/HeJ mice
  2859. Characterization of lactoferrin receptor on human spermatozoa
  2860. Bovine lactoferrin ameliorates ferric nitrilotriacetate-induced renal oxidative damage in rats
  2861. lactoferrin promotes hyaluronan synthesis in human dermal fibroblasts
  2862. A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice
  2863. Clinical utility of calprotectin and lactoferrin in patients with inflammatory bowel disease: is there something new from the literature?
  2864. Effects of lactoferrin-containing formula in the prevention of enterovirus and rotavirus infection and impact on serum cytokine levels: A randomized trial
  2865. lactoferrin protects against lipopolysaccharide-induced acute lung injury in mice
  2866. Laboratory diagnosis of Clostridium difficile infection. An evaluation of tests for faecal toxin, glutamate dehydrogenase, lactoferrin and toxigenic culture in the …
  2867. lactoferrin inhibits the inflammatory and angiogenic activation of bovine aortic endothelial cells
  2868. Simultaneous isolation of lactoferrin and lactoperoxidase from bovine colostrum by SPEC 70 SLS cation exchange resin
  2869. Iron-saturated lactoferrin stimulates cell cycle progression through PI3K/Akt pathway
  2870. Metabolic effects of lactoferrin during energy restriction and weight regain in diet-induced obese mice
  2871. Efficacy and tolerability of oral lactoferrin supplementation in mild to moderate acne vulgaris: an exploratory study
  2872. The relationship of fetuin-A and lactoferrin with bone mass in elderly women
  2873. “Iron-saturated” bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice
  2874. Bovine lactoferrin structures promoting corneal epithelial wound healing in vitro
  2875. The role of lactoferrin binding protein B in mediating protection against human lactoferricin
  2876. The human lactoferrin-derived peptide hLF1-11 primes monocytes for an enhanced TLR-mediated immune response
  2877. The effects of lactoferrin on the intestinal environment of broiler chickens
  2878. Meta‐Analysis: The Effect of Supplementation with lactoferrin on Eradication Rates and Adverse Events During Helicobacter pylori Eradication Therapy
  2879. The antiproliferative effect of bovine lactoferrin on canine mammary gland tumor cells
  2880. lactoferrin–Endothelin-1 Axis Contributes to the Development and Invasiveness of Triple-Negative Breast Cancer Phenotypeslactoferrin–Endothelin Axis in TNBC …
  2881. Recovery of lactoferrin from whey using cross-flow cation exchange mixed matrix membrane chromatography
  2882. Inhibitory effects of bovine lactoferrin and lactoferricin B on Enterobacter sakazakii
  2883. The role of lactoferrin in the iron metabolism. Part II. Antimicrobial and antiinflammatory effect of lactoferrin by chelation of iron
  2884. lactoferrin induces growth arrest and nuclear accumulation of Smad-2 in HeLa cells
  2885. Novel antibacterial lactoferrin peptides generated by rennet digestion and autofocusing technique
  2886. Human lactoferrin suppresses TNF-α-induced intercellular adhesion molecule-1 expression via competition with NF-κB in endothelial cells
  2887. Experimental antibacterial therapy with puroindolines, lactoferrin and lysozyme in Listeria monocytogenes-infected mice
  2888. Transdermal administration of lactoferrin with sophorolipid
  2889. Influence of desiccation on the sensitivity of Cronobacter spp. to lactoferrin or nisin in broth and powdered infant formula
  2890. Effects of pepsin and trypsin on the anti-adipogenic action of lactoferrin against pre-adipocytes derived from rat mesenteric fat
  2891. lactoferrin and lactoferrin chimera inhibit damage caused by enteropathogenic Escherichia coli in HEp-2 cells
  2892. lactoferrin‐derived peptides and Lactoferricin chimera inhibit virulence factor production and biofilm formation in Pseudomonas aeruginosa
  2893. Determination of bovine lactoferrin in infant formula by capillary electrophoresis with ultraviolet detection
  2894. Selectivity and antimicrobial action of bovine lactoferrin derived peptides against wine lactic acid bacteria
  2895. Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread
  2896. Production of recombinant human lactoferrin from transgenic plants
  2897. Calorimetric and Raman investigation of cow’s milk lactoferrin
  2898. Antibacterial activity of lactoferrin and Lactoferricin against oral Streptococci
  2899. Iron-saturated lactoferrin and pathogenic protozoa: could this protein be an iron source for their parasitic style of life?
  2900. A remedy against obesity? The role of lactoferrin in the metabolism of glucose and lipids
  2901. The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of …
  2902. Use of Wisteria floribunda agglutinin affinity chromatography in the structural analysis of the bovine lactoferrin N-linked glycosylation
  2903. Thermal stability of the iron–lactoferrin complex in aqueous solution is improved by soluble soybean polysaccharide
  2904. Growth Suppression Effects of Recombinant Adenovirus Expressing Human lactoferrin on Cervical Cancer In Vitro and In Vivo
  2905. Examination of bovine lactoferrin binding to bifidobacteria
  2906. Relationship of concentration of lactoferrin and lysozyme in saliva and dental caries in primary dentition
  2907. The effects of lactoferrin in a rat model of catecholamine cardiotoxicity
  2908. lactoferrin modulation of mycobacterial cord factor trehalose 6-6′-dimycolate induced granulomatous response
  2909. Bovine lactoferrin (LTF) gene promoter haplotypes have different basal transcriptional activities
  2910. O-GlcNAcylation/phosphorylation cycling at Ser10 controls both transcriptional activity and stability of Δ-lactoferrin
  2911. A lactoferrin-derived peptide (PXL01) for the reduction of adhesion formation in flexor tendon surgery: an experimental study in rabbits
  2912. Emulsions based on the interactions between lactoferrin and chitosans
  2913. lactoferrin: interactions and biological functions
  2914. The role of lactoferrin in the iron metabolism. Part I. Effect of lactofferin on intake, transport and iron storage
  2915. A prospective study of faecal calprotectin and lactoferrin in the monitoring of acute radiation proctitis in prostate cancer treatment
  2916. Inhibition of the wine spoilage yeast Dekkera bruxellensis by bovine lactoferrin-derived peptides
  2917. Effect of lactoferrin peptide (PXL01) on rabbit digit mobility after flexor tendon repair
  2918. New immunosensor for lactoferrin determination in human milk and several pharmaceutical dairy milk products recommended for the unweaned diet
  2919. Selected factors determining the content of lactoferrin, lysozyme and immunoglobulins G in bovine milk
  2920. lactoferrin enhances efficacy of the BCG vaccine: comparison between two inbred mice strains (C57BL/6 and BALB/c)
  2921. lactoferrin Decreases Inflammatory Response by Cystic Fibrosis Bronchial Cells Invaded with Burkholderia Cenocepacia Iron-Modulated Biofilm
  2922. Endogenous steroids are responsible for lactoferrin-induced myelopoiesis in mice
  2923. lactoferrin augmentation of the BCG vaccine leads to increased pulmonary integrity
  2924. Effect of lactoferrin and its derivatives, high hydrostatic pressure, and their combinations, on Escherichia coli O157: H7 and Pseudomonas fluorescens in chicken filets
  2925. Kinetics of in vitro lactoferrin deposition on silicone hydrogel and FDA group II and group IV hydrogel contact lens materials
  2926. lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation
  2927. Reduction of Escherichia coli O157: H7 excretion in sheep by oral lactoferrin administration
  2928. lactoferrin-derived antimicrobial peptide induces a micellar cubic phase in a model membrane system
  2929. Effect of dietary bovine lactoferrin on growth, haematology and non‐specific immune response in rainbow trout (Oncorhynchus mykiss)
  2930. A new lactoferrin-and iron-dependent lysosomal death pathway is induced by benzo [a] pyrene in hepatic epithelial cells
  2931. A lactoferrin‐derived peptide with cationic residues concentrated in a region of its helical structure induces necrotic cell death in a leukemic cell line (HL‐60)
  2932. Generation of human lactoferrin transgenic cloned goats using donor cells with dual markers and a modified selection procedure
  2933. Flagellum-Mediated Biofilm Defense Mechanisms of Pseudomonas aeruginosa against Host-Derived lactoferrin
  2934. The multifunctional glycolytic protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a novel macrophage lactoferrin receptor
  2935. Induction of lactoferrin gene expression by innate immune stimuli in mouse mammary epithelial HC-11 cells
  2936. Preparation of chitosan/alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats
  2937. Protection of ceruloplasmin by lactoferrin against hydroxyl radicals is pH dependent
  2938. Fungistatic activity of iron-free bovin lactoferrin against several fungal plant pathogens and antagonists
  2939. Bovine lactoferrin digested with human gastrointestinal enzymes inhibits replication of human echovirus 5 in cell culture
  2940. lactoferrin supplementation to prevent nosocomial infections in preterm infants
  2941. … structural basis for the prevention of nonsteroidal antiinflammatory drug-induced gastrointestinal tract damage by the C-lobe of bovine colostrum lactoferrin
  2942. Bovine lactoferrin potently inhibits liver mitochondrial 8-OHdG levels and retrieves hepatic OGG1 activities in Long-Evans Cinnamon rats
  2943. Effects of a composition containing lactoferrin and lactoperoxidase on oral malodor and salivary bacteria: a randomized, double-blind, crossover, placebo-controlled …
  2944. Oral administration of lactoferrin attenuates intestinal ischemia-reperfusion injury in rats
  2945. High-level expression of bioactive recombinant human lysozyme in the milk of transgenic mice using a modified human lactoferrin BAC
  2946. A mWAP–hLF hybrid gene locus gave extremely high level expression of human lactoferrin in the milk of transgenic mice
  2947. Adenoviral vector mediates high expression levels of human lactoferrin in the milk of rabbits
  2948. Isolation and purification of lactoferrin and immunoglobulin G from bovine colostrum with serial cation-anion exchange chromatography
  2949. Bovine lactoferrin region responsible for binding to bifidobacterial cell surface proteins
  2950. Questionnaire survey on the subjective effects of a lactoferrin supplement
  2951. Clinical use of lactoferrin in preterm neonates: an update.
  2952. In vitro antioxidative potential of lactoferrin and black tea polyphenols and protective effects in vivo on carcinogen activation, DNA damage, proliferation, invasion, and …
  2953. lactoferrin decreases primary bovine mammary epithelial cell viability and casein expression
  2954. Neuroprotection in a 6‐hydroxydopamine‐lesioned Parkinson model using lactoferrin‐modified nanoparticles
  2955. Destruction of single-species biofilms of Escherichia coli or Klebsiella pneumoniae subsp. pneumoniae by dextranase, lactoferrin, and lysozyme
  2956. A selectively terminable transgenic rice line expressing human lactoferrin
  2957. Serum lactoferrin level as a serologic biomarker for allergic rhinitis
  2958. Comparing efficacy of BCG/lactoferrin primary vaccination versus booster regimen
  2959. Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin
  2960. miR-214 regulates lactoferrin expression and pro-apoptotic function in mammary epithelial cells
  2961. Efficiency of human lactoferrin transgenic donor cell preparation for SCNT
  2962. In vitro effects of bovine lactoferrin on autoaggregation ability and surface hydrophobicity of bifidobacteria
  2963. Anticancer activity of lactoferrin isolated from caprine colostrum on human cancer cell lines
  2964. Inhibitory effect of bovine lactoferrin on human parainfluenza virus type 2 infection
  2965. Utilization of interfacial engineering to produce novel emulsion properties: pre-mixed lactoferrin/β-lactoglobulin protein emulsifiers
  2966. Inhibitory effect of lactoferrin on hypertrophic differentiation of ATDC5 mouse chondroprogenitor cells
  2967. Porcine lactoferrin expression in transgenic rice and its effects as a feed additive on early weaned piglets
  2968. lactoferrin–A Potential Anabolic Intervention in Osteoporosis
  2969. Crystal structure of the N-lobe of lactoferrin binding protein B from Moraxella bovis1
  2970. Faecal lactoferrin, capsule endoscopy and Crohn’s disease. Is there a three way relationship? A pilot study
  2971. lactoferrin protects against concanavalin A‐induced liver injury in mice
  2972. lactoferrin in gingival crevicular fluid and peripheral blood during experimental gingivitis
  2973. Positive selection drives lactoferrin evolution in mammals
  2974. A novel polypeptide derived from human lactoferrin in sodium hyaluronate prevents postsurgical adhesion formation in the rat
  2975. Histomorphometric study of role of lactoferrin in atrophy of the intestinal mucosa of rats
  2976. lactoferrin immuno-expression in human normal and neoplastic bone tissue
  2977. Bactericidal Activity of lactoferrin and Its Amidated and Pepsin-Digested Derivatives against Pseudomonas fluorescens in Ground Beef and Meat Fractions
  2978. ANTIBACTERIAL ACTIVITY AND BINDING ABILITY OF BOVINE lactoferrin AGAINST PSEUDOMONAS SPP.
  2979. lactoferrin Glu561Asp polymorphism is associated with susceptibility to herpes simplex keratitis
  2980. Porcine lactoferrin administration enhances peripheral lymphocyte proliferation and assists infectious bursal disease vaccination in native chickens
  2981. Association of bovine lactoferrin gene polymorphism with occurrence of mastitis.
  2982. Effect of lactoferrin and its derivatives against gram-positive bacteria in vitro and, combined with high pressure, in chicken breast fillets
  2983. Effects of acupuncture on lactoferrin content in tears and tear secretion in patients suffering from dry eyes: a randomized controlled trial
  2984. lactoferrin gene polymorphism of Holstein cows in Isfahan province.
  2985. Evaluation of the protective effect of bovine lactoferrin against lipopolysaccharides in a bovine mammary epithelial cell line
  2986. Various routes of administration of 99mTc-labeled synthetic lactoferrin antimicrobial peptide hLF 1–11 enables monitoring and effective killing of multidrug-resistant …
  2987. Combination chemoprevention of hamster buccal pouch carcinogenesis by bovine milk lactoferrin and black tea polyphenols
  2988. Evaluation of the cytoprotective effects of bovine lactoferrin against intestinal toxins using cellular model systems
  2989. Recombinant pseudoadenovirus nanostructure with the human lactoferrin gene: Production and study of lactoferrin expression and properties in vivo
  2990. Screening of Bifidobacterium spp. based on in vitro growth responses to bovine lactoferrin
  2991. Effect of selenium-saturated bovine lactoferrin (Se-bLF) on antioxidant enzyme activities in human gut epithelial cells under oxidative stress
  2992. The potential role of lactoferrin and derivatives in the management of infectious and inflammatory complications of hematology patients receiving a hematopoietic stem …
  2993. Survival and bone-active properties of bovine lactoferrin supplemented into stirred yoghurt
  2994. Faecal calprotectin and lactoferrin values during irradiation of prostate cancer correlate with chronic radiation proctitis: results of a prospective study
  2995. miR-584 mediates post-transcriptional expression of lactoferrin receptor in Caco-2 cells and in mouse small intestine during the perinatal period
  2996. Further development of lactoferrin immunosensor (part III)
  2997. Transgenic plants expressing antimicrobial lactoferrin protein are resistant to a fungal pathogen
  2998. Effects of esterified lactoferrin and lactoferrin on control of postharvest blue mold of apple fruit and their possible mechanisms of action
  2999. lactoferrin inhibits the growth of nasal polyp fibroblasts
  3000. Interfacial adsorption and denaturization of human milk and recombinant rice lactoferrin
  3001. A novel polymorphism of the lactoferrin gene and its association with milk composition and body traits in dairy goats
  3002. Production of recombinant human lactoferrin in the allantoic fluid of embryonated chicken eggs and its characteristics
  3003. Surface display of human lactoferrin using a glycosylphosphatidylinositol-anchored protein of Saccharomyces cerevisiae in Pichia pastoris
  3004. Contribution of bovine lactoferrin inter-lobe region to iron binding stability and antimicrobial activity against Staphylococcus aureus
  3005. … pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement-and lactoferrin-mediated bactericidal activity
  3006. Effect of bovine lactoferrin on the internalization of coagulase-negative staphylococci into bovine mammary epithelial cells under in-vitro conditions
  3007. Bovine lactoferrin inhibits the efficiency of invasion of respiratory A549 cells of different iron-regulated morphological forms of Pseudomonas aeruginosa and …
  3008. The relationship between dry eye and lactoferrin levels in tears
  3009. Distribution of mucins and antimicrobial substances lysozyme and lactoferrin in the laryngeal subglottic region
  3010. Nutritional evaluation of genetically modified rice expressing human lactoferrin gene
  3011. CD209/DC-SIGN mediates efficient infection of monocyte-derived dendritic cells by clinical adenovirus 2C isolates in the presence of bovine lactoferrin
  3012. Mechanisms of the antibacterial activity of lactoferrin and lactoferrin-derived peptides
  3013. The bone-strengthening activity of milk basic protein is not dependent on lactoferrin
  3014. Efficiency of donor cell preparation and recipient oocyte source for production of transgenic cloned dairy goats harboring human lactoferrin
  3015. Bovine milk lactoferrin induces synthesis of the angiogenic factors VEGF and FGF2 in osteoblasts via the p44/p42 MAP kinase pathway
  3016. Generation of transgenic barley lines producing human lactoferrin using mutant alpha-tubulin gene as the selective marker
  3017. Apoptosis of stomach cancer cell SGC-7901 and regulation of Akt signaling way induced by bovine lactoferrin
  3018. … consisting of a milk protein promoter and a cytomegalovirus enhancer significantly increase mammary‐specific expression of human lactoferrin in transgenic mice
  3019. Bovine lactoferrin induces interleukin-11 production in a hepatitis mouse model and human intestinal myofibroblasts
  3020. Effect of Bovine lactoferrin and Casein Peptide Powder on Microbial Growth and Glucose Utilization by Microorganisms in Pork Meat During Storage at 4oC
  3021. Effects of bovine lactoferrin on the immune system and the intestinal microflora of adult dogs
  3022. lactoferrin regulates an axis involving CD11b and CD49d integrins and the chemokines MIP-1α and MCP-1 in GM-CSF-treated human primary eosinophils
  3023. Changes of hepatic lactoferrin gene expression in two mouse models of the acute phase reaction
  3024. Proteomic approach to the identification of novel delta-lactoferrin target genes: Characterization of DcpS, an mRNA scavenger decapping enzyme
  3025. The concerted action of lactoferrin and bacteriophages in the clearance of bacteria in sublethally infected mice.
  3026. The biological effects of bovine lactoferrin on inflammatory cytokine expression in the PMA stimulated cells
  3027. A study of the effect of ceruloplasmin and lactoferrin on the chlorination activity of leukocytic myeloperoxidase using the chemiluminescence method
  3028. The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea
  3029. Clinical utility of calprotectin and lactoferrin as markers of inflammation in patients with inflammatory bowel disease
  3030. Effects of orally administered lactoferrin and lactoperoxidase-containing tablets on clinical and bacteriological profiles in chronic periodontitis patients
  3031. Endocytosis and trafficking of human lactoferrin in macrophage-like human THP-1 cells
  3032. Recombinant human lactoferrin inhibits matrix metalloproteinase (MMP‐2, MMP‐3, and MMP‐9) activity in a rabbit preterm delivery model
  3033. Bovine lactoferrin, human lactoferrin, and bioactivity
  3034. Requirement of the JNK-associated Bcl-2 pathway for human lactoferrin-induced apoptosis in the Jurkat leukemia T cell line
  3035. Cloning, expression and characterization of Kunming mice lactoferrin and its N-lobe
  3036. Involvement of the nitric oxide–cyclic GMP–protein kinase G–K+ channel pathway in the antihyperalgesic effects of bovine lactoferrin in a model of neuropathic pain
  3037. Can lactoferrin prevent neonatal sepsis and necrotizing enterocolitis?
  3038. DNA, oligosaccharides, and mononucleotides stimulate oligomerization of human lactoferrin
  3039. Reduction of ultraviolet light-induced DNA damage in human colon cancer cells treated with a lactoferrin-derived peptide
  3040. The expression of ferritin, lactoferrin, transferrin receptor and solute carrier family 11A1 in the host response to BCG-vaccination and Mycobacterium tuberculosis …
  3041. Somatic cell count, lactoferrin and NAGase activity in milk of infected and non-infected udder halves of dairy goats
  3042. lactoferrin is associated with a decrease in oocyte depletion in mice receiving cyclophosphamide
  3043. Effects of colostrum replacer supplemented with lactoferrin on the blood plasma immunoglobulin G concentration and intestinal absorption of xylose in the neonatal …
  3044. Size evolution of luminescent lactoferrin protected gold clusters
  3045. Two splice variants of the bovine lactoferrin gene identified in Staphylococcus aureus isolated from mastitis in dairy cattle
  3046. Effects of hydrostatic high pressure on the structure and antibacterial activity of recombinant human lactoferrin from transgenic rice
  3047. Antimicrobial effect of lactoferrin and its amidated and pepsin-digested derivatives against Salmonella Enteritidis and Pseudomonas fluorescens
  3048. PEGylated lactoferrin enhances its hepatoprotective effects on acute liver injury induced by D-galactosamine and lipopolysaccharide in rats
  3049. Anti-nociceptive effect of bovine milk-derived lactoferrin in a rat lumbar disc herniation model
  3050. High-level expression and production of human lactoferrin in
  3051. Modulation of HIV binding to epithelial cells and HIV transfer from immature dendritic cells to CD4 T lymphocytes by human lactoferrin and its major exposed …
  3052. Stabilization of glycoprotein liquid formulation using arginine: A study with lactoferrin as a model protein
  3053. Preparation and in vitro evaluation of chitosan-coated alginate/calcium complex microparticles loaded with fluorescein-labeled lactoferrin
  3054. Effects of in vitro lactoferricin and lactoferrin on the head kidney cells of European sea bass (Dicentrarchus labrax, L.)
  3055. Polymorphism of lactoferrin gene with PCR-RFLP and its association with subclinical mastitis in dairy cows
  3056. Pheromonicin-SA affects mRNA expression of toll-like receptors, cytokines, and lactoferrin by Staphylococcus aureus-infected bovine mammary epithelial …
  3057. Immunolocalization of lactoferrin in cartilage-forming neoplasms
  3058. Bovine lactoferrin interacts with cable pili of Burkholderia cenocepacia
  3059. Recombination adenovirus-mediated human lactoferrin cDNA inhibits the growth of human MCF-7 breast cancer cells
  3060. PEGylated lactoferrin enhanced its hepatoprotective effects on acute liver injury induced by carbon tetrachloride in rats
  3061. Tamm-Horsfall glycoprotein enhances PMN phagocytosis by binding to cell surface-expressed lactoferrin and cathepsin G that activates MAP kinase pathway
  3062. An overview on the antiviral activity of lactoferrin
  3063. Purification and characterization of Mongolian mare lactoferrin
  3064. Porcine lactoferrin as feedstuff additive elevates avian immunity and potentiates vaccination
  3065. ToF-SIMS investigation of FIB-patterning of lactoferrin by using self-assembled monolayers of iron complexes
  3066. Influence of orally administered bovine lactoferrin on lipid metabolism in lipopolysaccharide‐injected preruminant calves
  3067. Concentrations of bovine lactoferrin and citrate in milk during experimental endotoxin mastitis in early-versus late-lactating dairy cows
  3068. Development of tissue conditioner capable of binding with anti-microbial protein lactoferrin
  3069. lactoferrin and its hydrolysate bind directly to the oleate‐activated form of the lipolysis stimulated lipoprotein receptor
  3070. Assessment of dietary bovine lactoferrin in enhancement of immune function and disease resistance in Nile Tilapia (Oreochromis niloticus)
  3071. Kinetic and thermodynamic parameters for heat denaturation of human recombinant lactoferrin from rice
  3072. Effects of adenovirus vectors mediated human lactoferrin cDNA on mice bearing EMT6 breast carcinoma
  3073. Characterization of lactoferrin oil-in-water emulsions and their stability in recombined milk
  3074. lactoferrin and desferrioxamine are ineffective in the treatment of Helicobacter pylori infection and may enhance H. pylori growth and gastric inflammation in mice
  3075. Specific interactions of C-terminal half (C-lobe) of lactoferrin protein with edible sugars: binding and structural studies with implications on diabetes
  3076. Effects of recombinant human lactoferrin on improving the iron status of IDA rats
  3077. Preliminary evaluation of a vaginal cream containing lactoferrin in the treatment of vulvovaginal candidosis
  3078. Possible involvement of prolactin in the synthesis of lactoferrin in bovine mammary epithelial cells
  3079. Helical peptides derived from lactoferrin bind hepatitis C virus envelope protein E2
  3080. Seven novel single nucleotide polymorphisms identified within river buffalo (Bubalus bubalis) lactoferrin gene
  3081. Long-term enteral immunonutrition containing lactoferrin in tube-fed bedridden patients: immunological and nutritional status
  3082. lactoferrin a promising bone-growth promoting milk-derived glycoprotein
  3083. lactoferrin restrains allergen-induced pleurisy in mice
  3084. In vitro effects of lactoferrin on lipopolysaccharide-induced proliferation, gene expression, and prostanoid production by bovine peripheral blood mononuclear cells
  3085. Study of interaction of ceruloplasmin, lactoferrin, and myeloperoxidase by photon correlation spectroscopy
  3086. iron–lactoferrin complex reduces iron‐catalyzed Off‐flavor formation in powdered milk with added fish oil
  3087. Patterns of sequence variation within the Neisseria meningitidis lactoferrin binding proteins
  3088. Canonical correlation of milk immunoglobulins, lactoferrin concentration and Dairy Herd Improvement data of Chinese Holstein cows
  3089. The assessment of a rapid noninvasive immunochromatographic assay test for fecal lactoferrin in patients with suspected inflammation of the ileal pouch
  3090. Antimicrobial efficacy of lactoferrin, its amidated and pepsin‐digested derivatives, and their combinations, on Escherichia coli O157:H7 and Serratia liquefaciens
  3091. lactoferrin levels in the gastric tissue of Helicobacter pylori-positive and-negative patients and its effect on anemia
  3092. Antimicrobial activity of recombinant human lactoferrin from Aspergillus awamori, human milk lactoferrin and their hydrolysates
  3093. Polymorphism within TATA-box of bovine lactoferrin gene and its association with performance traits in Holstein cattle
  3094. Immunohistochemical evidence of lactoferrin in human embryo–fetal bone and cartilage tissues
  3095. Interactions of ocular isolates of gram-negative bacteria with lactoferrin
  3096. Studies on the interaction between IgA, lactoferrin and lysozyme in the breastmilk of lactating women with sick and healthy babies
  3097. High concentration of human lactoferrin in milk of rhLf-transgenic cows relieves signs of bovine experimental Staphylococcus chromogenes intramammary infection
  3098. Recombinant lactoferrin (Lf) of Vechur cow, the critical breed of Bos indicus and the Lf gene variants
  3099. Influence of ceruloplasmin and lactoferrin on the chlorination activity of leukocyte myeloperoxidase assayed by chemiluminescence
  3100. An investigation of growth factors and lactoferrin in naturally occurring ovine pulmonary adenomatosis
  3101. Expression of lactoferrin in the boar epididymis: effects of reduced estrogen
  3102. Analyses of diverse mammals’ milk and lactoferrin glycans using five pathogenic bacterial lectins
  3103. … serotype 5 infects human dendritic cells via a coxsackievirus–adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN
  3104. Response surface methodology for the optimization of lactoferrin nano-liposomes
  3105. The pepsin hydrolysate of bovine lactoferrin causes a collapse of the membrane potential in Escherichia coli O157: H7
  3106. Recent advances of metal binding protein lactoferrin as an anti-microbial agent
  3107. Effect of prolonged administration of bovine lactoferrin in neuropathic pain: Involvement of opioid receptors, nitric oxide and TNF-α
  3108. Effect of the ionic strength of pulsed electric field treatment medium on the physicochemical and structural characteristics of lactoferrin
  3109. Oral administration of bovine lactoferrin upregulates neutrophil functions in a dog with familial β2-integrin-related neutrophil dysfunction
  3110. The effects of lactoferrin on gram-negative
  3111. Dietary Bovine lactoferrin Increases Resistance of Juvenile Channel Catfish, Ictalurus punctatus, to Enteric Septicemia
  3112. Effect of bovine lactoferrin on functions of activated feline peripheral blood mononuclear cells during chronic feline immunodeficiency virus infection
  3113. Structural and binding studies of C-terminal half (C-lobe) of lactoferrin protein with COX-2-specific non-steroidal anti-inflammatory drugs (NSAIDs)
  3114. Effect of bovine lactoferrin feeding on lipopolysaccharide‐induced metabolic and hormonal disturbances in preruminant calves
  3115. The effects of corticosteroid on tissue lactoferrin in patients with nasal polyposis
  3116. Bactericidal Effect of lactoferrin and Its Amidated and Pepsin-Digested Derivatives on Pseudomonasfluorescens: Influence of Environmental and Physiological …
  3117. Ascites fluid lactoferrin: data emerges for a logical biomarker
  3118. Dietary lactoferrin does not prevent dextran sulfate sodium induced murine intestinal lymphocyte death
  3119. Sequence analysis of the lactoferrin gene and variation of g. 7605C→ T in 10 Chinese indigenous goat breeds
  3120. Cost-effectiveness of quantitative fecal lactoferrin assay for diagnosis of symptomatic patients with ileal pouch-anal anastomosis
  3121. Retinoids, retinoid analogs, and lactoferrin interact and differentially affect cell viability of 2 bovine mammary cell types in vitro
  3122. Does lactoferrin behave as an immunohistochemical oncofetal marker in bone and cartilage human neoplasms?
  3123. Physicochemical characterization and functional site analysis of lactoferrin gene of Vechur cow
  3124. Native, but not thermally denatured lactoferrin solubilizes iron in the presence of bicarbonate ions
  3125. Human lactoferrin increases Helicobacter pylori internalisation into AGS cells
  3126. Histologic and histomorphometric evaluation of the effect of lactoferrin combined with anorganic bovine bone on healing of experimentally induced bony …
  3127. lactoferrin levels in human breast milk among lactating mothers with sick and healthy babies in Kaduna State, Nigeria
  3128. Antimicrobial action of lactoferrin on Staphylococcus aureus inoculated in Minas frescal cheese
  3129. Histological and immunohistochemical evaluation of duodenal and colonic biopsies after oral bovine lactoferrin supplementation in beagle puppies
  3130. Survival of Cronobacter Species in Reconstituted Herbal Infant Teas and their Sensitivity to Bovine lactoferrin
  3131. Recent advances in lactoferrin research and development during the past two years (2007–2009): in lieu of a preface of the special issue lactoferrin
  3132. Breed effects for lactoferrin concentration determined by Fourier transform infrared spectroscopy.
  3133. Relationship between lactoferrin, minerals, and somatic cells in bovine milk
  3134. A preliminary approach to creating an overview of lactoferrin multi-functionality utilizing a text mining method
  3135. Anti-inflammatory and anti-tumoral activity of human recombinant lactoferrin
  3136. Antineutrophil cytoplasmic antibodies against myeloperoxidase, proteinase 3, elastase, cathepsin G and lactoferrin in Japanese patients with rheumatoid arthritis
  3137. Molecular cloning, promoter analysis and SNP identification of Italian Nicastrese and Saanen lactoferrin gene
  3138. Construction and identification of mammary expressional vector for cDNA of human lactoferrin
  3139. Characterization of single nucleotide polymorphism in the 5′-untranslated region (5′-UTR) of lactoferrin gene and its association with reproductive parameters …
  3140. The lactoferrin receptor is differentially expressed across several human epithelial cell types
  3141. E2F1-directed activation of Bcl-2 is correlated with lactoferrin-induced apoptosis in Jurkat leukemia T lymphocytes
  3142. The effect of implanting an antigen release device on lactoferrin concentration in serum and milk
  3143. Recombinant human lactoferrin and iron transport across Caco-2 monolayers: Effect of heat treatment on the binding to cells
  3144. Utilizing Automated Chip Electrophoresis for Study of lactoferrin and Matrix Metalloproteinases
  3145. Pregnancies resulting from transgenic embryos with human lactoferrin gene produced by somatic cell nuclear transfer
  3146. Amino group PEGylation of bovine lactoferrin by linear polyethylene glycol-p-nitrophenyl active esters
  3147. Purification and characterization of recombinant human lactoferrin expressed in a cattle mammary bioreactor
  3148. 28-Day repeated dose oral toxicity of recombinant human apo-lactoferrin or recombinant human lysozyme in rats
  3149. Effect of some flavonic compounds and ascorbic acid on lactoferrin stimulation of erythrocyte glycolysis and Na+/K+-atpase activity
  3150. Genetic polymorphism in 5′-flanking region of the lactoferrin gene and its associations with mastitis in Chinese Holstein cows
  3151. Serum disposition of bovine lactoferrin after oral and anal administration and its proteolytic cleavage by gastric transit in rainbow trout (Oncorhynchus mykiss W.)
  3152. Transport of iron bound to recombinant human lactoferrin from rice and iron citrate across Caco-2 cell monolayers
  3153. Association of genotypes at promoter region of lactoferrin gene with mastitis in crossbred cattle.
  3154. lactoferrin-monophosphoryl lipid A complex enhances immunity of mice to Plesiomonas shigelloides CNCTC 138/92.
  3155. lactoferrin at basal side of mouse mammary epithelium derives in part from stroma cells
  3156. Effect of bovine lactoferrin on the minimum inhibitory concentrations of ampicillin and trimethoprim–sulfamethoxazole for clinical Shigella spp. strains
  3157. lactoferrin in canine sera: a pyometra study
  3158. Effect of polysaccharides on biological activity of human lactoferrin
  3159. The state of health and the reproductive potential of transgenic mice secreting recombinant human lactoferrin in milk
  3160. Inhibitory effect of human lactoferrin (neolactoferrin) on the growth of transplantable tumor in the uterine cervix of mice
  3161. Are extrinsic black stains of teeth iron-saturated bovine lactoferrin and a sign of iron deficient anemia or iron overload?
  3162. lactoferrin effect on lymphocyte cytokines and apoptosis is independent of exercise.
  3163. Bovine lactoferrin appears to decrease the incidence of sepsis in very low–birth weight infants
  3164. lactoferrin Inhibits the Acquisition of Dry-Resistance of Salmonella spp.
  3165. Determination of the genetic diversity of the lactoferrin gene polymorphism in indigenous anatolian goat breeds
  3166. Ytterbium-substituted transferrin and lactoferrin for near-infrared luminescent pH indication
  3167. Antiviral activity of lactoferrin and ovotransferrin derived peptides towards herpesviridae
  3168. Bovine lactoferrin protects RSC96 Schwann cells from tumor necrosis factor-α–induced growth arrest via extracellular-signal-regulated kinase 1/2
  3169. Single nucleotide polymorphism (SNP) identification and sequence analysis of 5′ flanking region of lactoferrin gene in Indian buffaloes (Bubalus bubalis)
  3170. A 90-day safety study in Sprague-Dawley rats fed milk powder containing recombinant human lactoferrin (rhLF) derived from transgenic cloned cattle
  3171. Iron-dependent binding of bovine milk α-casein with holo-lactoferrin, but not holo-transferrin
  3172. lactoferrin in bovine intramammary infection
  3173. Secreted lactoferrin and lactoferrin-related peptides: Insight into structure and biological functions
  3174. Prophylactic effect of bovine lactoferrin against acute toxoplasmosis in immunocompetent and immunosuppressed mice.
  3175. lactoferrin as a signaling mediator
  3176. Influence of protein expression system on elicitation of IgE antibody responses: experience with lactoferrin
  3177. Immunochemical studies of salivary lactoferrin
  3178. In vitro effects of lactoferrin on intestinal and mammary epithelial cell lines
  3179. Physicochemical and textural properties, and shelf-life effects of low-fat sausages manufactured with various levels of activated lactoferrin during refrigerated storage
  3180. RU486‐inducible recombination in the salivary glands of lactoferrin promoter‐driven green fluorescent Cre transgenic mice
  3181. 28-Day repeated dose oral toxicity of recombinant human holo-lactoferrin in rats
  3182. Effects of lactoferrin on Skin Wound Healing
  3183. Effect of transgenic human lactoferrin goats′ milk on growth and metabolic performance in rats
  3184. Detection of single nucleotide polymorphism in TATA box of lactoferrin gene and association with uterine infections in cows.
  3185. Development of transgenic rice lines expressing the human lactoferrin gene
  3186. A comparison of different treatment conditions on the conformation changes of bovine lactoferrin
  3187. lactoferrin stimulates mouse macrophage to express BAFF via Smad3 pathway
  3188. Characterization of bovine lactoferrin C-lobe on bifidobacteria and pathogenic bacteria.
  3189. Purification and identification of lactoferrin from bovine milk
  3190. The Effect of Retroviral Vector on Uptake of Human lactoferrin DNA by Yak (Bos Grunniens) Spermatozoa and their Fertilizability In Vitro
  3191. Indirect determination of lactoferrin in milk powder by atomic absorption spectrophotometer
  3192. Human lactoferrin biopharming in New Zealand scientific risk assessment
  3193. Glycosaminoglycans are not indispensable for the anti-herpes simplex virus type 2 activity of lactoferrin
  3194. Development and evaluation of a beta-glucan biopolymer formulation of lactoferrin produced using a novel cryomilling technique
  3195. Production and characterization of recombinant human lactoferrin
  3196. Antioxidative-related activities of lactoferrin and lactoperoxidase in milk from cows with different forms of mastitis
  3197. lactoferrin from bovine milk inhibits bovine herpesvirus 1 in cell culture but suppresses development of in vitro-produced bovine embryos
  3198. Spectrofluorometric study of iron removal from bovine lactoferrin by ethylenediamminetetraacetic acid
  3199. Structural analysis of the lactoferrin iron binding pockets
  3200. Nutritional components and sub-chronic toxicity of genetically modified rice expressing human lactoferrin
  3201. Study of inhibition effect of bovine lactoferrin in vitro on hepatitis B surface antigen
  3202. A multicenter, randomized trial on prophylactic bovine lactoferrin in preterm neonates for prevention of late-onset sepsis
  3203. The use of plasma lactoferrin in the diagnosis of pyonecrotic infections of soft tissues and sepsis
  3204. Estrous cycle-dependent activity of neutrophils in the porcine endometrium: possible involvement of heat shock protein 27 and lactoferrin
  3205. Presence of lactoferrin in a bovine skim milk fraction with acid phosphatase activity
  3206. Cloning of porcine lactoferrin gene and construction of expression system in recombinant Lactobacillus
  3207. lactoferrin Structure Function and Genetics
  3208. lactoferrin inhibits platelet production from human megakaryocytes in vitro
  3209. Brain lactoferrin: an endogenous peptide or merely an intruder
  3210. Probable Role of lactoferrin in the Transport of Iron Across the Intestinal Brush Border
  3211. Efficacy of Lysozme–lactoferrin as a bioenhancer (immunomodulator) in the treatment of Tuberculosis
  3212. Early diagnosis of infectious diarrhea using lactoferrin and hemoglobin markers
  3213. Histologic and histomorphometric study on the effects of lactoferrin and porous bovine bone mineral (Bio-Oss) on the regeneration of bone defects made on rabbit …
  3214. … infusion of recombinant bovine interleukin-8 at dry-off induces the prolonged secretion of leukocyte elastase, inflammatory lactoferrin-derived peptides, and …
  3215. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in preterm very-low-birth-weight neonates: a randomized trial
  3216. The impact of selection on milk production on the lactoferrin content of milk in Irish Holstein-Friesians
  3217. Parasites’ receptors for human transferrin and lactoferrin
  3218. Identification and characterization of recombinant human lactoferrin in the milk of transgenic goats
  3219. Integrin-linked kinase is involved in lactoferrin-induced anchorage-independent cell growth and survival in PC12 cells
  3220. Transgenic expression of lactoferrin imparts resistance to a soilborne fungal pathogen Rhizoctonia solani
  3221. Seminal plasma of brown trout, Salmo trutta fario (L.) contains a factor able to retain iron at acid pH, typical feature of lactoferrin
  3222. Immunosensors for the Direct Determination of Proteins: lactoferrin and HIgG
  3223. Effects of Fe-lactoferrin via oral administration on mental stress.
  3224. lactoferrin-conjugated superparamagnetic iron oxide nanoparticles
  3225. Suppressive effect of lactoferrin with 70 irons via oral administration on dysmenorrheal.
  3226. Breeding and expression stability of human lactoferrin transgenic goat.
  3227. Study on sub-chronic toxicity of powdered milk containing transgenic lactoferrin on SD rats.
  3228. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates
  3229. Innovative study on lactoferrin in periodontal disease
  3230. Can fecal calprotectin or lactoferrin identify postoperative recurrence in Crohn’s disease?
  3231. Immunomodulation and metabolism: possible role of lactoferrin
  3232. Apo‐lactoferrin regulates transcription of the TGFβ1 gene and may thus stimulate intestinal differentiation
  3233. Nanoencapsulation of bovine lactoferrin for oral hygiene applications
  3234. New function of lactoferrin: Protection against cancer development and metastasis
  3235. Nuclear transfer of goat somatic cells transgenic for human lactoferrin gene
  3236. Immunolocalization of lactoferrin in the Rodent Epididymis.
  3237. Interaction of lactoferrin and its peptides with DPPC and DPPG liposomes studied by Raman spectroscopy
  3238. Haloperidol-like effects of α-lactalbumin, lactoferrin and lysozyme in laboratory animals.
  3239. Separation of a milk acid phosphatase from a purified lactoferrin fraction and identification as a member of the mammalian purple acid phosphatase family
  3240. Synthesis and Evaluation of Oleanolic Acid-Conjugated lactoferrin for β-Amyloid Plaque Imaging
  3241. DNA and oligosaccharides stimulate oligomerization of human milk lactoferrin
  3242. Urinary lactoferrin as a promising, new, improved surrogate marker for urinary tract infection
  3243. Study of inhibition effect of zinc-, iron-and manganese-saturated bovine lactoferrin on hepatitis B virus DNA in vitro
  3244. Antimicrobial effect of lactoferrin and its amidated and pepsin-digested derivatives against Salmonella Enteritidis and Pseudomonas fluorescens.
  3245. lactoferrin an antimicrobial protein of bovine milk: a review.
  3246. Interference of some modulators of protein phosphorylation and ion transport with lactoferrin stimulatory effect on erythrocyte glycolysis
  3247. Oral human recombinant lactoferrin prevents acute graft-versus-host disease and stimulates reconstitution of donor bone marrow-derived T-cells in a mouse …
  3248. A SURVEY ON THE EFFECT OF BOVINE lactoferrin ON THE GROWTH PARAMETERS OF RAINBOW TROUT (ONCORHYNCHUS MYKISS)
  3249. Bovine lactoferrin gene polymorphism applicability in the selection of cows resistant to mastitis
  3250. Expression and characterization of bovine milk antimicrobial proteins lactoperoxidase and lactoferrin by vaccinia virus
  3251. In the search of genetic polymorphism of lactoferrin with PCR-RFLP in imported Holsteins in a large Tunisian herd
  3252. The effect of heating and postfermentation on lactoferrin of fresh and kefir goat milk
  3253. Investigation of Antimicrobial and Lipid Perturbing Properties of lactoferrin Peptides
  3254. Effects of two different diets on lactoferrin concentrations in bovine milk.
  3255. Development of transgenic sweet potato producing human lactoferrin
  3256. Efficacy and safety of oral lactoferrin supplementation associated with rHuEPOβ for the treatment of anemia in advanced cancer patients submitted to chemotherapy.
  3257. lactoferrin inhibits DNA-induced IFN-alpha production by human plasmacytoid dendritic cells (111.4)
  3258. Cross selectivity immunoaffinity and applications for lactoferrin immunosensor
  3259. Clinical effects of bovine lactoferrin on two canine cases with familial neutrophil dysfunction
  3260. The Impact of Phagocyte—lactoferrin
  3261. lactoferrin AT 2.5 Å RESOLUTION
  3262. The combination of orally ingested lactoferrin and glycine inhibits arthritis development in a model of collagen-induced arthritis
  3263. Bovine lactoferrin C-lobe Promotes Corneal Epithelial Wound Healing
  3264. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: A randomized controlled trial
  3265. Preface to the special issue on lactoferrin
  3266. lactoferrin-conjugated poly (ethylene glycol)-coated Fe3O4 nanoparticles
  3267. Effects of lactoferrin supplementation on growth performance, intestinal microflora and mucosal morphology of early weaned piglets.
  3268. Cloning goat producing human lactoferrin with genetically modified donor cells selected by single or dual markers
  3269. The Role of Bovine lactoferrin and Bovine Lactoferricin in the Ocular Angiogenesis
  3270. Thioredoxin and lactoferrin differentially regulate Langerhans’ cell migration (102.4)
  3271. The effects of lactoferrin on broiler performance, gut microbial communities and intestinal mucosal immune system.
  3272. Iron binding and receptor: lactoferrin and tonb receptors
  3273. Combined use of topical retinol and oral lactoferrin in mild and moderate acne: a multicenter study
  3274. Acylated lactoferrin Peptides Using Solid State NMR and All-Atom Molecular Dynamics Simulations
  3275. Biomimetic affinity purification of recombinant human lactoferrin from the milk of transgenic cows.
  3276. lactoferrin: an anti‐inflammatory molecule released by apoptotic cells to inhibit granulocyte migration
  3277. Bovine lactoferrin and bovine lactoferricin are internalized by colon cancer cells and exhibit elevated apoptosis
  3278. Current Trends in lactoferrin Research and Development
  3279. Factors affecting lactoferrin concentration at drying off and infection status at calving in dairy cows on an intermittent milking schedule prior to drying off
  3280. Antimicrobial action of the pepsin hydrolysate of lactoferrin (LfH) on Escherichia coli O157:H7
  3281. lactoferrin: a natural immunomodulator
  3282. Growth inhibition of pathogenic bacteria by lactoferrin pepsin hydrolysate fractions from milk of carabao (Bubalus bubalis L.).
  3283. Mechanism of lactoferrin in cancer treatment
  3284. and lactoferrin in Granulopoietic Cells
  3285. Research status and prospect of lactoferrin.
  3286. Abstract A36: Doxorubicin loaded lactoferrin nanoparticles: Treatment of hepatocellular carcinoma in rats induced by diethylnitrosamine
  3287. THE MONOCYTIC RECEPTOR FOR lactoferrin AND ITS INVOLVEMENT IN lactoferrin-MEDIATED IRON
  3288. Plasma IGF-I and lactoferrin as biomarkers of post-weaning stress and the effect of feeding probiotic to low body weight calves for the improvement of growth …
  3289. Utilization of lactoferrin-Bound and
  3290. Nanohydrogels from bovine lactoferrin: a vector for iron in food applications
  3291. Recombinant Human lactoferrin and Its Variants
  3292. Association of bovine lactoferrin gene polymorphism with occur
  3293. Inhibition of Microbes in the Presence of lactoferrin and Its Derivatives
  3294. lactoferrin levels in mother’s milk
  3295. Impact of a Novel Multipurpose Solution on the Structural and Functional Integrity of Human lactoferrin
  3296. Establishment of a method of lactoferrin enzyme lmmunoassay with and primary practical application
  3297. Erratum to: Bioinformatics Analysis of lactoferrin Gene for Several Species
  3298. DENATURATION OF BOVINE lactoferrin IN MILK
  3299. lactoferrin IN THE HYDROLYSIS OF NUCLEIC ACIDS
  3300. Advances on Heterogenous Expression of lactoferrin Towards Antimicrobial Role
  3301. Bacterial lactoferrin Receptors
  3302. lactoferrin: Possible use as a therapeutic agent in breast cancer?
  3303. Functional Significance of the Binding of lactoferrin to DNA
  3304. Purification and Characterization of Mongolian Mare lactoferrin
  3305. The radioprotective effect of human lactoferrin in mice
  3306. Chemopreventive effects of 5-fluorouracil and lactoferrin on goldfish intestinal carcinogenesis induced by 1, 2-dimethylhydrazine
  3307. Apply of Textmining Method to Study the Roles in Improving the Health by lactoferrin, a Multi-Functional Milk Protein
  3308. lactoferrin levels in mother’s milk
  3309. Purification and Identification of lactoferrin from Bovine Milk
  3310. INTEGRATION EFFECIENCY OF THE HUMAN lactoferrin GENE IN THE MOUSE AND RABBIT GENOM
  3311. The Human lactoferrin-Derived Peptide
  3312. Use of lactoferrin in the Treatment of Patients with Severe Concomitant Injury
  3313. lactoferrin GENE POLYMORPHISM GLU561ASP COULD BE ASSOCIATED WITH EPITHELIAL HEALING OF INFECTIOUS CORNEAL ULCERS
  3314. The Signification Of lactoferrin In Secondary Corneal Amyloidosis
  3315. and Iron Binding in lactoferrin Mutants
  3316. THE ANTI-INFLAMMATORY ACTIVITIES OF LACTOPRIL® A PHARMACEUTICAL GRADE lactoferrin
  3317. A possible molecular mechanism for parasitic inhibition by lactoferrin
  3318. Human lactoferrin Induces Apoptosis-Like
  3319. Characterization of the recombinant N-and C-lobe of human lactoferrin
  3320. Preparation of monoclonal antibody against bovine lactoferrin.
  3321. IDENTIFICATION OF CONSERVED FUNCTIONAL MOTIFS IN lactoferrin USING MEME
  3322. Effect of lactoferrin on Oral Biofilm Formation
  3323. In vitro effects of lactoferrin on intestinal and mammary epithelial cell lines
  3324. Determination of lactoferrin in human prostate carcinoma cells
  3325. Interactions of Phospholipid Liposomes and Bovine lactoferrin
  3326. MATERNAL lactoferrin IN THE URINE OF PRETERM INFANTS
  3327. The pH-dependent formation of PEGylated bovine lactoferrin by
  3328. Regulation effect analysis of lactoferrin gene promoter elements.
  3329. The serum lactoferrin level as a diagnostic marker for allergic rhinitis
  3330. Notice of Retraction: Immunomodulatory Effects of Bovine lactoferrin on BALB/C Mice
  3331. Determination of lactoferrin using high performance liquid chromatography.
  3332. Longitudinal changes in lactoferrin concentrations in human and bovine milk–a global systematic review
  3333. THE PRODUCTION OF lactoferrin-PRODUCING BACTEROIDES UNIFORMIS
  3334. Anti-microbial activities of novel nanoformulated lactoferrin through oral administration
  3335. Transcriptional activities of bovine lactoferrin (LTF) gene promoter haplotypes
  3336. Development and characterization of nanohydrogels formed by lactoferrin-Glycomacropeptide interactions for food applications
  3337. Treatment of E. coli O157: H7 infected sheep with lactoferrin
  3338. Structure, stability and digestion of caprine and bovine lactoferrin: a comparative study
  3339. Effects of lactoferrin on vascular endothelial growth factor and basic fibroblast growth factor expression in human Tca8113 cell line
  3340. In vitro effect of bovine lactoferrin on the activity of chicken blood leukocytes.
  3341. lactoferrin in Immune Function, Cancer and Disease Resistance
  3342. Molecular cloning and characterization of Taiwan macaque lactoferrin
  3343. Immunomodulatory Effects Of Bovine lactoferrin On Antigen Presenting Cells
  3344. Effect of jieze No. 1 gel on vaginal levels of lactobacillus, glycogen and lactoferrin in mice
  3345. Identification of lactoferrin‐binding Proteins from Human Serum
  3346. Serum lactoferrin levels in children with viral hepatitis A
  3347. High-level expression and antimicrobial activity of recombinant N-terminal porcine lactoferrin
  3348. Bovine lactoferrin and its effects on innate immune cells in a complex milk matrix
  3349. Genetics of the mid-infrared predicted lactoferrin content in milk of dairy cows
  3350. Human lactoferrin upregulates BCL-3 in the K562 erythroleukemia cell
  3351. ISOLATION AND CHARACTERIZATION OF lactoferrin FROM CARABAO’S (Bubalus bubalis L.) MILK WHEY
  3352. Molecular cloning and characterization of the human lactoferrin receptor gene promoter
  3353. An in vivo study of the biologic activity of the recombinant pseudoadenovirus nanostructure containing lactoferrin gene
  3354. Role of Bovine lactoferrin in Corneal Epithelial wound Healing
  3355. lactoferrin Treatment For Age Related Dry Eye In Mice
  3356. Study on separation and purification of lactoferrin in cheese whey.
  3357. Iron-saturated lactoferrin A Novel Adjuvant for Cancer Chemotherapy
  3358. Bovine lactoferrin: potential antioxidant effector molecule in colon carcinoma
  3359. Mid-infrared predictions of lactoferrin content in bovine milk
  3360. Dynamics of quantitative indicators of human lactoferrin in milk of transgenic goat producers
  3361. Cytotoxicity research of recombinant human lactoferrin on Primary Hepatocyte and Nephrocyte Cell.
  3362. lactoferrin for Prevention of Sepsis and Necrotizing Enterocolitis
  3363. Aetiology, Malnutrition and Faecal lactoferrin Levels in Paediatric Diarrhoea
  3364. Diagnostic importance of ferritin and lactoferrin in acute calculous cholecystitis
  3365. Investigations into the Effects of lactoferrin on Microbial Ecology, using Helicobacter pylori as a Model Organism
  3366. The Utility of Fecal lactoferrin in Identifying Crohn’s Disease Activity in Children: 1350
  3367. In vivo study of biological activity of recombinant pseudoadenovirus nanostructure containing human lactoferrin gene
  3368. From cell to the whole bone: a multiscale approach to understand the influence of lactoferrin therapy on bone strength
  3369. Study of the lactoferrin Level in Tear Fluid as a Possible Marker of Progressive Myopia
  3370. Relative expression of lactoferrin in the mammary gland of mice under immune state.
  3371. lactoferrin induces TIMP-4 mediated anti-apoptosis in breast cancer
  3372. lactoferrin enhances BCG efficacy to protect against tuberculosis disease pathology (106.28)
  3373. Effects of Bovine lactoferrin on Lipopolysaccharide-Induced Uveitis in Mice
  3374. The correlation of fecal calprotectin and lactoferrin with intestinal mucosa lesions in Crohn′ s disease patients
  3375. Bovine lactoferrin Inhibits OVA-Specific Allergic Responses
  3376. lactoferrin in the Retina and Retinal Pigment Epithelium of Humans and Mice
  3377. Reductive release of Fe (III) from bovine lactoferrin by ascorbic acid
  3378. Development of Tissue Conditioner Capable of Binding with Antimicrobial Protein lactoferrin
  3379. Binding of lactoferrin to IGBP1 triggers apoptosis in a lung adenocarcinoma cell line
  3380. Oral lactoferrin and glycine display in vivo synergistic anti-inflammatory activity
  3381. Effects of lactoferrin on T cell and the development of intestinal mucous membrane in neonatal SD rat
  3382. Purification and antibacterial activity of recombinant human lactoferrin in milk of transgenic mice
  3383. Effects of lactoferrin on activity of PKG in spinal dorsal horn in a rat model of neuropathic pain
  3384. Dietary Bovine lactoferrin Stimulates Intestinal Proliferation in Piglets
  3385. Lack of association of lactoferrin gene polymorphism with mastitis in Murrah buffaloes.
  3386. Genetics of the mid-infrared prediction of lactoferrin content in milk for Holstein first-parity cows
  3387. The concentrations of certain cytokins and lactoferrin in blood and supernatants of cell cultures in patients with autoimmune thyroiditis
  3388. Assessment of lactoferrin concentration in human milk and survey on it’s relation with age, childbirth time, and after childbirth
  3389. Possibilities of applying lactoferrin as an immunostimulant in fish and crustacean farming.
  3390. Effect of bovine lactoferrin feeding on lipid metabolism in lipopolysaccharide-injected calves.
  3391. SEPARATION OF lactoferrin FROM WHEY IN THREE-PHASE EXTRACTION SYSTEMS (TPP METHOD)
  3392. Preparation and molecular characterization of nanostructures of conjugated deferasirox to lactoferrin
  3393. Human recombinant lactoferrin as a new adjuvant in specific DNA vaccination against ErbB2 (75.2)
  3394. Human oviductal lactoferrin shows a cycle-dependent expression and modulates gamete interaction in vitro
  3395. Inhibitory Effect of Bovine lactoferrin on Human Hepatitis B Virus Replication in HepG2. 2.15 Cells
  3396. Effect of lactoferrin on microbiology, lipid oxidation and browning of basil-based Pesto spreads
  3397. Kinetics of in vitro lactoferrin Deposition on FDA Group II, FDA Group IV and Silicone Hydrogel Contact Lens Materials
  3398. Research Of The Allergenicity Evaluation System Of Recombinant Human lactoferrin (rhLF) With BN Rats
  3399. Activation of Lysozyme and lactoferrin in Endolymphatic Duct of Rats.
  3400. Influence of Antimicrobial Peptides of lactoferrin Family on the Phase Behavior of Model Membranes
  3401. Recombinant Human lactoferrin Production in Transgenic Zebrafish
  3402. Induced in vitro expression of Human lactoferrin in goat mammary gland epithelial cell
  3403. Influence of lactoferrin on metal element contents in serum and excrement and antioxidant capacity of early weaned piglets.
  3404. Zebrafish Muscle Promoter Assay for Human lactoferrin Expression
  3405. Studies on the immunization regulating function of lactoferrin and bovine colostrum particles.
  3406. lactoferrin as an Adjunctive Agent in the Treatment of Bacterial Infections Associated with Diabetic Foot Ulcers
  3407. Preparation and biological performance evaluation of lactoferrin/Nanosized hydroxyapatite/Collagen I composite material
  3408. lactoferrin PROMOTES NERVE GROWTH FACTOR SYNTHESIS/SECRETION IN MOUSE FIBROBLAST LM
  3409. Interaction of Escherichia coli with catecholamine hormones, transferrin and lactoferrin
  3410. THE EFFECTS OF ORAL ADMINISTRATION OF lactoferrin ON SOME NON-SPECIFIC IMMUNE RESPONSES IN RAINBOW TROUT (ONCORHYNCHUS …
  3411. Prophylactic effect of Bovine lactoferrin against acute toxoplasmosis in immunocompetent and immunosuppressed mice
  3412. Dehydroepiandrosterone (DHEA) and lactoferrin: Potential new biomarkers for acute exercise stress
  3413. Human lactoferrin attracts monocytes and activates monocyte‐derived Dendritic Cells to become mature antigen‐presenting cells
  3414. The role of microRNA in the regulation of post-transcriptional expression of lactoferrin receptor (LfR) and its implication for regional development of the small …
  3415. Postprandial lipemia and lactoferrin: the Lipolysis Stimulated Receptor as a potential target
  3416. TWO NEW SCREEN-PRINTED IMMUNOSENSORS FOR HIgG AND lactoferrin DETERMINATION: COMPARISON BY TWO CORRESPONDING CLASSICAL …
  3417. lactoferrin interferes with the Akt-GSK3b-cyclin D1 growth signaling of human prostate cancer cells
  3418. Determination of the concentration of C-reactive protein, oligopeptides and lactoferrin of blood as a method of early diagnosis of mesenchymal sepsis
  3419. Effect of lipopolysaccharides on plasminogen activator activity and lactoferrin mRNA expression in a bovine mammary epithelial cell line
  3420. Effect of bovine lactoferrin on T lymphocyte cell phenotype and function and the response to vaccination in the neonatal piglet
  3421. Purification of Recombinant Human lactoferrin Expressed in A Cattle Mammary Bioreactor
  3422. Porcine lactoferrin as feedstuff additive elevates avian immunity and potentiates vaccination
  3423. lactoferrin modulates lipopolysaccharide‐induced perturbations in gene expression in human fetal intestinal epithelial cells
  3424. Human lactoferrin down‐regulates expression of adhesion molecules via inhibition of MAP kinases and NF‐κB pathways
  3425. lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model
  3426. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial
  3427. Effects of lactoferrin on altered brain metabolism in pup rats after prenatal exposure to Dexamethasone
  3428. Artificial extracellular matrices of collagen fibrils and lactoferrin as coatings to enhance osteoblast behavior
  3429. Spray dried combinations of lactoferrin with antibiotics appear superior to monotherapy for reducing biofilm formation by pseudomonas aeruginosa
  3430. Fertilizing ability of sperm and alien DNA transmission to progeny from human lactoferrin gene of primary goat producers
  3431. Bovine lactoferrin promoter polymorphisms associate with reproductive performance and somatic cell count in Holstein-Friesian cattle in Ireland
  3432. DIETARY BOVINE lactoferrin ENHANCES DISEASE RESISTANCE AGAINST Aeromonas hydrophila CHALLENGE IN RAINBOW TROUT Oncorhynchus mykiss
  3433. Apo‐lactoferrin stimulates proliferation of mouse crypt cells by activating the MAPK signaling pathway
  3434. Synthesis, preparation and characterization of novel nanostructures of deferasirox-lactoferrin conjugates for metal chelation therapy in neurodegenerative …
  3435. SD Apo lactoferrin-Tobramycin/Gentamicin Combinations are superior to monotherapy in the eradication of Pseudomonas aeruginosa Biofilm in the lungs
  3436. Integrin-linked kinase is involved in lactoferrin-induced anchorage-independent cell growth and survival in PC12 cells
  3437. PWE-225 Efficacy of faecal lactoferrin in IBS and IBD: a comparative study
  3438. Bovine lactoferrin Promotes Alkali-Induced Wound Healing in Corneal Epithelial Cells by Up-Regulating IL-6 and PDGF
  3439. The Interactions of Macrophages and Apoptotic Cells During the Resolution of Inflammationeffect on the Generation of Lipid Mediators and lactoferrin …
  3440. Evaluation of selected probiotics and bovine lactoferrin as feed supplements for rainbow trout (Oncorhynchus mykiss Walbaum) for applications in aquaculture
  3441. Growth Inhibition Of Pathogenic Bacteria By lactoferrin Pepsin Hydrolysate Fractions From Milk Of Carabao (Bubalus bubalis L.)
  3442. lactoferrin gene expression upregulation in liver during turpentine oil-or bacterial LPS-induced acute phase reaction
  3443. Effect of lactoferrin, probiotics and SM3 (milk extract enriched in sphingolipides) on immune function in mice
  3444. Dietary bovine lactoferrin does not alter intestinal lymphocyte apoptosis but decreases TNF‐α production during exercise induced intestinal inflammation
  3445. Preparation and amplification of colony of goat transgenic fetal fibroblast and mammary gland epithelial cell with human lactoferrin gene
  3446. Effect of bovine lactoferrin on the minimum inhibitory concentrations of ampicillin and trimethoprim-sulfamethoxazole for clinical Shigella spp. strains.
  3447. Synthesis and Evaluation of Oleanolic Acid-Conjugated lactoferrin for β-Amyloid Plaque Imaging [Author’s correction]
  3448. Immunoglobulin A, G, M, lactoferrin and somatic cell count dynamics in cow milk in relation with cow seasonal keeping and pathogens presence in mammary gland …
  3449. Oral administration of bovine lactoferrin upregulates neutrophil functions in a dog with familial β2-integrin-related neutrophil dysfunction
  3450. Effect of Retinoid Analogs, Bovine lactoferrin, and Retinoid Receptor Expression in Bovine Mammary Cells
  3451. Exploring Metallic Flavor Perception: Analysis of Human Salivary Proteins and the Use of the Iron-Binding Protein lactoferrin in Reducing Metallic Off-Flavors
  3452. Effect of bovine lactoferrin on T cell and NK cell populations and NK cell cytotoxicity in neonatal piglets
  3453. Lack of effect of feeding lactoferrin on intestinal populations and fecal shedding of Salmonella typhimurium in experimentally-infected weaned pigs
  3454. Effects of Dietary Bovine lactoferrin on Intestinal Lymphocytes of Mice After Dextran Sulfate Sodium or Acute Exercise Challenge
  3455. Production of transgenic dairy goats harboring human lactoferrin by nuclear transfer from cultured adult somatic cells
  3456. Laboratory animal science: PEGylated lactoferrin enhances its hepatoprotective effects on acute liver injury induced by D-galactosamine and lipopolysaccharide in …
  3457. Oral lactoferrin Prophylaxis to Prevent Sepsis and Necrotising Enterocolitis of Very Low Birth Weight Neonates in Neonatal Intensive Care Unit and Effect on T …
  3458. Involvement of Both the N-Glycan-relevant and N-Glycan-irrelevant Structural Elements in the Recognition of Human Milk lactoferrin by the 1CF11 Monoclonal …
  3459. Non-Reducing Terminal Fucose within N-Linked Glycan Plays a Significant Role in the Recognition of Human Milk lactoferrin by the 1CF11 Monoclonal Antibody
  3460. Scientific Opinion on the substantiation of a health claim related to ProteQuine® and bovine lactoferrin and increasing suppressed concentrations of secretory IgA and …
  3461. INVITED SPEAKERS: I-11: COPRO-ANTIAPOPTOTIC PROTEIN SURVIVIN AND lactoferrin BIOMARKERS FOR IMPROVED DETECTION AND …
  3462. MP-09.06: Molecular Cloning and Characterization of lactoferrin Receptor (LfR) on Human Spermatozoa
  3463. 583 lactoferrin Supplementation Protects Brain Development in Rat Pups Exposed to Prenatal Dexamethasone
  3464. 338 Nutrient for Neuroprotection: MRI Assessment of lactoferrin Supplementation after HI Injury in the P3 Rat Brain
  3465. It has been reported that lactoferrin (LF) participates in the host immune response against Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) invasion by …
  3466. 185 lactoferrin as a Therapeutic to Decrease Immune-Mediated Tissue Damage in Infectious Diseases
  3467. by Christian Santi/15 Mar/In Articles, lactoferrin
  3468. Modulation of Gene Expression of Iron Regulatory Proteins, Hemeoxygenase-1 and lactoferrin, in Mice Liver and Muscle by Different Cytokines, In Two …
  3469. Co-expression of Human Proteins (IL-10, TPO and/or lactoferrin) into Milk of Cross-Breed Transgenic Mouse
  3470. Porcine antimicrobial peptide PR-39 is modulated by lactoferrin in marrow cells.
  3471. lactoferrin for prevention of common viral infections
  3472. Immunomodulatory effects of lactoferrin
  3473. Overview of lactoferrin as a natural immune modulator
  3474. Physico-chemical properties of different forms of bovine lactoferrin
  3475. lactoferrin: Antimicrobial activity and therapeutic potential
  3476. Clinical benefits of lactoferrin for infants and children
  3477. Nanoencapsulation of bovine lactoferrin for food and biopharmaceutical applications
  3478. lactoferrin from milk: Nutraceutical and pharmacological properties
  3479. Anticancer effects of lactoferrin: Underlying mechanisms and future trends in cancer therapy
  3480. lactoferrin, a pleiotropic protein in health and disease
  3481. Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions
  3482. Mini-review: lactoferrin: a bioinspired, anti-biofilm therapeutic
  3483. Antimicrobial activity of lactoferrin-related peptides and applications in human and veterinary medicine
  3484. The role of lactoferrin in gastrointestinal and immune development and function: a preclinical perspective
  3485. Potential lactoferrin activity against pathogenic viruses
  3486. Longitudinal changes in lactoferrin concentrations in human milk: a global systematic review
  3487. Technological options for the production of lactoferrin
  3488. lactoferrin and bifidobacteria
  3489. Analysis of the thermally induced structural changes of bovine lactoferrin
  3490. lactoferrin suppresses neutrophil extracellular traps release in inflammation
  3491. Structural heterogeneity and multifunctionality of lactoferrin
  3492. Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children
  3493. Antimicrobial lactoferrin peptides: the hidden players in the protective function of a multifunctional protein
  3494. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants
  3495. A high-throughput method for the quantification of iron saturation in lactoferrin preparations
  3496. Silver-lactoferrin nanocomplexes as a potent antimicrobial agent
  3497. Stability of lactoferrin in stored human milk
  3498. C-lobe of lactoferrin: the whole story of the half-molecule
  3499. Identification of lactoferrin peptides generated by digestion with human gastrointestinal enzymes
  3500. Oral delivery of lactoferrin: a review
  3501. Bacterial cellulose-lactoferrin as an antimicrobial edible packaging
  3502. In vitro and in vivo effect of human lactoferrin on glioblastoma growth
  3503. Comparison of anticancer activity between lactoferrin nanoliposome and lactoferrin in Caco-2 cells in vitro
  3504. Emulsions stabilization by lactoferrin nano-particles under in vitro digestion conditions
  3505. Correlation between lactoferrin and beneficial microbiota in breast milk and infant’s feces
  3506. C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review …
  3507. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial
  3508. Bovine lactoferrin binds oleic acid to form an anti-tumor complex similar to HAMLET
  3509. Plant‐based biopharming of recombinant human lactoferrin
  3510. lactoferrin and necrotizing enterocolitis
  3511. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in …
  3512. Randomized controlled trial of lactoferrin for prevention of sepsis in Peruvian neonates< 2500 grams
  3513. lactoferrin-iCre: A New Mouse Line to Study Uterine Epithelial Gene Function
  3514. Impact of dietary fibers on the properties and proteolytic digestibility of lactoferrin nano-particles
  3515. Effects of bovine lactoferrin on the immature porcine intestine
  3516. Relationship of salivary lactoferrin and lysozyme concentrations with early childhood caries
  3517. In vitro evaluation of bovine lactoferrin potential as an anticancer agent
  3518. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery
  3519. The Antimicrobial effect of lactoferrin on Gram-negative and Gram-positive bacteria
  3520. Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study
  3521. Studies on lactoferrin nanoparticles of gambogic acid for oral delivery
  3522. Novel recombinant human lactoferrin: differential activation of oxidative stress related gene expression
  3523. lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting
  3524. lactoferrin: a roadmap to the borderland between caries and periodontal disease
  3525. Camel milk lactoferrin reduces the proliferation of colorectal cancer cells and exerts antioxidant and DNA damage inhibitory activities
  3526. Dietary bovine lactoferrin increases intestinal cell proliferation in neonatal piglets
  3527. lactoferrin for prevention of neonatal sepsis
  3528. Bovine lactoferrin inhibits lung cancer growth through suppression of both inflammation and expression of vascular endothelial growth factor
  3529. Characterization of goat milk lactoferrin N‐glycans and comparison with the N‐glycomes of human and bovine milk
  3530. lactoferrin deficiency promotes colitis-associated colorectal dysplasia in mice
  3531. Structural characterization and functional evaluation of lactoferrin–polyphenol conjugates formed by free-radical graft copolymerization
  3532. lactoferrin differently modulates the inflammatory response in epithelial models mimicking human inflammatory and infectious diseases
  3533. Iron metabolism in infants: influence of bovine lactoferrin from iron-fortified formula
  3534. Enhanced gene expression in the brain following intravenous administration of lactoferrin-bearing polypropylenimine dendriplex
  3535. Complex coacervates obtained from lactoferrin and gum arabic: Formation and characterization
  3536. Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy
  3537. Impact of the Maillard reaction on the antioxidant capacity of bovine lactoferrin
  3538. Responsiveness of emulsions stabilized by lactoferrin nano-particles to simulated intestinal conditions
  3539. Preparation and antimicrobial action of three tryptic digested functional molecules of bovine lactoferrin
  3540. Isolation of a bifidogenic peptide from the pepsin hydrolysate of bovine lactoferrin
  3541. Development and characterization of lactoferrin-GMP nanohydrogels: Evaluation of pH, ionic strength and temperature effect
  3542. Inhibition of Mayaro virus infection by bovine lactoferrin
  3543. Production of human lactoferrin and lysozyme in the milk of transgenic dairy animals: past, present, and future
  3544. Antimicrobial potential for the combination of bovine lactoferrin or its hydrolysate with lactoferrin-resistant probiotics against foodborne pathogens
  3545. Conjugation of polyphenols prevents lactoferrin from thermal aggregation at neutral pH
  3546. Physicochemical properties of whey protein, lactoferrin and Tween 20 stabilised nanoemulsions: Effect of temperature, pH and salt
  3547. Effects of lactoferrin on intestinal epithelial cell growth and differentiation: an in vivo and in vitro study
  3548. Illness in breastfeeding infants relates to concentration of lactoferrin and secretory Immunoglobulin A in mother’s milk
  3549. Structure and functions of lactoferrin as ingredient in infant formulas
  3550. Antioxidant effects of bovine lactoferrin on dexamethasone-induced hypertension in rat
  3551. Protective effect of human lactoferrin in the gastrointestinal tract
  3552. lactoferrin conjugated iron oxide nanoparticles for targeting brain glioma cells in magnetic particle imaging
  3553. Distance-based tear lactoferrin assay on microfluidic paper device using interfacial interactions on surface-modified cellulose
  3554. lactoferrin-based nanoparticles as a vehicle for iron in food applications–Development and release profile
  3555. In-vitro digestion of different forms of bovine lactoferrin encapsulated in alginate micro-gel particles
  3556. lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration
  3557. Immunomodulatory lactoferrin in the regulation of apoptosis modulatory proteins in cancer
  3558. Heteroprotein complex coacervation: Bovine β-lactoglobulin and lactoferrin
  3559. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells
  3560. An antibody-free microfluidic paper-based analytical device for the determination of tear fluid lactoferrin by fluorescence sensitization of Tb 3+
  3561. In Vitro and in Vivo Evaluation of lactoferrin-Conjugated Liposomes as a Novel Carrier to Improve the Brain Delivery
  3562. High-Level Expression of Recombinant Bovine lactoferrin in Pichia pastoris with Antimicrobial Activity
  3563. lactoferrin during lactation protects the immature hypoxic‐ischemic rat brain
  3564. Bone regeneration is promoted by orally administered bovine lactoferrin in a rabbit tibial distraction osteogenesis model
  3565. Studies on anticancer activities of lactoferrin and lactoferricin
  3566. lactoferrin and the newborn: current perspectives
  3567. Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer
  3568. lactoferrin and necrotizing enterocolitis
  3569. Tumor regression following intravenous administration of lactoferrin-and lactoferricin-bearing dendriplexes
  3570. Kinetic parameters for high-pressure-induced denaturation of lactoferrin in human milk
  3571. Study on the therapeutic benefit on lactoferrin in patients with colorectal cancer receiving chemotherapy
  3572. Calprotectin or lactoferrin: do they help
  3573. Comparison of lactoferrin activity in fresh and stored human milk
  3574. Protective effects of human lactoferrin during Aggregatibacter actinomycetemcomitans-induced bacteremia in lactoferrin-deficient mice
  3575. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment
  3576. lactoferrin-modified poly (ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas
  3577. lactoferrin concentration in buffalo milk
  3578. The iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration by preserving mitochondrial calcium homeostasis
  3579. The effect of oral administration of iron saturated-bovine lactoferrin encapsulated chitosan-nanocarriers on osteoarthritis
  3580. Bactericidal effect of bovine lactoferrin and synthetic peptide lactoferrin chimera in Streptococcus pneumoniae and the decrease in luxS gene expression by lactoferrin
  3581. Dietary prebiotics, milk fat globule membrane, and lactoferrin affects structural neurodevelopment in the young piglet
  3582. Screening the anti infectivity potentials of native N-and C-lobes derived from the camel lactoferrin against hepatitis C virus
  3583. Bacterial receptors for host transferrin and lactoferrin: molecular mechanisms and role in host–microbe interactions
  3584. Effect of bovine lactoferrin from iron-fortified formulas on diarrhea and respiratory tract infections of weaned infants in a randomized controlled trial
  3585. Antimicrobial activity and synergism of lactoferrin and lysozyme against cariogenic microorganisms
  3586. Nano-encapsulation of isolated lactoferrin from camel milk by calcium alginate and evaluation of its release
  3587. Influence of polysaccharides on the physicochemical properties of lactoferrin–polyphenol conjugates coated β-carotene emulsions
  3588. Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn’s disease after ileocolonic …
  3589. Renoprotective effect of lactoferrin against chromium-induced acute kidney injury in rats: involvement of IL-18 and IGF-1 inhibition
  3590. Encapsulation and controlled release of bioactive compounds in lactoferrin-glycomacropeptide nanohydrogels: Curcumin and caffeine as model compounds
  3591. Efficacy of bovine lactoferrin supplementation in preventing late-onset sepsis in low birth weight neonates: a randomized placebo-controlled clinical trial
  3592. Interactions between different forms of bovine lactoferrin and sodium alginate affect the properties of their mixtures
  3593. Neuroprotective effect of curcumin-loaded lactoferrin nano particles against rotenone induced neurotoxicity
  3594. Growth and tolerance of formula with lactoferrin in infants through one year of age: double-blind, randomized, controlled trial
  3595. Antihypertensive mechanism of lactoferrin-derived peptides: angiotensin receptor blocking effect
  3596. Spontaneous co-assembly of lactoferrin and β-lactoglobulin as a promising biocarrier for vitamin B9
  3597. Sensitivity of emulsions stabilised by bovine β-casein and lactoferrin to heat and CaCl2
  3598. lactoferrin versus ferrous sulphate for the treatment of iron deficiency anemia during pregnancy: a randomized clinical trial
  3599. lactoferrin levels in human milk after preterm and term delivery
  3600. Human milk secretory immunoglobulin a and lactoferrin N-glycans are altered in women with gestational diabetes mellitus
  3601. Pepsin-digested bovine lactoferrin prevents Mozzarella cheese blue discoloration caused by Pseudomonas fluorescens
  3602. lactoferrin, myeloperoxidase, and ceruloplasmin: complementary gearwheels cranking physiological and pathological processes
  3603. lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma
  3604. Characterization of novel lactoferrin loaded capsules prepared with polyelectrolyte complexes
  3605. Improved safety, bioavailability and pharmacokinetics of zidovudine through lactoferrin nanoparticles during oral administration in rats
  3606. Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation
  3607. Protective effects of maternal nutritional supplementation with lactoferrin on growth and brain metabolism
  3608. PFR peptide, one of the antimicrobial peptides identified from the derivatives of lactoferrin, induces necrosis in leukemia cells
  3609. Phase separation and composition of coacervates of lactoferrin and caseins
  3610. Evaluation of different methods for determination of the iron saturation level in bovine lactoferrin
  3611. The impact of the Maillard reaction on the in vitro proteolytic breakdown of bovine lactoferrin in adults and infants
  3612. Antihypertensive effects of lactoferrin hydrolyzates: Inhibition of angiotensin-and endothelin-converting enzymes
  3613. Dietary bovine lactoferrin alters mucosal and systemic immune cell responses in neonatal piglets
  3614. The protective effects of lactoferrin against murine norovirus infection through inhibition of both viral attachment and replication
  3615. Stability during in vitro digestion of lactoferrin-loaded liposomes prepared from milk fat globule membrane-derived phospholipids
  3616. Fecal lactoferrin in discriminating inflammatory bowel disease from irritable bowel syndrome: a diagnostic meta-analysis
  3617. Improved separation of bovine serum albumin and lactoferrin mixtures using charged ultrafiltration membranes
  3618. Effect of lactoferrin protein on red blood cells and macrophages: mechanism of parasite–host interaction
  3619. Composition and isolation of lactoferrin from colostrum and milk of various goat breeds
  3620. The clinical efficacy of a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) for the common cold: A double blind randomized study
  3621. Assessment of lactoferrin-conjugated solid lipid nanoparticles for efficient targeting to the lung
  3622. Bovine lactoferrin induces cell cycle arrest and inhibits mTOR signaling in breast cancer cells
  3623. lactoferrin-loaded contact lenses: eye protection against oxidative stress
  3624. Effects of high pressure processing on the structural and functional properties of bovine lactoferrin
  3625. lactoferrin promotes early neurodevelopment and cognition in postnatal piglets by upregulating the BDNF signaling pathway and polysialylation
  3626. Cytoprotective and antioxidant effects of human lactoferrin against H2O2-induced oxidative stress in human umbilical vein endothelial cells
  3627. Bovine lactoferrin inhibits Toscana virus infection by binding to heparan sulphate
  3628. lactoferrin prevents LPS-induced decrease of the iron exporter ferroportin in human monocytes/macrophages
  3629. Bovine lactoferrin activity against Chikungunya and Zika viruses
  3630. Fecal lactoferrin: reliable biomarker for intestinal inflammation in pediatric IBD
  3631. Identification of milk proteins enhancing the antimicrobial activity of lactoferrin and lactoferricin
  3632. Bovine lactoferrin regulates cell survival, apoptosis and inflammation in intestinal epithelial cells and preterm pig intestine
  3633. Calprotectin and lactoferrin Faecal Levels in Patients with Clostridium difficile Infection (CDI): A Prospective Cohort Study
  3634. Gene targeting by TALEN-induced homologous recombination in goats directs production of β-lactoglobulin-free, high-human lactoferrin milk
  3635. lactoferrin-and antitransferrin-modified liposomes for brain targeting of the NK3 receptor agonist senktide: preparation and in vivo evaluation
  3636. Consecutive monitoring of fecal calprotectin and lactoferrin for the early diagnosis and prediction of pouchitis after restorative proctocolectomy for ulcerative colitis
  3637. Diagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: a meta-analysis
  3638. Diagnostics and prognostics of inflammatory bowel disease with fecal neutrophil-derived biomarkers calprotectin and lactoferrin
  3639. Structural diversity and mode of action on lipid membranes of three lactoferrin candidacidal peptides
  3640. lactoferrin administration into the nostril alleviates murine allergic rhinitis and its mechanisms
  3641. Production of recombinant human lactoferrin from the milk of goat-producers and its physiological effects
  3642. The impact of lactoferrin with different levels of metal saturation on the intestinal epithelial barrier function and mucosal inflammation
  3643. lactoferrin selectively triggers apoptosis in highly metastatic breast cancer cells through inhibition of plasmalemmal V-H+-ATPase
  3644. Prophylactic effect of human lactoferrin against Streptococcus mutans bacteremia in lactoferrin knockout mice
  3645. Structure of bovine β-lactoglobulin–lactoferrin coacervates
  3646. Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection
  3647. Exosomes: tunable nano vehicles for macromolecular delivery of transferrin and lactoferrin to specific intracellular compartment
  3648. Influence of soybean soluble polysaccharides and beet pectin on the physicochemical properties of lactoferrin-coated orange oil emulsion
  3649. Bovine lactoferrin and its functions in animals-A review
  3650. Collagen‐lactoferrin fibrillar coatings enhance osteoblast proliferation and differentiation
  3651. The use of fecal calprotectin and lactoferrin in patients with IBD: review
  3652. The Lacuna Trial: a double-blind randomized controlled pilot trial of lactoferrin supplementation in the very preterm infant
  3653. Unraveling the mechanisms of action of lactoferrin-derived antihypertensive peptides: ACE inhibition and beyond
  3654. Bovine lactoferrin reduces visceral fat and liver triglycerides in ICR mice
  3655. Biological activity of lactoferrin-functionalized biomimetic hydroxyapatite nanocrystals
  3656. lactoferrin stimulates osteoblast differentiation through PKA and p38 pathways independent of lactoferrin‘s receptor LRP1
  3657. Antibacterial activity of bovine milk lactoferrin on the emerging foodborne pathogen Cronobacter sakazakii: Effect of media and heat treatment
  3658. lactoferrin during lactation reduces lipopolysaccharide‐induced brain injury
  3659. lactoferrin and neonatology–role in neonatal sepsis and necrotizing enterocolitis: present, past and future
  3660. Cystatin C and lactoferrin concentrations in biological fluids as possible prognostic factors in eye tumor development
  3661. lactoferrin prevents invasion and inflammatory response following E. coli strain LF82 infection in experimental model of Crohn’s disease
  3662. Molecular determinants of milk lactoferrin as a bioactive compound in early neurodevelopment and cognition
  3663. lactoferrin acts as an adjuvant during influenza vaccination of neonatal mice
  3664. Fecal lactoferrin, a marker of intestinal inflammation in children with inflammatory bowel disease.
  3665. Expression and characterization of recombinant bovine lactoferrin in E. coli
  3666. Effect of iron saturation level of lactoferrin on osteogenic activity in vitro and in vivo
  3667. Bovine lactoferrin suppresses high-fat diet induced obesity and modulates gut microbiota in C57BL/6J mice
  3668. Effects of lactoferrin, a protein present in the female reproductive tract, on parameters of human sperm capacitation and gamete interaction
  3669. The biological properties of lactoferrin
  3670. lactoferrin directly scavenges hydroxyl radicals and undergoes oxidative self-degradation: a possible role in protection against oxidative DNA damage
  3671. Enhanced brain delivery of deferasirox–lactoferrin conjugates for iron chelation therapy in neurodegenerative disorders: in vitro and in vivo studies
  3672. Anti-infective efficacy of the lactoferrin-derived antimicrobial peptide HLR1r
  3673. Selective coacervation between lactoferrin and the two isoforms of β-lactoglobulin
  3674. Antibacterial performance of bovine lactoferrin-fish gelatine electrospun membranes
  3675. Immunomodulatory effects of recombinant lactoferrin during MRSA infection
  3676. Novel Antihypertensive lactoferrin-Derived Peptides Produced by Kluyveromyces marxianus: Gastrointestinal Stability Profile and In Vivo Angiotensin I-Converting …
  3677. Effect of oral lactoferrin on cataract surgery induced dry eye: a randomised controlled trial
  3678. lactoferrin causes IgA and IgG2b isotype switching through betaglycan binding and activation of canonical TGF-β signaling
  3679. Characterization of alginate–lactoferrin beads prepared by extrusion gelation method
  3680. Human lactoferrin triggers a mitochondrial-and caspase-dependent regulated cell death in Saccharomyces cerevisiae
  3681. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin-and folic acid-grafted poly (lactide-co-glycolide) nanoparticles
  3682. Protein composition of different sized casein micelles in milk after the binding of lactoferrin or lysozyme
  3683. lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma
  3684. Influence of bovine lactoferrin on the growth of selected probiotic bacteria under aerobic conditions
  3685. … of environmental stresses on the physicochemical stability of orange oil bilayer emulsions coated by lactoferrin–soybean soluble polysaccharides and lactoferrin …
  3686. The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn’s disease activity
  3687. lactoferrin dampens high-fructose corn syrup-induced hepatic manifestations of the metabolic syndrome in a murine model
  3688. Oral delivery of bovine lactoferrin using pectin‐and chitosan‐modified liposomes and solid lipid particles: improvement of stability of lactoferrin
  3689. Study of the interactions between rosmarinic acid and bovine milk whey protein α-Lactalbumin, β-Lactoglobulin and lactoferrin
  3690. Glycosylation improves the functional characteristics of chlorogenic acid–lactoferrin conjugate
  3691. Oral lactoferrin protects against experimental candidiasis in mice
  3692. Passive immunity in lambs: Serum lactoferrin concentrations as a predictor of IgG concentration and its relation to health status from birth to 12 weeks of life
  3693. lactoferrin enhanced apoptosis and protected against thioacetamide-induced liver fibrosis in rats
  3694. Potent lipolytic activity of lactoferrin in mature adipocytes
  3695. Milk with and without lactoferrin can influence intestinal damage in a pig model of malnutrition
  3696. … of self-assembled polymersomes and their neuroprotection by enhancing a neuroprotective peptide across the blood–brain barrier after modification with lactoferrin
  3697. A lactoferrin-receptor, intelectin 1, affects uptake, sub-cellular localization and release of immunochemically detectable lactoferrin by intestinal epithelial Caco-2 cells
  3698. Determination of bovine lactoferrin in dairy products by ultra-high performance liquid chromatography–tandem mass spectrometry based on tryptic signature peptides …
  3699. lactoferrin suppresses lipopolysaccharide-induced endometritis in mice via down-regulation of the NF-κB pathway
  3700. Randomized control trial of human recombinant lactoferrin: a substudy reveals effects on the fecal microbiome of very low birth weight infants
  3701. A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and …
  3702. Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae killing
  3703. Elevated lactoferrin is associated with moderate to severe Clostridium difficile disease, stool toxin, and 027 infection
  3704. lactoferrin decreases the intestinal inflammation triggered by a soybean meal-based diet in zebrafish
  3705. Safety and efficacy of lactoferrin versus ferrous sulphate in curing iron deficiency and iron deficiency anaemia in hereditary thrombophilia pregnant women: an …
  3706. Expression of bovine lactoferrin N-lobe by the green alga, Chlorella vulgaris
  3707. Physicochemical properties of β-carotene emulsions stabilized by chlorogenic acid–lactoferrin–glucose/polydextrose conjugates
  3708. Effect of bovine apo-lactoferrin on the growth and virulence of Actinobacillus pleuropneumoniae
  3709. Usefulness of ascitic fluid lactoferrin levels in patients with liver cirrhosis
  3710. Dietary supplementation with a combination of lactoferrin, fish oil, and Enterococcus faecium WB2000 for treating dry eye: a rat model and human clinical study
  3711. lactoferrin inhibits IL-1β-induced chondrocyte apoptosis through AKT1-induced CREB1 activation
  3712. Structural insight into the lactoferrin receptors from pathogenic Neisseria
  3713. Complex equilibria, speciation, and heteroprotein coacervation of lactoferrin and β-lactoglobulin
  3714. Significant antibacterial activity and synergistic effects of camel lactoferrin with antibiotics against methicillin-resistant Staphylococcus aureus (MRSA)
  3715. Interfacial structures of whey protein isolate (WPI) and lactoferrin on hydrophobic surfaces in a model system monitored by quartz crystal microbalance with dissipation …
  3716. Human lactoferrin protects against Streptococcus mutans‐induced caries in mice
  3717. lactoferrin and ovotransferrin contribute toward antioxidative effects of Edible Bird’s Nest against hydrogen peroxide-induced oxidative stress in human SH-SY5Y cells
  3718. EndoE from Enterococcus faecalis Hydrolyzes the Glycans of the Biofilm Inhibiting Protein lactoferrin and Mediates Growth
  3719. Recombinant human lactoferrin induces human and mouse dendritic cell maturation via Toll‐like receptors 2 and 4
  3720. Porcine lactoferrin-derived peptide LFP-20 protects intestinal barrier by maintaining tight junction complex and modulating inflammatory response
  3721. Effect of periodontal therapy on lactoferrin levels in gingival crevicular fluid
  3722. The clinical value of faecal calprotectin and lactoferrin measurement in postoperative Crohn’s disease
  3723. Partitioning of bovine lactoferrin in aqueous two-phase system containing poly (ethylene glycol) and sodium citrate
  3724. A pH-sensitive hyaluronic acid prodrug modified with lactoferrin for glioma dual-targeted treatment
  3725. Comparisons between myeloperoxidase, lactoferrin, calprotectin and lipocalin-2, as fecal biomarkers of intestinal inflammation in malnourished children
  3726. Anticancer effect of lactoferrin on gastric cancer cell line AGS
  3727. lactoferrin from Camelus dromedarius inhibits nuclear transcription factor-kappa B activation, cyclooxygenase-2 expression and prostaglandin E2 production …
  3728. Direct capture of lactoferrin from cheese whey on supermacroporous column of polyacrylamide cryogel with copper ions
  3729. Behavioral effects of bovine lactoferrin administration during postnatal development of rats
  3730. Stress-protective effect of human lactoferrin
  3731. Improved RP‐HPLC method for determination of bovine lactoferrin and its proteolytic degradation in simulated gastrointestinal fluids
  3732. Fabrication mechanism and structural characteristics of the ternary aggregates by lactoferrin, pectin, and (−)-epigallocatechin gallate using multispectroscopic …
  3733. Dual‐Targeting lactoferrin‐Conjugated Polymerized Magnetic Polydiacetylene‐Assembled Nanocarriers with Self‐Responsive Fluorescence/Magnetic Resonance …
  3734. Serum albumin forms a lactoferrin-like soluble iron-binding complex in presence of hydrogen carbonate ions
  3735. Reuterin, lactoperoxidase, lactoferrin and high hydrostatic pressure on the inactivation of food-borne pathogens in cooked ham
  3736. Potential biological fate of emulsion-based delivery systems: lipid particles nanolaminated with lactoferrin and β-lactoglobulin coatings
  3737. A protein isolated from human oviductal tissue in vitro secretion, identified as human lactoferrin, interacts with spermatozoa and oocytes and modulates gamete …
  3738. Enteral supplementation of bovine lactoferrin improves gut barrier function in rats after massive bowel resection
  3739. lactoferrin-immobilized surfaces onto functionalized PLA assisted by the gamma-rays and nitrogen plasma to create materials with multifunctional properties
  3740. Effect of hydroxyapatite nanocrystals functionalized with lactoferrin in osteogenic differentiation of mesenchymal stem cells
  3741. Faecal lactoferrin, calprotectin, PMN-elastase, CRP, and white blood cell count as indicators for mucosal healing and clinical course of disease in patients with mild to …
  3742. Antimicrobial functions of lactoferrin promote genetic conflicts in ancient primates and modern humans
  3743. Inhibition of initial bacterial adhesion on titanium surfaces by lactoferrin coating
  3744. Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
  3745. Optimization of lactoferrin and bovine serum albumin separation using ion-exchange membrane chromatography
  3746. Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine
  3747. Structure and domain dynamics of human lactoferrin in solution and the influence of Fe (III)-ion ligand binding
  3748. lactoferrin expression in human and murine ocular tissue
  3749. Inhibitory effect of lactoferrin against gray mould on tomato plants caused by Botrytis cinerea and possible mechanisms of action
  3750. Role of lactoferrin in the carcinogenesis of triple-negative breast cancer
  3751. Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by lactoferrin
  3752. lactoferrin Adsorbed onto Biomimetic Hydroxyapatite Nanocrystals Controlling – In Vivo – the Helicobacter pylori Infection
  3753. lactoferrin induced neuronal differentiation: A boon for brain tumours
  3754. Protection of SK-N-MC cells against β-amyloid peptide-induced degeneration using neuron growth factor-loaded liposomes with surface lactoferrin
  3755. Oral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism
  3756. Study of lactoferrin gene expression in human and mouse adipose tissue, human preadipocytes and mouse 3T3-L1 fibroblasts. Association with adipogenic and …
  3757. lactoferrin moderates LPS-induced hypotensive response and gut injury in rats
  3758. Bovine lactoferrin-derived ACE inhibitory tripeptide LRP also shows antioxidative and anti-inflammatory activities in endothelial cells
  3759. In vivo angiotensin I-converting enzyme inhibition by long-term intake of antihypertensive lactoferrin hydrolysate in spontaneously hypertensive rats
  3760. Bovine lactoferrin and lactoferricin on plasma-deposited coating against spoilage Pseudomonas spp.
  3761. Protective effect of lactoferrin on cisplatin-induced nephrotoxicity in rats
  3762. LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI …
  3763. Targeted chemotherapy of visceral leishmaniasis by lactoferrin-appended amphotericin B-loaded nanoreservoir: in vitro and in vivo studies.
  3764. Single-domain antibody-based ligands for immunoaffinity separation of recombinant human lactoferrin from the goat lactoferrin of transgenic goat milk
  3765. Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients …
  3766. Antifungal Mechanism of Action of lactoferrin: Identification of H+-ATPase (P3A-Type) as a New Apoptotic-Cell Membrane Receptor
  3767. Role of LRP1 and ERK and cAMP signaling pathways in lactoferrin-induced lipolysis in mature rat adipocytes
  3768. The protective effect of lactoferrin on ventral mesencephalon neurons against MPP+ is not connected with its iron binding ability
  3769. Determination of the effects of lactoferrin in a preclinical mouse model of experimental colitis
  3770. Identification of unprecedented anticancer properties of high molecular weight biomacromolecular complex containing bovine lactoferrin (HMW-bLf)
  3771. lactoferrin gene knockdown leads to similar effects to iron chelation in human adipocytes
  3772. Preparation and characterization of biopolymer nanoparticles based on lactoferrin-polysaccharide complexes
  3773. Clearance of Escherichia coli O157: H7 infection in calves by rectal administration of bovine lactoferrin
  3774. lactoferrin is an allosteric enhancer of the proteolytic activity of cathepsin G
  3775. Radioprotection of mice by lactoferrin against irradiation with sublethal X-rays
  3776. Vaginal lactoferrin administration before genetic amniocentesis decreases amniotic interleukin-6 levels
  3777. lactoferrin suppresses the Epstein–Barr virus-induced inflammatory response by interfering with pattern recognition of TLR2 and TLR9
  3778. Levels of the antimicrobial proteins lactoferrin and chromogranin in the saliva of individuals with oral dryness
  3779. lactoferrin protects against prion protein-induced cell death in neuronal cells by preventing mitochondrial dysfunction
  3780. Organism burden, toxin concentration, and lactoferrin concentration do not distinguish between clinically significant and nonsignificant diarrhea in patients with …
  3781. Doxorubicin conjugated to immunomodulatory anticancer lactoferrin displays improved cytotoxicity overcoming prostate cancer chemo resistance and inhibits …
  3782. Modification by SUMOylation controls both the transcriptional activity and the stability of delta-lactoferrin
  3783. Development of novel formulations containing Lysozyme and lactoferrin and evaluation of antibacterial effects on Mutans Streptococci and Lactobacilli
  3784. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model
  3785. Retinoic acid enhances lactoferrin-induced IgA responses by increasing betaglycan expression
  3786. Coupling hydroxyapatite nanocrystals with lactoferrin as a promising strategy to fine regulate bone homeostasis
  3787. Native and thermally modified protein–polyphenol coassemblies: lactoferrin-based nanoparticles and submicrometer particles as protective vehicles for (−) …
  3788. Bovine lactoferrin promotes corneal wound healing and suppresses IL-1 expression in alkali wounded mouse cornea
  3789. Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing …
  3790. Profiling temporal changes in bovine milk lactoferrin glycosylation using lectin microarrays
  3791. lactoferrin expression and secretion in the stallion epididymis
  3792. The negatively charged regions of lactoferrin binding protein B, an adaptation against anti-microbial peptides
  3793. lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
  3794. Ionic liquid-based three phase partitioning (ILTPP) for lactoferrin recovery
  3795. Oral administration of encapsulated bovine lactoferrin protein nanocapsules against intracellular parasite Toxoplasma gondii
  3796. Effects of bovine lactoferrin in surgically created bone defects on bone regeneration around implants
  3797. Recombinant human lactoferrin as a biomaterial for bone tissue engineering: mechanism of antiapoptotic and osteogenic activity
  3798. Consumption of transgenic cows’ milk containing human lactoferrin results in beneficial changes in the gastrointestinal tract and systemic health of young pigs
  3799. Inhibitory effects of human lactoferrin on U14 cervical carcinoma through upregulation of the immune response
  3800. A heterodimer comprised of two bovine lactoferrin antimicrobial peptides exhibits powerful bactericidal activity against Burkholderia pseudomallei
  3801. Human recombinant lactoferrin for sepsis: too good to be true?
  3802. Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens
  3803. Selenium-binding lactoferrin is taken into corneal epithelial cells by a receptor and prevents corneal damage in dry eye model animals
  3804. Use of lactoferrin in the newborn: where do we stand?
  3805. Monitoring lactoferrin iron levels by fluorescence resonance energy transfer: a combined chemical and computational study
  3806. Bovine lactoferrin and its tryptic peptides: Antibacterial activity against different species
  3807. lactoferrin-derived resistance against plant pathogens in transgenic plants
  3808. Effects of induced energy deficiency on lactoferrin concentration in milk and the lactoferrin reaction of primary bovine mammary epithelial cells in vitro
  3809. Effect of indomethacin and lactoferrin on human tenocyte proliferation and collagen formation in vitro
  3810. Recognition of specific and nonspecific DNA by human lactoferrin
  3811. Effect of lactoferrin-impregnated porous poly (lactide-co-glycolide)(PLGA) microspheres on osteogenic differentiation of rabbit adipose-derived stem cells (rADSCs)
  3812. Recombinant human lactoferrin modulates human PBMC derived macrophage responses to BCG and LPS
  3813. The structure of lactoferrin-binding protein B from Neisseria meningitidis suggests roles in iron acquisition and neutralization of host defences
  3814. Milk lactoferrin in heifers: Influence of health status and stage of lactation
  3815. Conjugation magnetic PAEEP-PLLA nanoparticles with lactoferrin as a specific targeting MRI contrast agent for detection of brain glioma in rats
  3816. The importance of lactoferrin in bone regeneration
  3817. lactoferrin Knockout Mice Demonstrates Greater Susceptibility to Aggregatibacter actinomycetemcomitans–Induced Periodontal Disease
  3818. Tear lipocalin, lysozyme and lactoferrin concentrations in postmenopausal women
  3819. One-step purification of lactoferrin from crude sweet whey using cation-exchange expanded bed adsorption
  3820. Bovine lactoferrin free of lipopolysaccharide can induce a proinflammatory response of macrophages
  3821. Modulatory effects of oral bovine lactoferrin on the IgA response at inductor and effector sites of distal small intestine from BALB/c mice
  3822. Physicochemical stability of citral emulsions stabilized by milk proteins (lactoferrin, α-lactalbumin, β-lactoglobulin) and beet pectin
  3823. Inhibition of the aggregation of lactoferrin and (−)-epigallocatechin gallate in the presence of polyphenols, oligosaccharides, and collagen peptide
  3824. Direct binding of Concanvalin A onto iron oxide nanoparticles for fast magne